[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f0GZncn5LLUd_z9rUZiMOoJCJeyxXTysfBxEvVXc6In8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":8,"truncated":9,"activeTrials":10,"phase3Count":11,"totalEnrollment":12,"activePrograms":13,"nonDrugCount":14,"topConditions":15,"upcomingReadouts":38,"phaseBuckets":88,"rows":95},"London Health Sciences Centre",[6,4,7],"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","London Health Sciences Centre Research Institute",738,false,125,66,798511,40,539,[16,19,22,25,28,31,34,36],{"name":17,"count":18},"Prostate Cancer",17,{"name":20,"count":21},"Depression",16,{"name":23,"count":24},"Anxiety",13,{"name":26,"count":27},"Stroke",12,{"name":29,"count":30},"Coronary Artery Disease",11,{"name":32,"count":33},"Knee Osteoarthritis",10,{"name":35,"count":33},"Hemodialysis",{"name":37,"count":33},"Heart Failure",[39,44,49,54,59,64,69,74,78,83],{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT03772899","Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)","2021-09-14","Fecal Microbial Transplantation",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT04163289","Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation","2023-11-28","Fecal Microbiota Transplantation",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT04583254","Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study","2023-12-14","Concurrent Chemotherapy",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT03976245","Advanced Therapeutics in Rheumatoid Arthritis (RA)","2025-03","Etanercept",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT05790356","Fecal Microbial Transplantation for Rheumatoid Arthritis Trial","2025-08-01","Fecal Microbial transplant",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT06546358","Quetiapine Versus Trazadone in Women With Postpartum Depression","2025-09","Trazodone",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT04869436","Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis","2025-09-01","Dupilumab 300 MG\u002F2 ML Subcutaneous Solution [DUPIXENT]",{"nctId":75,"briefTitle":76,"date":72,"intervention":77},"NCT06634108","Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy","Genistein",{"nctId":79,"briefTitle":80,"date":81,"intervention":82},"NCT06262048","Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial","2025-12-30","Tamsulosin Hydrochloride",{"nctId":84,"briefTitle":85,"date":86,"intervention":87},"NCT05383495","Anxiolysis for Laceration Repair in Children","2025-12-31","Dexmedetomidine",[89,90,91,92,93,94],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[96,138,161,179,202,246,276,294,319,346,364,389,407,453,488,514,543,571,595,621,643,665,686,707,727,748,770,788,811,848,874,898,923,951,969,993,1018,1036,1063,1088,1111,1161,1207,1248,1275,1308,1350,1386,1414,1439,1463,1486,1512,1540,1558,1583,1612,1630,1648,1674,1692,1718,1742,1760,1783,1807,1830,1852,1870,1892,1915,1941,1959,1984,2002,2028,2055,2073,2097,2115,2141,2159,2177,2195,2213,2238,2268,2286,2311,2329,2355,2373,2396,2422,2447,2465,2488,2506,2530,2553,2578,2603,2621,2645,2663,2686,2708,2732,2755,2781,2799,2823,2852,2870,2888,2906,2930,2954,2972,2990,3017,3035,3059,3085,3109,3127,3155,3173,3202,3224,3242,3269,3287,3322,3347,3371,3394,3420,3438,3463,3487,3505,3530,3553,3577,3604,3622,3647,3665,3689,3712,3730,3756,3778,3805,3831,3849,3872,3890,3912,3930,3952,3977,4002,4023,4049,4072,4097,4115,4133,4160,4187,4205,4228,4246,4269,4293,4316,4340,4370,4388,4414,4432,4450,4468,4493,4517,4535,4559,4583,4601,4624,4648,4672,4698,4716,4776,4810,4836,4864,4889,4912,4936,4954,4978,5003,5029,5052,5074,5092,5110,5134,5152,5177,5200,5229,5252,5270,5292,5314,5337,5362,5380,5398,5424,5449,5476,5494,5512,5537,5555,5578,5600,5624,5648,5673,5696,5714,5732,5756,5779,5803,5821,5844,5869,5891,5916,5934,5960,5984,6009,6032,6050,6073,6091,6113],{"intervention":97,"totalTrials":98,"cells":99},"Celecoxib",2,{"EARLY_PHASE1":100,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":121,"NA":136},{"trials":101,"activeCount":102},[],0,{"trials":104,"activeCount":102},[],{"trials":106,"activeCount":102},[],{"trials":108,"activeCount":102},[109],{"nctId":110,"briefTitle":111,"status":112,"phases":113,"primaryCompletion":114,"completion":114,"start":115,"enrollment":116,"conditions":117,"interventions":120},"NCT02726659","Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression","TERMINATED",[92],"2019-01-16","2016-05",1,[118,119],"Bipolar Disorder","Postpartum Depression",[97],{"trials":122,"activeCount":116,"soonestReadout":128},[123],{"nctId":124,"briefTitle":125,"status":126,"phases":127,"primaryCompletion":128,"completion":129,"start":130,"enrollment":131,"conditions":132,"interventions":135},"NCT04147013","Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS","ACTIVE_NOT_RECRUITING",[93],"2026-02","2026-07","2020-02-18",44,[133,134],"Chronic Rhinosinusitis with Nasal Polyps","Aspirin-exacerbated Respiratory Disease",[97],{"trials":137,"activeCount":102},[],{"intervention":58,"totalTrials":116,"cells":139},{"EARLY_PHASE1":140,"PHASE1":142,"PHASE2":144,"PHASE3":146,"PHASE4":148,"NA":159},{"trials":141,"activeCount":102},[],{"trials":143,"activeCount":102},[],{"trials":145,"activeCount":102},[],{"trials":147,"activeCount":102},[],{"trials":149,"activeCount":116,"soonestReadout":57},[150],{"nctId":55,"briefTitle":56,"status":151,"phases":152,"primaryCompletion":57,"completion":57,"start":153,"enrollment":154,"conditions":155,"interventions":157},"RECRUITING",[93],"2020-03-01",144,[156],"Rheumatoid Arthritis",[58,158],"tofacitinib",{"trials":160,"activeCount":102},[],{"intervention":158,"totalTrials":116,"cells":162},{"EARLY_PHASE1":163,"PHASE1":165,"PHASE2":167,"PHASE3":169,"PHASE4":171,"NA":177},{"trials":164,"activeCount":102},[],{"trials":166,"activeCount":102},[],{"trials":168,"activeCount":102},[],{"trials":170,"activeCount":102},[],{"trials":172,"activeCount":116,"soonestReadout":57},[173],{"nctId":55,"briefTitle":56,"status":151,"phases":174,"primaryCompletion":57,"completion":57,"start":153,"enrollment":154,"conditions":175,"interventions":176},[93],[156],[58,158],{"trials":178,"activeCount":102},[],{"intervention":73,"totalTrials":116,"cells":180},{"EARLY_PHASE1":181,"PHASE1":183,"PHASE2":185,"PHASE3":187,"PHASE4":189,"NA":200},{"trials":182,"activeCount":102},[],{"trials":184,"activeCount":102},[],{"trials":186,"activeCount":102},[],{"trials":188,"activeCount":102},[],{"trials":190,"activeCount":116,"soonestReadout":72},[191],{"nctId":70,"briefTitle":71,"status":151,"phases":192,"primaryCompletion":72,"completion":193,"start":194,"enrollment":195,"conditions":196,"interventions":199},[93],"2025-12-01","2021-07-19",27,[197,198],"Chronic Rhinosinusitis With Nasal Polyps","Olfactory Disorder",[73],{"trials":201,"activeCount":102},[],{"intervention":203,"totalTrials":98,"cells":204},"epinephrine",{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":211,"PHASE4":242,"NA":244},{"trials":206,"activeCount":102},[],{"trials":208,"activeCount":102},[],{"trials":210,"activeCount":102},[],{"trials":212,"activeCount":116,"soonestReadout":234},[213,230],{"nctId":214,"briefTitle":215,"status":216,"phases":217,"primaryCompletion":218,"start":219,"enrollment":220,"conditions":221,"interventions":225},"NCT02540070","Evaluation of Motor Sparing Knee Block to Infiltration Analgesia for Pain Following Knee Arthroplasty","UNKNOWN",[92],"2017-12","2014-08",135,[222,223,224],"Osteoarthritis","Knee Arthroplasty","Pain Management",[226,203,227,228,87,229],"Ropivacaine","morphine","Ketorolac","saline",{"nctId":231,"briefTitle":232,"status":151,"phases":233,"primaryCompletion":234,"completion":235,"start":236,"enrollment":237,"conditions":238,"interventions":240},"NCT05166343","POHCA Resuscitation: Evaluation of IM Epinephrine",[91,92],"2028-01","2029-01","2024-01-08",284,[239],"Pediatric Out-of-Hospital Cardiac Arrest",[241],"Epinephrine",{"trials":243,"activeCount":102},[],{"trials":245,"activeCount":102},[],{"intervention":247,"totalTrials":116,"cells":248},"calcium gluconate",{"EARLY_PHASE1":249,"PHASE1":251,"PHASE2":253,"PHASE3":255,"PHASE4":272,"NA":274},{"trials":250,"activeCount":102},[],{"trials":252,"activeCount":102},[],{"trials":254,"activeCount":102},[],{"trials":256,"activeCount":116,"soonestReadout":262},[257],{"nctId":258,"briefTitle":259,"status":260,"phases":261,"primaryCompletion":262,"completion":263,"start":264,"enrollment":265,"conditions":266,"interventions":270},"NCT06820645","Calcium Administration in Life-saving Management During Massive Hemorrhage","NOT_YET_RECRUITING",[91,92],"2026-04-30","2026-05","2025-05-01",81,[267,268,269],"Massive Hemorrhage","Trauma","Hypocalcemia",[247,271],"Control: Placebo",{"trials":273,"activeCount":102},[],{"trials":275,"activeCount":102},[],{"intervention":271,"totalTrials":116,"cells":277},{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":290,"NA":292},{"trials":279,"activeCount":102},[],{"trials":281,"activeCount":102},[],{"trials":283,"activeCount":102},[],{"trials":285,"activeCount":116,"soonestReadout":262},[286],{"nctId":258,"briefTitle":259,"status":260,"phases":287,"primaryCompletion":262,"completion":263,"start":264,"enrollment":265,"conditions":288,"interventions":289},[91,92],[267,268,269],[247,271],{"trials":291,"activeCount":102},[],{"trials":293,"activeCount":102},[],{"intervention":295,"totalTrials":116,"cells":296},"Transarterial Chemoembolization",{"EARLY_PHASE1":297,"PHASE1":299,"PHASE2":301,"PHASE3":303,"PHASE4":315,"NA":317},{"trials":298,"activeCount":102},[],{"trials":300,"activeCount":102},[],{"trials":302,"activeCount":102},[],{"trials":304,"activeCount":116,"soonestReadout":309},[305],{"nctId":306,"briefTitle":307,"status":151,"phases":308,"primaryCompletion":309,"completion":309,"start":310,"enrollment":311,"conditions":312,"interventions":314},"NCT03895359","Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma",[92],"2027-06-01","2019-05-27",128,[313],"Hepatocellular Carcinoma",[295],{"trials":316,"activeCount":102},[],{"trials":318,"activeCount":102},[],{"intervention":320,"totalTrials":116,"cells":321},"Heparin",{"EARLY_PHASE1":322,"PHASE1":324,"PHASE2":326,"PHASE3":328,"PHASE4":342,"NA":344},{"trials":323,"activeCount":102},[],{"trials":325,"activeCount":102},[],{"trials":327,"activeCount":102},[],{"trials":329,"activeCount":116,"soonestReadout":334},[330],{"nctId":331,"briefTitle":332,"status":151,"phases":333,"primaryCompletion":334,"completion":335,"start":336,"enrollment":337,"conditions":338,"interventions":340},"NCT04374799","Heparin vs Placebo for Cardiac Catheterization",[92],"2026-08","2026-12","2020-10-05",1623,[339],"Cardiac Disease",[320,341],"Placebos",{"trials":343,"activeCount":102},[],{"trials":345,"activeCount":102},[],{"intervention":341,"totalTrials":116,"cells":347},{"EARLY_PHASE1":348,"PHASE1":350,"PHASE2":352,"PHASE3":354,"PHASE4":360,"NA":362},{"trials":349,"activeCount":102},[],{"trials":351,"activeCount":102},[],{"trials":353,"activeCount":102},[],{"trials":355,"activeCount":116,"soonestReadout":334},[356],{"nctId":331,"briefTitle":332,"status":151,"phases":357,"primaryCompletion":334,"completion":335,"start":336,"enrollment":337,"conditions":358,"interventions":359},[92],[339],[320,341],{"trials":361,"activeCount":102},[],{"trials":363,"activeCount":102},[],{"intervention":365,"totalTrials":116,"cells":366},"Midazolam Nasal Spray",{"EARLY_PHASE1":367,"PHASE1":369,"PHASE2":371,"PHASE3":373,"PHASE4":385,"NA":387},{"trials":368,"activeCount":102},[],{"trials":370,"activeCount":102},[],{"trials":372,"activeCount":102},[],{"trials":374,"activeCount":116,"soonestReadout":86},[375],{"nctId":84,"briefTitle":85,"status":151,"phases":376,"primaryCompletion":86,"completion":377,"start":378,"enrollment":379,"conditions":380,"interventions":383},[92],"2026-12-31","2023-12-19",300,[381,382],"Laceration of Skin","Distress, Emotional",[87,365,384],"Nitrous oxide",{"trials":386,"activeCount":102},[],{"trials":388,"activeCount":102},[],{"intervention":384,"totalTrials":116,"cells":390},{"EARLY_PHASE1":391,"PHASE1":393,"PHASE2":395,"PHASE3":397,"PHASE4":403,"NA":405},{"trials":392,"activeCount":102},[],{"trials":394,"activeCount":102},[],{"trials":396,"activeCount":102},[],{"trials":398,"activeCount":116,"soonestReadout":86},[399],{"nctId":84,"briefTitle":85,"status":151,"phases":400,"primaryCompletion":86,"completion":377,"start":378,"enrollment":379,"conditions":401,"interventions":402},[92],[381,382],[87,365,384],{"trials":404,"activeCount":102},[],{"trials":406,"activeCount":102},[],{"intervention":87,"totalTrials":408,"cells":409},4,{"EARLY_PHASE1":410,"PHASE1":412,"PHASE2":414,"PHASE3":427,"PHASE4":437,"NA":439},{"trials":411,"activeCount":102},[],{"trials":413,"activeCount":102},[],{"trials":415,"activeCount":102},[416],{"nctId":417,"briefTitle":418,"status":419,"phases":420,"primaryCompletion":421,"completion":421,"start":422,"enrollment":423,"conditions":424,"interventions":426},"NCT03957304","Intranasal Dexmedetomidine Dose-finding Study","COMPLETED",[91],"2022-03-30","2020-02-20",55,[425],"Laceration Repair",[87],{"trials":428,"activeCount":116,"soonestReadout":86},[429,433],{"nctId":214,"briefTitle":215,"status":216,"phases":430,"primaryCompletion":218,"start":219,"enrollment":220,"conditions":431,"interventions":432},[92],[222,223,224],[226,203,227,228,87,229],{"nctId":84,"briefTitle":85,"status":151,"phases":434,"primaryCompletion":86,"completion":377,"start":378,"enrollment":379,"conditions":435,"interventions":436},[92],[381,382],[87,365,384],{"trials":438,"activeCount":102},[],{"trials":440,"activeCount":102},[441],{"nctId":442,"briefTitle":443,"status":419,"phases":444,"primaryCompletion":445,"completion":446,"start":447,"enrollment":448,"conditions":449,"interventions":451},"NCT01981369","Effect of Intravenous Dexmedetomidine on Analgesic Duration of Infraclavicular Block",[94],"2016-07","2016-12","2014-01",100,[450],"Postoperative Pain",[87,452],"Propofol",{"intervention":454,"totalTrials":98,"cells":455},"Brentuximab Vedotin",{"EARLY_PHASE1":456,"PHASE1":458,"PHASE2":460,"PHASE3":482,"PHASE4":484,"NA":486},{"trials":457,"activeCount":102},[],{"trials":459,"activeCount":102},[],{"trials":461,"activeCount":116,"soonestReadout":476},[462,472],{"nctId":463,"briefTitle":464,"status":419,"phases":465,"primaryCompletion":466,"completion":467,"start":468,"enrollment":30,"conditions":469,"interventions":471},"NCT03198689","Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis",[91],"2023-06-07","2023-08-28","2019-05-07",[470],"Diffuse Cutaneous Systemic Sclerosis",[454],{"nctId":473,"briefTitle":474,"status":151,"phases":475,"primaryCompletion":476,"completion":477,"start":478,"enrollment":30,"conditions":479,"interventions":480},"NCT05149768","Open Label Extension Study of Brentuximab Vedotin in Early dcSSc",[91],"2026-02-14","2026-07-01","2024-02-14",[470],[481],"Brentuximab vedotin",{"trials":483,"activeCount":102},[],{"trials":485,"activeCount":102},[],{"trials":487,"activeCount":102},[],{"intervention":489,"totalTrials":116,"cells":490},"Ambroxol Hydrochloride",{"EARLY_PHASE1":491,"PHASE1":493,"PHASE2":495,"PHASE3":508,"PHASE4":510,"NA":512},{"trials":492,"activeCount":102},[],{"trials":494,"activeCount":102},[],{"trials":496,"activeCount":116,"soonestReadout":501},[497],{"nctId":498,"briefTitle":499,"status":260,"phases":500,"primaryCompletion":501,"completion":502,"start":503,"enrollment":504,"conditions":505,"interventions":507},"NCT04405596","Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia",[90,91],"2026-01","2027-01","2025-01",15,[506],"Lewy Body Disease",[489],{"trials":509,"activeCount":102},[],{"trials":511,"activeCount":102},[],{"trials":513,"activeCount":102},[],{"intervention":515,"totalTrials":116,"cells":516},"Pembrolizumab",{"EARLY_PHASE1":517,"PHASE1":519,"PHASE2":521,"PHASE3":537,"PHASE4":539,"NA":541},{"trials":518,"activeCount":102},[],{"trials":520,"activeCount":102},[],{"trials":522,"activeCount":116,"soonestReadout":527},[523],{"nctId":524,"briefTitle":525,"status":151,"phases":526,"primaryCompletion":527,"completion":528,"start":529,"enrollment":13,"conditions":530,"interventions":536},"NCT07188246","Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer",[91],"2027-07","2029-02","2026-01-19",[531,532,533,534,535],"Breast Cancer","Breast Cancer Stage II","Breast Cancer Stage III","Breast Cancer Invasive","Breast Cancer Triple Negative",[515],{"trials":538,"activeCount":102},[],{"trials":540,"activeCount":102},[],{"trials":542,"activeCount":102},[],{"intervention":544,"totalTrials":116,"cells":545},"Experimental",{"EARLY_PHASE1":546,"PHASE1":548,"PHASE2":550,"PHASE3":565,"PHASE4":567,"NA":569},{"trials":547,"activeCount":102},[],{"trials":549,"activeCount":102},[],{"trials":551,"activeCount":116,"soonestReadout":556},[552],{"nctId":553,"briefTitle":554,"status":260,"phases":555,"primaryCompletion":556,"completion":557,"start":558,"enrollment":559,"conditions":560,"interventions":564},"NCT07076914","Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy",[91],"2028-01-02","2032-10-02","2025-10-02",58,[561,562,563],"Primary Lung Cancer","Non Small Cell Lung Cancer","Small Cell Lung Cancer",[544],{"trials":566,"activeCount":102},[],{"trials":568,"activeCount":102},[],{"trials":570,"activeCount":102},[],{"intervention":572,"totalTrials":116,"cells":573},"AV-001 or Placebo",{"EARLY_PHASE1":574,"PHASE1":576,"PHASE2":578,"PHASE3":589,"PHASE4":591,"NA":593},{"trials":575,"activeCount":102},[],{"trials":577,"activeCount":102},[],{"trials":579,"activeCount":116,"soonestReadout":584},[580],{"nctId":581,"briefTitle":582,"status":151,"phases":583,"primaryCompletion":584,"completion":584,"start":585,"enrollment":586,"conditions":587,"interventions":588},"NCT07234890","Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury.",[91],"2027-12-31","2025-12-16",60,[35],[572],{"trials":590,"activeCount":102},[],{"trials":592,"activeCount":102},[],{"trials":594,"activeCount":102},[],{"intervention":596,"totalTrials":116,"cells":597},"Interdialytic peritoneal ultrafiltration with 10% dextrose solution",{"EARLY_PHASE1":598,"PHASE1":600,"PHASE2":602,"PHASE3":615,"PHASE4":617,"NA":619},{"trials":599,"activeCount":102},[],{"trials":601,"activeCount":102},[],{"trials":603,"activeCount":116,"soonestReadout":608},[604],{"nctId":605,"briefTitle":606,"status":126,"phases":607,"primaryCompletion":608,"completion":608,"start":609,"enrollment":33,"conditions":610,"interventions":614},"NCT04603014","Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients",[91],"2026-12-30","2021-01-01",[611,35,612,613],"End Stage Renal Disease on Dialysis","Peritoneal Dialysis","Nonosmotic Sodium Storage",[596],{"trials":616,"activeCount":102},[],{"trials":618,"activeCount":102},[],{"trials":620,"activeCount":102},[],{"intervention":622,"totalTrials":116,"cells":623},"UVADEX",{"EARLY_PHASE1":624,"PHASE1":626,"PHASE2":628,"PHASE3":637,"PHASE4":639,"NA":641},{"trials":625,"activeCount":102},[],{"trials":627,"activeCount":102},[],{"trials":629,"activeCount":116,"soonestReadout":129},[630],{"nctId":631,"briefTitle":632,"status":260,"phases":633,"primaryCompletion":129,"completion":527,"start":634,"enrollment":504,"conditions":635,"interventions":636},"NCT04986605","Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis",[91],"2025-07-01",[470],[622],{"trials":638,"activeCount":102},[],{"trials":640,"activeCount":102},[],{"trials":642,"activeCount":102},[],{"intervention":53,"totalTrials":116,"cells":644},{"EARLY_PHASE1":645,"PHASE1":647,"PHASE2":649,"PHASE3":659,"PHASE4":661,"NA":663},{"trials":646,"activeCount":102},[],{"trials":648,"activeCount":102},[],{"trials":650,"activeCount":116,"soonestReadout":52},[651],{"nctId":50,"briefTitle":51,"status":151,"phases":652,"primaryCompletion":52,"completion":653,"start":654,"enrollment":655,"conditions":656,"interventions":658},[91],"2028-12-14","2021-02-04",48,[657],"Cervical Cancer",[53],{"trials":660,"activeCount":102},[],{"trials":662,"activeCount":102},[],{"trials":664,"activeCount":102},[],{"intervention":82,"totalTrials":116,"cells":666},{"EARLY_PHASE1":667,"PHASE1":669,"PHASE2":671,"PHASE3":680,"PHASE4":682,"NA":684},{"trials":668,"activeCount":102},[],{"trials":670,"activeCount":102},[],{"trials":672,"activeCount":116,"soonestReadout":81},[673],{"nctId":79,"briefTitle":80,"status":151,"phases":674,"primaryCompletion":81,"completion":675,"start":676,"enrollment":586,"conditions":677,"interventions":679},[91],"2026-02-01","2024-10-01",[678],"Urinary Retention Postoperative",[82],{"trials":681,"activeCount":102},[],{"trials":683,"activeCount":102},[],{"trials":685,"activeCount":102},[],{"intervention":77,"totalTrials":116,"cells":687},{"EARLY_PHASE1":688,"PHASE1":690,"PHASE2":692,"PHASE3":701,"PHASE4":703,"NA":705},{"trials":689,"activeCount":102},[],{"trials":691,"activeCount":102},[],{"trials":693,"activeCount":116,"soonestReadout":72},[694],{"nctId":75,"briefTitle":76,"status":151,"phases":695,"primaryCompletion":72,"completion":193,"start":696,"enrollment":697,"conditions":698,"interventions":700},[90,91],"2024-09-27",20,[699],"Amyloid Cardiomyopathy",[77],{"trials":702,"activeCount":102},[],{"trials":704,"activeCount":102},[],{"trials":706,"activeCount":102},[],{"intervention":43,"totalTrials":116,"cells":708},{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":719,"PHASE3":721,"PHASE4":723,"NA":725},{"trials":710,"activeCount":102},[],{"trials":712,"activeCount":116,"soonestReadout":42},[713],{"nctId":40,"briefTitle":41,"status":126,"phases":714,"primaryCompletion":42,"completion":334,"start":715,"enrollment":697,"conditions":716,"interventions":718},[90],"2019-03-27",[717],"Melanoma",[43],{"trials":720,"activeCount":102},[],{"trials":722,"activeCount":102},[],{"trials":724,"activeCount":102},[],{"trials":726,"activeCount":102},[],{"intervention":48,"totalTrials":116,"cells":728},{"EARLY_PHASE1":729,"PHASE1":731,"PHASE2":740,"PHASE3":742,"PHASE4":744,"NA":746},{"trials":730,"activeCount":102},[],{"trials":732,"activeCount":116,"soonestReadout":47},[733],{"nctId":45,"briefTitle":46,"status":126,"phases":734,"primaryCompletion":47,"completion":735,"start":736,"enrollment":697,"conditions":737,"interventions":739},[90],"2028-11","2020-01-23",[738],"Renal Cell Carcinoma",[48],{"trials":741,"activeCount":102},[],{"trials":743,"activeCount":102},[],{"trials":745,"activeCount":102},[],{"trials":747,"activeCount":102},[],{"intervention":68,"totalTrials":116,"cells":749},{"EARLY_PHASE1":750,"PHASE1":760,"PHASE2":762,"PHASE3":764,"PHASE4":766,"NA":768},{"trials":751,"activeCount":116,"soonestReadout":67},[752],{"nctId":65,"briefTitle":66,"status":260,"phases":753,"primaryCompletion":67,"completion":754,"start":755,"enrollment":756,"conditions":757,"interventions":758},[89],"2025-12","2024-09",50,[119],[68,759],"Quetiapine",{"trials":761,"activeCount":102},[],{"trials":763,"activeCount":102},[],{"trials":765,"activeCount":102},[],{"trials":767,"activeCount":102},[],{"trials":769,"activeCount":102},[],{"intervention":759,"totalTrials":116,"cells":771},{"EARLY_PHASE1":772,"PHASE1":778,"PHASE2":780,"PHASE3":782,"PHASE4":784,"NA":786},{"trials":773,"activeCount":116,"soonestReadout":67},[774],{"nctId":65,"briefTitle":66,"status":260,"phases":775,"primaryCompletion":67,"completion":754,"start":755,"enrollment":756,"conditions":776,"interventions":777},[89],[119],[68,759],{"trials":779,"activeCount":102},[],{"trials":781,"activeCount":102},[],{"trials":783,"activeCount":102},[],{"trials":785,"activeCount":102},[],{"trials":787,"activeCount":102},[],{"intervention":789,"totalTrials":116,"cells":790},"Levocarnitine",{"EARLY_PHASE1":791,"PHASE1":801,"PHASE2":803,"PHASE3":805,"PHASE4":807,"NA":809},{"trials":792,"activeCount":116,"soonestReadout":377},[793],{"nctId":794,"briefTitle":795,"status":151,"phases":796,"primaryCompletion":377,"completion":377,"start":797,"enrollment":697,"conditions":798,"interventions":800},"NCT07201714","Oral Carnitine in Heart Failure Patients",[89],"2025-11-12",[37,799],"Carnitine Deficiency",[789],{"trials":802,"activeCount":102},[],{"trials":804,"activeCount":102},[],{"trials":806,"activeCount":102},[],{"trials":808,"activeCount":102},[],{"trials":810,"activeCount":102},[],{"intervention":812,"totalTrials":98,"cells":813},"Furosemide",{"EARLY_PHASE1":814,"PHASE1":816,"PHASE2":818,"PHASE3":820,"PHASE4":835,"NA":837},{"trials":815,"activeCount":102},[],{"trials":817,"activeCount":102},[],{"trials":819,"activeCount":102},[],{"trials":821,"activeCount":102},[822],{"nctId":823,"briefTitle":824,"status":825,"phases":826,"primaryCompletion":827,"completion":828,"start":829,"enrollment":102,"conditions":830,"interventions":831},"NCT00372762","Bumetanide Versus Furosemide in Heart Failure","WITHDRAWN",[92],"2013-01","2013-06","2011-01",[37],[812,832,833,834],"Bumetanide","furosemide","bumetanide",{"trials":836,"activeCount":102},[],{"trials":838,"activeCount":116,"soonestReadout":608},[839],{"nctId":840,"briefTitle":841,"status":126,"phases":842,"primaryCompletion":608,"completion":843,"start":844,"enrollment":756,"conditions":845,"interventions":847},"NCT04170855","Kidney Sodium Content in Cardiorenal Patients",[94],"2027-02-28","2020-10-20",[846],"Cardio-Renal Syndrome",[812],{"intervention":849,"totalTrials":116,"cells":850},"Pharmacogenetic testing",{"EARLY_PHASE1":851,"PHASE1":853,"PHASE2":855,"PHASE3":857,"PHASE4":859,"NA":861},{"trials":852,"activeCount":102},[],{"trials":854,"activeCount":102},[],{"trials":856,"activeCount":102},[],{"trials":858,"activeCount":102},[],{"trials":860,"activeCount":102},[],{"trials":862,"activeCount":116,"soonestReadout":262},[863],{"nctId":864,"briefTitle":865,"status":151,"phases":866,"primaryCompletion":262,"completion":262,"start":867,"enrollment":868,"conditions":869,"interventions":873},"NCT05830279","Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer",[],"2023-05-01",600,[870,871,872],"Nausea With Vomiting Chemotherapy-Induced","Depression, Reactive","Cancer Pain",[849],{"intervention":875,"totalTrials":116,"cells":876},"Desmopressin after protamine reversal",{"EARLY_PHASE1":877,"PHASE1":879,"PHASE2":881,"PHASE3":883,"PHASE4":885,"NA":887},{"trials":878,"activeCount":102},[],{"trials":880,"activeCount":102},[],{"trials":882,"activeCount":102},[],{"trials":884,"activeCount":102},[],{"trials":886,"activeCount":102},[],{"trials":888,"activeCount":116,"soonestReadout":893},[889],{"nctId":890,"briefTitle":891,"status":260,"phases":892,"primaryCompletion":893,"completion":584,"start":894,"enrollment":448,"conditions":895,"interventions":897},"NCT07179991","DDAVP Effect by TEG6 in Cardiac Surgery",[],"2027-12-01","2025-10-01",[896],"Intraoperative Bleeding",[875],{"intervention":899,"totalTrials":116,"cells":900},"Pharmacogenetics Testing",{"EARLY_PHASE1":901,"PHASE1":903,"PHASE2":905,"PHASE3":907,"PHASE4":909,"NA":911},{"trials":902,"activeCount":102},[],{"trials":904,"activeCount":102},[],{"trials":906,"activeCount":102},[],{"trials":908,"activeCount":102},[],{"trials":910,"activeCount":102},[],{"trials":912,"activeCount":116,"soonestReadout":917},[913],{"nctId":914,"briefTitle":915,"status":151,"phases":916,"primaryCompletion":917,"completion":917,"start":918,"enrollment":919,"conditions":920,"interventions":922},"NCT06335043","Personalized Pharmacotherapy Using Pharmacogenetics in Veterans",[94],"2027-04-25","2024-04-25",155,[921],"Pharmacogenetic Testing to Determine Pharmacological Treatment in PTSD",[899],{"intervention":924,"totalTrials":116,"cells":925},"Ropivacaine and Lidocaine",{"EARLY_PHASE1":926,"PHASE1":928,"PHASE2":930,"PHASE3":932,"PHASE4":934,"NA":936},{"trials":927,"activeCount":102},[],{"trials":929,"activeCount":102},[],{"trials":931,"activeCount":102},[],{"trials":933,"activeCount":102},[],{"trials":935,"activeCount":102},[],{"trials":937,"activeCount":116,"soonestReadout":942},[938],{"nctId":939,"briefTitle":940,"status":260,"phases":941,"primaryCompletion":942,"completion":943,"start":944,"enrollment":945,"conditions":946,"interventions":949},"NCT06671028","Mixed Local for Sciatic Block",[94],"2027-01-01","2027-07-01","2025-01-01",110,[947,948],"Regional Anesthesia","Local Anesthetic",[924,950],"Ropivacaine 0,5%",{"intervention":950,"totalTrials":116,"cells":952},{"EARLY_PHASE1":953,"PHASE1":955,"PHASE2":957,"PHASE3":959,"PHASE4":961,"NA":963},{"trials":954,"activeCount":102},[],{"trials":956,"activeCount":102},[],{"trials":958,"activeCount":102},[],{"trials":960,"activeCount":102},[],{"trials":962,"activeCount":102},[],{"trials":964,"activeCount":116,"soonestReadout":942},[965],{"nctId":939,"briefTitle":940,"status":260,"phases":966,"primaryCompletion":942,"completion":943,"start":944,"enrollment":945,"conditions":967,"interventions":968},[94],[947,948],[924,950],{"intervention":970,"totalTrials":116,"cells":971},"Cenergermin",{"EARLY_PHASE1":972,"PHASE1":974,"PHASE2":976,"PHASE3":978,"PHASE4":980,"NA":982},{"trials":973,"activeCount":102},[],{"trials":975,"activeCount":102},[],{"trials":977,"activeCount":102},[],{"trials":979,"activeCount":102},[],{"trials":981,"activeCount":102},[],{"trials":983,"activeCount":116,"soonestReadout":988},[984],{"nctId":985,"briefTitle":986,"status":260,"phases":987,"primaryCompletion":988,"completion":989,"start":62,"enrollment":33,"conditions":990,"interventions":992},"NCT07073729","Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study",[94],"2026-08-01","2027-08-01",[991],"Neurotrophic Keratitis",[970],{"intervention":994,"totalTrials":116,"cells":995},"High-Dose Cisplatin",{"EARLY_PHASE1":996,"PHASE1":998,"PHASE2":1000,"PHASE3":1002,"PHASE4":1004,"NA":1006},{"trials":997,"activeCount":102},[],{"trials":999,"activeCount":102},[],{"trials":1001,"activeCount":102},[],{"trials":1003,"activeCount":102},[],{"trials":1005,"activeCount":102},[],{"trials":1007,"activeCount":116,"soonestReadout":1012},[1008],{"nctId":1009,"briefTitle":1010,"status":151,"phases":1011,"primaryCompletion":1012,"completion":1012,"start":1013,"enrollment":448,"conditions":1014,"interventions":1016},"NCT03649048","Low-Dose Weekly vs High-Dose Cisplatin",[94],"2028-09","2018-11-05",[1015],"Locally Advanced Head and Neck Squamous Cell Carcinoma",[994,1017],"Low-Dose Cisplatin",{"intervention":1017,"totalTrials":116,"cells":1019},{"EARLY_PHASE1":1020,"PHASE1":1022,"PHASE2":1024,"PHASE3":1026,"PHASE4":1028,"NA":1030},{"trials":1021,"activeCount":102},[],{"trials":1023,"activeCount":102},[],{"trials":1025,"activeCount":102},[],{"trials":1027,"activeCount":102},[],{"trials":1029,"activeCount":102},[],{"trials":1031,"activeCount":116,"soonestReadout":1012},[1032],{"nctId":1009,"briefTitle":1010,"status":151,"phases":1033,"primaryCompletion":1012,"completion":1012,"start":1013,"enrollment":448,"conditions":1034,"interventions":1035},[94],[1015],[994,1017],{"intervention":1037,"totalTrials":116,"cells":1038},"Whole gene sequencing",{"EARLY_PHASE1":1039,"PHASE1":1041,"PHASE2":1043,"PHASE3":1045,"PHASE4":1047,"NA":1049},{"trials":1040,"activeCount":102},[],{"trials":1042,"activeCount":102},[],{"trials":1044,"activeCount":102},[],{"trials":1046,"activeCount":102},[],{"trials":1048,"activeCount":102},[],{"trials":1050,"activeCount":116,"soonestReadout":1012},[1051],{"nctId":1052,"briefTitle":1053,"status":1054,"phases":1055,"primaryCompletion":1012,"completion":1012,"start":1056,"enrollment":448,"conditions":1057,"interventions":1062},"NCT07100054","Pharmacogenomic and Circulating Biomarkers for CDK4\u002F6 Inhibitors","ENROLLING_BY_INVITATION",[],"2025-10-10",[1058,531,1059,1060,1061],"CDK4\u002F6 Inhibitor","CYP3A4 Protein, Human","Drug Interaction","Pharmacogenetic Testing",[1037],{"intervention":1064,"totalTrials":116,"cells":1065},"Prospective iNO Administration",{"EARLY_PHASE1":1066,"PHASE1":1068,"PHASE2":1070,"PHASE3":1072,"PHASE4":1074,"NA":1076},{"trials":1067,"activeCount":102},[],{"trials":1069,"activeCount":102},[],{"trials":1071,"activeCount":102},[],{"trials":1073,"activeCount":102},[],{"trials":1075,"activeCount":102},[],{"trials":1077,"activeCount":116,"soonestReadout":377},[1078],{"nctId":1079,"briefTitle":1080,"status":260,"phases":1081,"primaryCompletion":377,"completion":942,"start":72,"enrollment":1082,"conditions":1083,"interventions":1087},"NCT07125443","Effect Inhaled Nitric Oxide in Adult Liver Transplant",[94],260,[1084,1085,1086],"Liver Diseases","Reperfusion Injury","Vasoplegia",[1064],{"intervention":63,"totalTrials":116,"cells":1089},{"EARLY_PHASE1":1090,"PHASE1":1092,"PHASE2":1094,"PHASE3":1096,"PHASE4":1098,"NA":1100},{"trials":1091,"activeCount":102},[],{"trials":1093,"activeCount":102},[],{"trials":1095,"activeCount":102},[],{"trials":1097,"activeCount":102},[],{"trials":1099,"activeCount":102},[],{"trials":1101,"activeCount":116,"soonestReadout":62},[1102],{"nctId":60,"briefTitle":61,"status":151,"phases":1103,"primaryCompletion":62,"completion":1104,"start":1105,"enrollment":1106,"conditions":1107,"interventions":1110},[94],"2026-04-01","2023-08-01",30,[1108,1109,48],"Arthritis","Arthritis, Rheumatoid",[63],{"intervention":1112,"totalTrials":1113,"cells":1114},"tramacet",3,{"EARLY_PHASE1":1115,"PHASE1":1117,"PHASE2":1119,"PHASE3":1121,"PHASE4":1136,"NA":1159},{"trials":1116,"activeCount":102},[],{"trials":1118,"activeCount":102},[],{"trials":1120,"activeCount":102},[],{"trials":1122,"activeCount":102},[1123],{"nctId":1124,"briefTitle":1125,"status":419,"phases":1126,"primaryCompletion":1127,"completion":1127,"start":1128,"enrollment":1129,"conditions":1130,"interventions":1133},"NCT00679614","Effect of Combined Use of Naloxone and Tramacet on Postop Analgesia in Elderly Patients Having Joint Replacement Surgery",[92],"2011-05-31","2007-12-17",45,[1131,223,1132],"Hip Arthroplasty","Spinal Anesthesia",[1134,1112,1135],"tramacet, naloxone","Acetaminophen",{"trials":1137,"activeCount":102},[1138,1147],{"nctId":1139,"briefTitle":1140,"status":419,"phases":1141,"primaryCompletion":1142,"completion":1143,"start":1128,"enrollment":33,"conditions":1144,"interventions":1146},"NCT00665262","The Effect of the Combined Use of Naloxone and Tramacet on Postoperative Analgesia in the Elderly",[93],"2010-11-30","2011-08-12",[1145],"Arthroplasty",[1112],{"nctId":1148,"briefTitle":1149,"status":419,"phases":1150,"primaryCompletion":1151,"completion":1151,"start":1152,"enrollment":1153,"conditions":1154,"interventions":1156},"NCT02361567","Comparison of Tramacet Versus Percocet in Post Surgical Patients",[93],"2016-03","2015-04",160,[1155],"Post Operative Pain",[1157,1158],"Tramacet","Percocet",{"trials":1160,"activeCount":102},[],{"intervention":1162,"totalTrials":1113,"cells":1163},"Dalteparin",{"EARLY_PHASE1":1164,"PHASE1":1166,"PHASE2":1168,"PHASE3":1181,"PHASE4":1193,"NA":1205},{"trials":1165,"activeCount":102},[],{"trials":1167,"activeCount":102},[],{"trials":1169,"activeCount":102},[1170],{"nctId":1171,"briefTitle":1172,"status":419,"phases":1173,"primaryCompletion":1174,"completion":1174,"start":1175,"enrollment":1176,"conditions":1177,"interventions":1179},"NCT00216866","The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis",[91],"2006-03","2002-09",70,[1178],"Embolism and Thrombosis",[1162,1180],"Warfarin",{"trials":1182,"activeCount":102},[1183],{"nctId":1184,"briefTitle":1185,"status":216,"phases":1186,"primaryCompletion":1187,"completion":1188,"start":1189,"enrollment":1190,"conditions":1191,"interventions":1192},"NCT00432796","PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.",[92],"2019-03","2020-12","2006-12",1473,[26],[1162],{"trials":1194,"activeCount":102},[1195],{"nctId":1196,"briefTitle":1197,"status":419,"phases":1198,"primaryCompletion":1199,"completion":1200,"start":1201,"enrollment":504,"conditions":1202,"interventions":1204},"NCT02607111","A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients",[93],"2018-07","2018-07-30","2016-08",[1203],"Kidney Failure",[1162],{"trials":1206,"activeCount":102},[],{"intervention":1135,"totalTrials":1113,"cells":1208},{"EARLY_PHASE1":1209,"PHASE1":1211,"PHASE2":1213,"PHASE3":1215,"PHASE4":1221,"NA":1246},{"trials":1210,"activeCount":102},[],{"trials":1212,"activeCount":102},[],{"trials":1214,"activeCount":102},[],{"trials":1216,"activeCount":102},[1217],{"nctId":1124,"briefTitle":1125,"status":419,"phases":1218,"primaryCompletion":1127,"completion":1127,"start":1128,"enrollment":1129,"conditions":1219,"interventions":1220},[92],[1131,223,1132],[1134,1112,1135],{"trials":1222,"activeCount":102},[1223,1234],{"nctId":1224,"briefTitle":1225,"status":216,"phases":1226,"primaryCompletion":1227,"start":1228,"enrollment":1229,"conditions":1230,"interventions":1232},"NCT02294071","Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children",[93],"2015-11","2014-12",120,[1231],"Fever",[1233,1135],"Ibuprofen",{"nctId":1235,"briefTitle":1236,"status":216,"phases":1237,"primaryCompletion":1238,"completion":1239,"start":1240,"enrollment":586,"conditions":1241,"interventions":1243},"NCT03323047","Perioperative Tonsillectomy Protocol Development",[93],"2021-05","2021-09","2018-03-01",[1242],"Tonsillitis",[1135,1244,1245],"Low-dose Dexamethasone","High-Dose Dexamethasone",{"trials":1247,"activeCount":102},[],{"intervention":227,"totalTrials":98,"cells":1249},{"EARLY_PHASE1":1250,"PHASE1":1252,"PHASE2":1254,"PHASE3":1256,"PHASE4":1262,"NA":1273},{"trials":1251,"activeCount":102},[],{"trials":1253,"activeCount":102},[],{"trials":1255,"activeCount":102},[],{"trials":1257,"activeCount":102},[1258],{"nctId":214,"briefTitle":215,"status":216,"phases":1259,"primaryCompletion":218,"start":219,"enrollment":220,"conditions":1260,"interventions":1261},[92],[222,223,224],[226,203,227,228,87,229],{"trials":1263,"activeCount":102},[1264],{"nctId":1265,"briefTitle":1266,"status":825,"phases":1267,"primaryCompletion":827,"completion":827,"start":1268,"enrollment":102,"conditions":1269,"interventions":1271},"NCT01689597","Epidural Morphine for Analgesia After Traumatic Vaginal Delivery",[93],"2012-09",[1270],"Traumatic Vaginal Delivery",[1272],"Morphine",{"trials":1274,"activeCount":102},[],{"intervention":1276,"totalTrials":98,"cells":1277},"Lacosamide",{"EARLY_PHASE1":1278,"PHASE1":1280,"PHASE2":1282,"PHASE3":1293,"PHASE4":1295,"NA":1306},{"trials":1279,"activeCount":102},[],{"trials":1281,"activeCount":102},[],{"trials":1283,"activeCount":102},[1284],{"nctId":1285,"briefTitle":1286,"status":112,"phases":1287,"primaryCompletion":1201,"completion":1201,"start":1288,"enrollment":1289,"conditions":1290,"interventions":1292},"NCT01724918","Lacosamide IV and EEG\u002FEKG (LIVE) Study",[91],"2013-05",72,[1291],"Focal Epilepsy",[1276],{"trials":1294,"activeCount":102},[],{"trials":1296,"activeCount":102},[1297],{"nctId":1298,"briefTitle":1299,"status":112,"phases":1300,"primaryCompletion":1227,"completion":1227,"start":219,"enrollment":1113,"conditions":1301,"interventions":1303},"NCT02409433","Comparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management",[93],[1302],"Seizures",[1304,1305],"lacosamide","Phenytoin",{"trials":1307,"activeCount":102},[],{"intervention":1309,"totalTrials":98,"cells":1310},"Rivaroxaban",{"EARLY_PHASE1":1311,"PHASE1":1313,"PHASE2":1315,"PHASE3":1317,"PHASE4":1336,"NA":1348},{"trials":1312,"activeCount":102},[],{"trials":1314,"activeCount":102},[],{"trials":1316,"activeCount":102},[],{"trials":1318,"activeCount":102},[1319],{"nctId":1320,"briefTitle":1321,"status":216,"phases":1322,"primaryCompletion":1323,"completion":1324,"start":1325,"enrollment":1326,"conditions":1327,"interventions":1334},"NCT03428373","Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma",[91,92],"2023-12-01","2024-09-30","2019-01-17",57,[1328,1329,1330,1331,1332,1333],"Multiple Myeloma in Relapse","Multiple Myeloma Progression","Multiple Myeloma Stage II","Multiple Myeloma Stage I","Multiple Myeloma With Failed Remission","Multiple Myeloma Stage III",[1309,1335],"ASA",{"trials":1337,"activeCount":102},[1338],{"nctId":1339,"briefTitle":1340,"status":419,"phases":1341,"primaryCompletion":115,"completion":1342,"start":1343,"enrollment":1176,"conditions":1344,"interventions":1347},"NCT01708850","Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)",[93],"2016-06","2012-11",[1345,1346],"Neoplasm","Central Venous Catheter Thrombosis",[1309],{"trials":1349,"activeCount":102},[],{"intervention":1351,"totalTrials":98,"cells":1352},"Normal saline",{"EARLY_PHASE1":1353,"PHASE1":1355,"PHASE2":1357,"PHASE3":1359,"PHASE4":1374,"NA":1384},{"trials":1354,"activeCount":102},[],{"trials":1356,"activeCount":102},[],{"trials":1358,"activeCount":102},[],{"trials":1360,"activeCount":102},[1361],{"nctId":1362,"briefTitle":1363,"status":216,"phases":1364,"primaryCompletion":1365,"completion":609,"start":1366,"enrollment":1367,"conditions":1368,"interventions":1372},"NCT03628040","Erector Spinae Plane Block for Video-assisted Thoracoscopic Surgery",[92],"2020-10-01","2019-09-01",82,[1369,1370,1371],"Thoracic Surgery","Peripheral Nerve Block","Analgesia",[1373,1351],"Ropivacaine Injection [Naropin]",{"trials":1375,"activeCount":102},[1376],{"nctId":1377,"briefTitle":1378,"status":419,"phases":1379,"primaryCompletion":219,"completion":1228,"start":1288,"enrollment":756,"conditions":1380,"interventions":1381},"NCT01692769","Trial Of Normal Saline Versus Ringer's Lactate In Paediatric Trauma Patients",[93],[268],[1382,1383],"Normal Saline","Ringer's Lactate",{"trials":1385,"activeCount":102},[],{"intervention":1233,"totalTrials":98,"cells":1387},{"EARLY_PHASE1":1388,"PHASE1":1390,"PHASE2":1392,"PHASE3":1404,"PHASE4":1406,"NA":1412},{"trials":1389,"activeCount":102},[],{"trials":1391,"activeCount":102},[],{"trials":1393,"activeCount":102},[1394],{"nctId":1395,"briefTitle":1396,"status":419,"phases":1397,"primaryCompletion":1398,"completion":1398,"start":1268,"enrollment":1399,"conditions":1400,"interventions":1402},"NCT01686802","Post-operative Oral Morphine Versus Ibuprofen",[91],"2016-09",132,[1401],"Post-operative Pain",[1403,1233],"oral morphine",{"trials":1405,"activeCount":102},[],{"trials":1407,"activeCount":102},[1408],{"nctId":1224,"briefTitle":1225,"status":216,"phases":1409,"primaryCompletion":1227,"start":1228,"enrollment":1229,"conditions":1410,"interventions":1411},[93],[1231],[1233,1135],{"trials":1413,"activeCount":102},[],{"intervention":1415,"totalTrials":116,"cells":1416},"Eylea",{"EARLY_PHASE1":1417,"PHASE1":1419,"PHASE2":1421,"PHASE3":1423,"PHASE4":1425,"NA":1437},{"trials":1418,"activeCount":102},[],{"trials":1420,"activeCount":102},[],{"trials":1422,"activeCount":102},[],{"trials":1424,"activeCount":102},[],{"trials":1426,"activeCount":102},[1427],{"nctId":1428,"briefTitle":1429,"status":419,"phases":1430,"primaryCompletion":1431,"completion":1431,"start":1432,"enrollment":1433,"conditions":1434,"interventions":1436},"NCT02142296","Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)",[93],"2016-11","2014-05",37,[1435],"Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration",[1415],{"trials":1438,"activeCount":102},[],{"intervention":1440,"totalTrials":116,"cells":1441},"corticosteroid nasal irrigation",{"EARLY_PHASE1":1442,"PHASE1":1444,"PHASE2":1446,"PHASE3":1448,"PHASE4":1450,"NA":1461},{"trials":1443,"activeCount":102},[],{"trials":1445,"activeCount":102},[],{"trials":1447,"activeCount":102},[],{"trials":1449,"activeCount":102},[],{"trials":1451,"activeCount":102},[1452],{"nctId":1453,"briefTitle":1454,"status":825,"phases":1455,"primaryCompletion":1456,"completion":1457,"start":1458,"enrollment":102,"conditions":1459,"interventions":1460},"NCT04374474","Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)",[93],"2021-12-10","2022-03-10","2021-01-10",[198],[1440],{"trials":1462,"activeCount":102},[],{"intervention":1464,"totalTrials":116,"cells":1465},"Angelica Sinensis",{"EARLY_PHASE1":1466,"PHASE1":1468,"PHASE2":1470,"PHASE3":1472,"PHASE4":1474,"NA":1484},{"trials":1467,"activeCount":102},[],{"trials":1469,"activeCount":102},[],{"trials":1471,"activeCount":102},[],{"trials":1473,"activeCount":102},[],{"trials":1475,"activeCount":102},[1476],{"nctId":1477,"briefTitle":1478,"status":419,"phases":1479,"primaryCompletion":1480,"completion":1480,"start":1481,"enrollment":131,"conditions":1482,"interventions":1483},"NCT00199485","Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer",[93],"2008-06","2002-10",[17],[1464],{"trials":1485,"activeCount":102},[],{"intervention":1487,"totalTrials":116,"cells":1488},"Gastrografin",{"EARLY_PHASE1":1489,"PHASE1":1491,"PHASE2":1493,"PHASE3":1495,"PHASE4":1497,"NA":1510},{"trials":1490,"activeCount":102},[],{"trials":1492,"activeCount":102},[],{"trials":1494,"activeCount":102},[],{"trials":1496,"activeCount":102},[],{"trials":1498,"activeCount":102},[1499],{"nctId":1500,"briefTitle":1501,"status":825,"phases":1502,"primaryCompletion":1503,"completion":1503,"start":1504,"enrollment":102,"conditions":1505,"interventions":1509},"NCT03334578","The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.",[93],"2020-12-17","2018-08-03",[1506,1507,1508],"Gastroschisis","Bowel Obstruction","Birth Defect",[1487],{"trials":1511,"activeCount":102},[],{"intervention":1513,"totalTrials":116,"cells":1514},"Iron dextran",{"EARLY_PHASE1":1515,"PHASE1":1517,"PHASE2":1519,"PHASE3":1521,"PHASE4":1523,"NA":1538},{"trials":1516,"activeCount":102},[],{"trials":1518,"activeCount":102},[],{"trials":1520,"activeCount":102},[],{"trials":1522,"activeCount":102},[],{"trials":1524,"activeCount":102},[1525],{"nctId":1526,"briefTitle":1527,"status":1528,"phases":1529,"primaryCompletion":1530,"completion":1530,"start":1531,"enrollment":1532,"conditions":1533,"interventions":1536},"NCT00593619","Trial Comparing the Safety of Two Different Intravenous Iron Formulations","SUSPENDED",[93],"2009-12","2008-01",200,[1534,1535],"Iron Deficiency Anemia","Perioperative Blood Conservation",[1513,1537],"Iron sucrose",{"trials":1539,"activeCount":102},[],{"intervention":1537,"totalTrials":116,"cells":1541},{"EARLY_PHASE1":1542,"PHASE1":1544,"PHASE2":1546,"PHASE3":1548,"PHASE4":1550,"NA":1556},{"trials":1543,"activeCount":102},[],{"trials":1545,"activeCount":102},[],{"trials":1547,"activeCount":102},[],{"trials":1549,"activeCount":102},[],{"trials":1551,"activeCount":102},[1552],{"nctId":1526,"briefTitle":1527,"status":1528,"phases":1553,"primaryCompletion":1530,"completion":1530,"start":1531,"enrollment":1532,"conditions":1554,"interventions":1555},[93],[1534,1535],[1513,1537],{"trials":1557,"activeCount":102},[],{"intervention":1559,"totalTrials":116,"cells":1560},"Volatile anesthetic",{"EARLY_PHASE1":1561,"PHASE1":1563,"PHASE2":1565,"PHASE3":1567,"PHASE4":1569,"NA":1581},{"trials":1562,"activeCount":102},[],{"trials":1564,"activeCount":102},[],{"trials":1566,"activeCount":102},[],{"trials":1568,"activeCount":102},[],{"trials":1570,"activeCount":102},[1571],{"nctId":1572,"briefTitle":1573,"status":419,"phases":1574,"primaryCompletion":1575,"completion":1575,"start":1576,"enrollment":1577,"conditions":1578,"interventions":1580},"NCT01477151","Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery",[93],"2015-03","2011-11",464,[29,1579],"Valvular Heart Disease",[1559],{"trials":1582,"activeCount":102},[],{"intervention":1584,"totalTrials":116,"cells":1585},"Hydrocodone 5Mg\u002FAcetaminophen 500Mg Tab",{"EARLY_PHASE1":1586,"PHASE1":1588,"PHASE2":1590,"PHASE3":1592,"PHASE4":1594,"NA":1610},{"trials":1587,"activeCount":102},[],{"trials":1589,"activeCount":102},[],{"trials":1591,"activeCount":102},[],{"trials":1593,"activeCount":102},[],{"trials":1595,"activeCount":102},[1596],{"nctId":1597,"briefTitle":1598,"status":216,"phases":1599,"primaryCompletion":1600,"completion":1601,"start":1602,"enrollment":1603,"conditions":1604,"interventions":1607},"NCT03375593","Narcotic Versus Non-narcotic Medication for Pain Management After Wrist\u002FHand Fractures",[93],"2021-10-01","2022-10-01","2019-08-01",250,[1605,224,1606],"Distal Radius Fracture","Metacarpal Fracture",[1584,1608,1609],"Acetaminophen 500Mg Tab","Ibuprofen 600 mg tab",{"trials":1611,"activeCount":102},[],{"intervention":1608,"totalTrials":116,"cells":1613},{"EARLY_PHASE1":1614,"PHASE1":1616,"PHASE2":1618,"PHASE3":1620,"PHASE4":1622,"NA":1628},{"trials":1615,"activeCount":102},[],{"trials":1617,"activeCount":102},[],{"trials":1619,"activeCount":102},[],{"trials":1621,"activeCount":102},[],{"trials":1623,"activeCount":102},[1624],{"nctId":1597,"briefTitle":1598,"status":216,"phases":1625,"primaryCompletion":1600,"completion":1601,"start":1602,"enrollment":1603,"conditions":1626,"interventions":1627},[93],[1605,224,1606],[1584,1608,1609],{"trials":1629,"activeCount":102},[],{"intervention":1609,"totalTrials":116,"cells":1631},{"EARLY_PHASE1":1632,"PHASE1":1634,"PHASE2":1636,"PHASE3":1638,"PHASE4":1640,"NA":1646},{"trials":1633,"activeCount":102},[],{"trials":1635,"activeCount":102},[],{"trials":1637,"activeCount":102},[],{"trials":1639,"activeCount":102},[],{"trials":1641,"activeCount":102},[1642],{"nctId":1597,"briefTitle":1598,"status":216,"phases":1643,"primaryCompletion":1600,"completion":1601,"start":1602,"enrollment":1603,"conditions":1644,"interventions":1645},[93],[1605,224,1606],[1584,1608,1609],{"trials":1647,"activeCount":102},[],{"intervention":1649,"totalTrials":116,"cells":1650},"Betamethasone",{"EARLY_PHASE1":1651,"PHASE1":1653,"PHASE2":1655,"PHASE3":1657,"PHASE4":1659,"NA":1672},{"trials":1652,"activeCount":102},[],{"trials":1654,"activeCount":102},[],{"trials":1656,"activeCount":102},[],{"trials":1658,"activeCount":102},[],{"trials":1660,"activeCount":102},[1661],{"nctId":1662,"briefTitle":1663,"status":216,"phases":1664,"primaryCompletion":1665,"completion":1666,"start":1667,"enrollment":1229,"conditions":1668,"interventions":1670},"NCT03156829","Effectiveness of Cortisone Injection and Splinting for Trigger Finger",[93],"2021-09-01","2022-09","2017-11-27",[1669],"Trigger Finger",[1649,1671],"Splint + Cortico-steroid",{"trials":1673,"activeCount":102},[],{"intervention":1671,"totalTrials":116,"cells":1675},{"EARLY_PHASE1":1676,"PHASE1":1678,"PHASE2":1680,"PHASE3":1682,"PHASE4":1684,"NA":1690},{"trials":1677,"activeCount":102},[],{"trials":1679,"activeCount":102},[],{"trials":1681,"activeCount":102},[],{"trials":1683,"activeCount":102},[],{"trials":1685,"activeCount":102},[1686],{"nctId":1662,"briefTitle":1663,"status":216,"phases":1687,"primaryCompletion":1665,"completion":1666,"start":1667,"enrollment":1229,"conditions":1688,"interventions":1689},[93],[1669],[1649,1671],{"trials":1691,"activeCount":102},[],{"intervention":1693,"totalTrials":116,"cells":1694},"Mirtazapine",{"EARLY_PHASE1":1695,"PHASE1":1697,"PHASE2":1699,"PHASE3":1701,"PHASE4":1703,"NA":1716},{"trials":1696,"activeCount":102},[],{"trials":1698,"activeCount":102},[],{"trials":1700,"activeCount":102},[],{"trials":1702,"activeCount":102},[],{"trials":1704,"activeCount":102},[1705],{"nctId":1706,"briefTitle":1707,"status":419,"phases":1708,"primaryCompletion":1709,"completion":1710,"start":1711,"enrollment":1712,"conditions":1713,"interventions":1715},"NCT01601002","LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression",[93],"2015-10","2015-12","2012-06",19,[1714],"Major Depressive Disorder",[1693],{"trials":1717,"activeCount":102},[],{"intervention":1719,"totalTrials":116,"cells":1720},"Epimorph",{"EARLY_PHASE1":1721,"PHASE1":1723,"PHASE2":1725,"PHASE3":1727,"PHASE4":1729,"NA":1740},{"trials":1722,"activeCount":102},[],{"trials":1724,"activeCount":102},[],{"trials":1726,"activeCount":102},[],{"trials":1728,"activeCount":102},[],{"trials":1730,"activeCount":102},[1731],{"nctId":1732,"briefTitle":1733,"status":419,"phases":1734,"primaryCompletion":1735,"completion":1735,"start":1268,"enrollment":1736,"conditions":1737,"interventions":1738},"NCT01667445","Evaluation of the Use of Spinal Epimorph in Total Knee Arthroplasty",[93],"2014-09",113,[1401,222],[1719,1739],"Spinal analgesia",{"trials":1741,"activeCount":102},[],{"intervention":1739,"totalTrials":116,"cells":1743},{"EARLY_PHASE1":1744,"PHASE1":1746,"PHASE2":1748,"PHASE3":1750,"PHASE4":1752,"NA":1758},{"trials":1745,"activeCount":102},[],{"trials":1747,"activeCount":102},[],{"trials":1749,"activeCount":102},[],{"trials":1751,"activeCount":102},[],{"trials":1753,"activeCount":102},[1754],{"nctId":1732,"briefTitle":1733,"status":419,"phases":1755,"primaryCompletion":1735,"completion":1735,"start":1268,"enrollment":1736,"conditions":1756,"interventions":1757},[93],[1401,222],[1719,1739],{"trials":1759,"activeCount":102},[],{"intervention":1761,"totalTrials":116,"cells":1762},"Mycophenolate to sirolimus switch",{"EARLY_PHASE1":1763,"PHASE1":1765,"PHASE2":1767,"PHASE3":1769,"PHASE4":1771,"NA":1781},{"trials":1764,"activeCount":102},[],{"trials":1766,"activeCount":102},[],{"trials":1768,"activeCount":102},[],{"trials":1770,"activeCount":102},[],{"trials":1772,"activeCount":102},[1773],{"nctId":1774,"briefTitle":1775,"status":419,"phases":1776,"primaryCompletion":1228,"completion":1228,"start":1777,"enrollment":30,"conditions":1778,"interventions":1780},"NCT01134952","Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)",[93],"2010-06",[1779],"Hepatitis C",[1761],{"trials":1782,"activeCount":102},[],{"intervention":1784,"totalTrials":116,"cells":1785},"Metoclopramide",{"EARLY_PHASE1":1786,"PHASE1":1788,"PHASE2":1790,"PHASE3":1792,"PHASE4":1794,"NA":1805},{"trials":1787,"activeCount":102},[],{"trials":1789,"activeCount":102},[],{"trials":1791,"activeCount":102},[],{"trials":1793,"activeCount":102},[],{"trials":1795,"activeCount":102},[1796],{"nctId":1797,"briefTitle":1798,"status":419,"phases":1799,"completion":1800,"start":1801,"enrollment":1106,"conditions":1802,"interventions":1804},"NCT00242450","Metoclopramide Use in Very Low Birth Weight Newborns",[93],"2005-07","2002-03",[1803],"Infant, Premature",[1784],{"trials":1806,"activeCount":102},[],{"intervention":1808,"totalTrials":116,"cells":1809},"Fexofenadine",{"EARLY_PHASE1":1810,"PHASE1":1812,"PHASE2":1814,"PHASE3":1816,"PHASE4":1818,"NA":1828},{"trials":1811,"activeCount":102},[],{"trials":1813,"activeCount":102},[],{"trials":1815,"activeCount":102},[],{"trials":1817,"activeCount":102},[],{"trials":1819,"activeCount":102},[1820],{"nctId":1821,"briefTitle":1822,"status":216,"phases":1823,"primaryCompletion":1824,"completion":1824,"start":1825,"enrollment":1106,"conditions":1826,"interventions":1827},"NCT03078777","The Effect Dialysis on the Pharmacokinetics of Fexofenadine",[93],"2020-08","2017-11-29",[35],[1808],{"trials":1829,"activeCount":102},[],{"intervention":1831,"totalTrials":116,"cells":1832},"celebrex",{"EARLY_PHASE1":1833,"PHASE1":1835,"PHASE2":1837,"PHASE3":1839,"PHASE4":1841,"NA":1850},{"trials":1834,"activeCount":102},[],{"trials":1836,"activeCount":102},[],{"trials":1838,"activeCount":102},[],{"trials":1840,"activeCount":102},[],{"trials":1842,"activeCount":102},[1843],{"nctId":1844,"briefTitle":1845,"status":825,"phases":1846,"enrollment":102,"conditions":1847,"interventions":1849},"NCT00664690","Effect of Celecoxib on Transitional Pain After Outpatient Surgery",[93],[1848],"Pain",[1831],{"trials":1851,"activeCount":102},[],{"intervention":1383,"totalTrials":116,"cells":1853},{"EARLY_PHASE1":1854,"PHASE1":1856,"PHASE2":1858,"PHASE3":1860,"PHASE4":1862,"NA":1868},{"trials":1855,"activeCount":102},[],{"trials":1857,"activeCount":102},[],{"trials":1859,"activeCount":102},[],{"trials":1861,"activeCount":102},[],{"trials":1863,"activeCount":102},[1864],{"nctId":1377,"briefTitle":1378,"status":419,"phases":1865,"primaryCompletion":219,"completion":1228,"start":1288,"enrollment":756,"conditions":1866,"interventions":1867},[93],[268],[1382,1383],{"trials":1869,"activeCount":102},[],{"intervention":1871,"totalTrials":116,"cells":1872},"Thoracic epidural analgesia",{"EARLY_PHASE1":1873,"PHASE1":1875,"PHASE2":1877,"PHASE3":1879,"PHASE4":1881,"NA":1890},{"trials":1874,"activeCount":102},[],{"trials":1876,"activeCount":102},[],{"trials":1878,"activeCount":102},[],{"trials":1880,"activeCount":102},[],{"trials":1882,"activeCount":102},[1883],{"nctId":1884,"briefTitle":1885,"status":419,"phases":1886,"primaryCompletion":1228,"completion":1228,"start":1887,"enrollment":1176,"conditions":1888,"interventions":1889},"NCT01735851","Comparison of Bilateral Thoracic Paravertebral Block to Thoracic Epidural Analgesia for Post Operative Analgesia in Patients Undergoing Abdominal Surgery",[93],"2012-12",[450],[1871],{"trials":1891,"activeCount":102},[],{"intervention":1893,"totalTrials":116,"cells":1894},"Alprostadil",{"EARLY_PHASE1":1895,"PHASE1":1897,"PHASE2":1899,"PHASE3":1901,"PHASE4":1903,"NA":1913},{"trials":1896,"activeCount":102},[],{"trials":1898,"activeCount":102},[],{"trials":1900,"activeCount":102},[],{"trials":1902,"activeCount":102},[],{"trials":1904,"activeCount":102},[1905],{"nctId":1906,"briefTitle":1907,"status":825,"phases":1908,"primaryCompletion":1710,"completion":1710,"start":1909,"enrollment":102,"conditions":1910,"interventions":1912},"NCT01776320","Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction",[93],"2013-12",[1911],"Erectile Dysfunction",[1893],{"trials":1914,"activeCount":102},[],{"intervention":1916,"totalTrials":116,"cells":1917},"Metformin and standard exercise",{"EARLY_PHASE1":1918,"PHASE1":1920,"PHASE2":1922,"PHASE3":1924,"PHASE4":1926,"NA":1939},{"trials":1919,"activeCount":102},[],{"trials":1921,"activeCount":102},[],{"trials":1923,"activeCount":102},[],{"trials":1925,"activeCount":102},[],{"trials":1927,"activeCount":102},[1928],{"nctId":1929,"briefTitle":1930,"status":419,"phases":1931,"primaryCompletion":1932,"completion":1932,"start":1933,"enrollment":586,"conditions":1934,"interventions":1937},"NCT00934570","Activity and Metformin Intervention in Obese Adolescents",[93],"2012-05","2009-04",[1935,1936],"Obesity","Type 2 Diabetes",[1916,1938],"Metformin Intensive exercise",{"trials":1940,"activeCount":102},[],{"intervention":1938,"totalTrials":116,"cells":1942},{"EARLY_PHASE1":1943,"PHASE1":1945,"PHASE2":1947,"PHASE3":1949,"PHASE4":1951,"NA":1957},{"trials":1944,"activeCount":102},[],{"trials":1946,"activeCount":102},[],{"trials":1948,"activeCount":102},[],{"trials":1950,"activeCount":102},[],{"trials":1952,"activeCount":102},[1953],{"nctId":1929,"briefTitle":1930,"status":419,"phases":1954,"primaryCompletion":1932,"completion":1932,"start":1933,"enrollment":586,"conditions":1955,"interventions":1956},[93],[1935,1936],[1916,1938],{"trials":1958,"activeCount":102},[],{"intervention":1960,"totalTrials":116,"cells":1961},"Spinal Hydromorphone",{"EARLY_PHASE1":1962,"PHASE1":1964,"PHASE2":1966,"PHASE3":1968,"PHASE4":1970,"NA":1982},{"trials":1963,"activeCount":102},[],{"trials":1965,"activeCount":102},[],{"trials":1967,"activeCount":102},[],{"trials":1969,"activeCount":102},[],{"trials":1971,"activeCount":102},[1972],{"nctId":1973,"briefTitle":1974,"status":419,"phases":1975,"primaryCompletion":1976,"completion":1976,"start":1977,"enrollment":1978,"conditions":1979,"interventions":1980},"NCT03592992","Spinal Hydromorphone Versus Morphine for Post-Cesarean Delivery Analgesia",[93],"2022-07-28","2020-11-11",126,[450],[1960,1981],"Spinal Morphine",{"trials":1983,"activeCount":102},[],{"intervention":1981,"totalTrials":116,"cells":1985},{"EARLY_PHASE1":1986,"PHASE1":1988,"PHASE2":1990,"PHASE3":1992,"PHASE4":1994,"NA":2000},{"trials":1987,"activeCount":102},[],{"trials":1989,"activeCount":102},[],{"trials":1991,"activeCount":102},[],{"trials":1993,"activeCount":102},[],{"trials":1995,"activeCount":102},[1996],{"nctId":1973,"briefTitle":1974,"status":419,"phases":1997,"primaryCompletion":1976,"completion":1976,"start":1977,"enrollment":1978,"conditions":1998,"interventions":1999},[93],[450],[1960,1981],{"trials":2001,"activeCount":102},[],{"intervention":2003,"totalTrials":116,"cells":2004},"Viagra",{"EARLY_PHASE1":2005,"PHASE1":2007,"PHASE2":2009,"PHASE3":2011,"PHASE4":2013,"NA":2026},{"trials":2006,"activeCount":102},[],{"trials":2008,"activeCount":102},[],{"trials":2010,"activeCount":102},[],{"trials":2012,"activeCount":102},[],{"trials":2014,"activeCount":102},[2015],{"nctId":2016,"briefTitle":2017,"status":419,"phases":2018,"primaryCompletion":2019,"completion":2020,"start":2021,"enrollment":2022,"conditions":2023,"interventions":2025},"NCT00199563","Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels",[93],"2007-10","2007-12","2004-08",24,[2024],"Impotence",[2003],{"trials":2027,"activeCount":102},[],{"intervention":2029,"totalTrials":116,"cells":2030},"High Volume Simethicone",{"EARLY_PHASE1":2031,"PHASE1":2033,"PHASE2":2035,"PHASE3":2037,"PHASE4":2039,"NA":2053},{"trials":2032,"activeCount":102},[],{"trials":2034,"activeCount":102},[],{"trials":2036,"activeCount":102},[],{"trials":2038,"activeCount":102},[],{"trials":2040,"activeCount":102},[2041],{"nctId":2042,"briefTitle":2043,"status":419,"phases":2044,"primaryCompletion":2045,"completion":2046,"start":2047,"enrollment":2048,"conditions":2049,"interventions":2051},"NCT02334631","High Volume Simethicone VCE Clinical Trial",[93],"2019-08","2019-10","2017-01",159,[2050],"Small Bowel Diseases",[2029,2052],"Standard Volume Simethicone",{"trials":2054,"activeCount":102},[],{"intervention":2052,"totalTrials":116,"cells":2056},{"EARLY_PHASE1":2057,"PHASE1":2059,"PHASE2":2061,"PHASE3":2063,"PHASE4":2065,"NA":2071},{"trials":2058,"activeCount":102},[],{"trials":2060,"activeCount":102},[],{"trials":2062,"activeCount":102},[],{"trials":2064,"activeCount":102},[],{"trials":2066,"activeCount":102},[2067],{"nctId":2042,"briefTitle":2043,"status":419,"phases":2068,"primaryCompletion":2045,"completion":2046,"start":2047,"enrollment":2048,"conditions":2069,"interventions":2070},[93],[2050],[2029,2052],{"trials":2072,"activeCount":102},[],{"intervention":2074,"totalTrials":116,"cells":2075},"dabigatran",{"EARLY_PHASE1":2076,"PHASE1":2078,"PHASE2":2080,"PHASE3":2082,"PHASE4":2084,"NA":2095},{"trials":2077,"activeCount":102},[],{"trials":2079,"activeCount":102},[],{"trials":2081,"activeCount":102},[],{"trials":2083,"activeCount":102},[],{"trials":2085,"activeCount":102},[2086],{"nctId":2087,"briefTitle":2088,"status":419,"phases":2089,"primaryCompletion":2047,"completion":2090,"start":2091,"enrollment":756,"conditions":2092,"interventions":2094},"NCT01468155","DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation",[93],"2017-06-07","2011-07-13",[2093],"Atrial Fibrillation",[2074],{"trials":2096,"activeCount":102},[],{"intervention":1305,"totalTrials":116,"cells":2098},{"EARLY_PHASE1":2099,"PHASE1":2101,"PHASE2":2103,"PHASE3":2105,"PHASE4":2107,"NA":2113},{"trials":2100,"activeCount":102},[],{"trials":2102,"activeCount":102},[],{"trials":2104,"activeCount":102},[],{"trials":2106,"activeCount":102},[],{"trials":2108,"activeCount":102},[2109],{"nctId":1298,"briefTitle":1299,"status":112,"phases":2110,"primaryCompletion":1227,"completion":1227,"start":219,"enrollment":1113,"conditions":2111,"interventions":2112},[93],[1302],[1304,1305],{"trials":2114,"activeCount":102},[],{"intervention":2116,"totalTrials":116,"cells":2117},"Ketamine only",{"EARLY_PHASE1":2118,"PHASE1":2120,"PHASE2":2122,"PHASE3":2124,"PHASE4":2126,"NA":2139},{"trials":2119,"activeCount":102},[],{"trials":2121,"activeCount":102},[],{"trials":2123,"activeCount":102},[],{"trials":2125,"activeCount":102},[],{"trials":2127,"activeCount":102},[2128],{"nctId":2129,"briefTitle":2130,"status":419,"phases":2131,"primaryCompletion":2132,"completion":2132,"start":2133,"enrollment":2134,"conditions":2135,"interventions":2137},"NCT00490997","Ketamine\u002FPropofol vs Ketamine Alone for Pediatric Fracture Reduction",[93],"2008-08","2007-06",140,[2136],"Fractures",[2116,2138],"Ketamine - Propofol",{"trials":2140,"activeCount":102},[],{"intervention":2138,"totalTrials":116,"cells":2142},{"EARLY_PHASE1":2143,"PHASE1":2145,"PHASE2":2147,"PHASE3":2149,"PHASE4":2151,"NA":2157},{"trials":2144,"activeCount":102},[],{"trials":2146,"activeCount":102},[],{"trials":2148,"activeCount":102},[],{"trials":2150,"activeCount":102},[],{"trials":2152,"activeCount":102},[2153],{"nctId":2129,"briefTitle":2130,"status":419,"phases":2154,"primaryCompletion":2132,"completion":2132,"start":2133,"enrollment":2134,"conditions":2155,"interventions":2156},[93],[2136],[2116,2138],{"trials":2158,"activeCount":102},[],{"intervention":1244,"totalTrials":116,"cells":2160},{"EARLY_PHASE1":2161,"PHASE1":2163,"PHASE2":2165,"PHASE3":2167,"PHASE4":2169,"NA":2175},{"trials":2162,"activeCount":102},[],{"trials":2164,"activeCount":102},[],{"trials":2166,"activeCount":102},[],{"trials":2168,"activeCount":102},[],{"trials":2170,"activeCount":102},[2171],{"nctId":1235,"briefTitle":1236,"status":216,"phases":2172,"primaryCompletion":1238,"completion":1239,"start":1240,"enrollment":586,"conditions":2173,"interventions":2174},[93],[1242],[1135,1244,1245],{"trials":2176,"activeCount":102},[],{"intervention":1245,"totalTrials":116,"cells":2178},{"EARLY_PHASE1":2179,"PHASE1":2181,"PHASE2":2183,"PHASE3":2185,"PHASE4":2187,"NA":2193},{"trials":2180,"activeCount":102},[],{"trials":2182,"activeCount":102},[],{"trials":2184,"activeCount":102},[],{"trials":2186,"activeCount":102},[],{"trials":2188,"activeCount":102},[2189],{"nctId":1235,"briefTitle":1236,"status":216,"phases":2190,"primaryCompletion":1238,"completion":1239,"start":1240,"enrollment":586,"conditions":2191,"interventions":2192},[93],[1242],[1135,1244,1245],{"trials":2194,"activeCount":102},[],{"intervention":1158,"totalTrials":116,"cells":2196},{"EARLY_PHASE1":2197,"PHASE1":2199,"PHASE2":2201,"PHASE3":2203,"PHASE4":2205,"NA":2211},{"trials":2198,"activeCount":102},[],{"trials":2200,"activeCount":102},[],{"trials":2202,"activeCount":102},[],{"trials":2204,"activeCount":102},[],{"trials":2206,"activeCount":102},[2207],{"nctId":1148,"briefTitle":1149,"status":419,"phases":2208,"primaryCompletion":1151,"completion":1151,"start":1152,"enrollment":1153,"conditions":2209,"interventions":2210},[93],[1155],[1157,1158],{"trials":2212,"activeCount":102},[],{"intervention":2214,"totalTrials":116,"cells":2215},"Antibiotic Prophylaxis",{"EARLY_PHASE1":2216,"PHASE1":2218,"PHASE2":2220,"PHASE3":2222,"PHASE4":2224,"NA":2236},{"trials":2217,"activeCount":102},[],{"trials":2219,"activeCount":102},[],{"trials":2221,"activeCount":102},[],{"trials":2223,"activeCount":102},[],{"trials":2225,"activeCount":102},[2226],{"nctId":2227,"briefTitle":2228,"status":419,"phases":2229,"primaryCompletion":2230,"completion":1151,"start":1268,"enrollment":2231,"conditions":2232,"interventions":2235},"NCT02357758","Effects of Antibiotic Prophylaxis on Recurrent UTI in Children",[93],"2016-01",59,[2233,2234],"Urinary Tract Infection","Recurrent Urinary Tract Infection",[2214],{"trials":2237,"activeCount":102},[],{"intervention":2239,"totalTrials":116,"cells":2240},"Grastofil®",{"EARLY_PHASE1":2241,"PHASE1":2243,"PHASE2":2245,"PHASE3":2247,"PHASE4":2264,"NA":2266},{"trials":2242,"activeCount":102},[],{"trials":2244,"activeCount":102},[],{"trials":2246,"activeCount":102},[],{"trials":2248,"activeCount":102},[2249],{"nctId":2250,"briefTitle":2251,"status":216,"phases":2252,"primaryCompletion":2253,"completion":2254,"start":2255,"enrollment":2256,"conditions":2257,"interventions":2262},"NCT06116734","Lapelga vs Gastrofil",[92],"2024-11-01","2025-11-01","2023-11-01",74,[2258,2259,2260,2261],"Multiple Myeloma","Lymphoma","Engagement, Patient","Febrile Neutropenia",[2239,2263],"Lapelga",{"trials":2265,"activeCount":102},[],{"trials":2267,"activeCount":102},[],{"intervention":2263,"totalTrials":116,"cells":2269},{"EARLY_PHASE1":2270,"PHASE1":2272,"PHASE2":2274,"PHASE3":2276,"PHASE4":2282,"NA":2284},{"trials":2271,"activeCount":102},[],{"trials":2273,"activeCount":102},[],{"trials":2275,"activeCount":102},[],{"trials":2277,"activeCount":102},[2278],{"nctId":2250,"briefTitle":2251,"status":216,"phases":2279,"primaryCompletion":2253,"completion":2254,"start":2255,"enrollment":2256,"conditions":2280,"interventions":2281},[92],[2258,2259,2260,2261],[2239,2263],{"trials":2283,"activeCount":102},[],{"trials":2285,"activeCount":102},[],{"intervention":2287,"totalTrials":116,"cells":2288},"Fentanyl",{"EARLY_PHASE1":2289,"PHASE1":2291,"PHASE2":2293,"PHASE3":2295,"PHASE4":2307,"NA":2309},{"trials":2290,"activeCount":102},[],{"trials":2292,"activeCount":102},[],{"trials":2294,"activeCount":102},[],{"trials":2296,"activeCount":102},[2297],{"nctId":2298,"briefTitle":2299,"status":419,"phases":2300,"primaryCompletion":2301,"completion":2302,"start":1909,"enrollment":2303,"conditions":2304,"interventions":2306},"NCT02004899","Trial of Onset of Epidural Pain Relief With Low Dose Bupivacaine and Different Doses of Fentanyl in Laboring Women",[92],"2014-10","2015-05",105,[2305],"Anesthetic, Sedative or Analgesic Complications in Labor or Delivery",[2287],{"trials":2308,"activeCount":102},[],{"trials":2310,"activeCount":102},[],{"intervention":228,"totalTrials":116,"cells":2312},{"EARLY_PHASE1":2313,"PHASE1":2315,"PHASE2":2317,"PHASE3":2319,"PHASE4":2325,"NA":2327},{"trials":2314,"activeCount":102},[],{"trials":2316,"activeCount":102},[],{"trials":2318,"activeCount":102},[],{"trials":2320,"activeCount":102},[2321],{"nctId":214,"briefTitle":215,"status":216,"phases":2322,"primaryCompletion":218,"start":219,"enrollment":220,"conditions":2323,"interventions":2324},[92],[222,223,224],[226,203,227,228,87,229],{"trials":2326,"activeCount":102},[],{"trials":2328,"activeCount":102},[],{"intervention":2330,"totalTrials":116,"cells":2331},"Oxybutynin",{"EARLY_PHASE1":2332,"PHASE1":2334,"PHASE2":2336,"PHASE3":2338,"PHASE4":2351,"NA":2353},{"trials":2333,"activeCount":102},[],{"trials":2335,"activeCount":102},[],{"trials":2337,"activeCount":102},[],{"trials":2339,"activeCount":102},[2340],{"nctId":2341,"briefTitle":2342,"status":419,"phases":2343,"primaryCompletion":2344,"completion":2345,"start":2346,"enrollment":697,"conditions":2347,"interventions":2349},"NCT01716624","Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder",[92],"2012-03","2012-04","2011-05",[2348],"Neurogenic Bladder",[2330,2350],"Botulinum Toxin A",{"trials":2352,"activeCount":102},[],{"trials":2354,"activeCount":102},[],{"intervention":2350,"totalTrials":116,"cells":2356},{"EARLY_PHASE1":2357,"PHASE1":2359,"PHASE2":2361,"PHASE3":2363,"PHASE4":2369,"NA":2371},{"trials":2358,"activeCount":102},[],{"trials":2360,"activeCount":102},[],{"trials":2362,"activeCount":102},[],{"trials":2364,"activeCount":102},[2365],{"nctId":2341,"briefTitle":2342,"status":419,"phases":2366,"primaryCompletion":2344,"completion":2345,"start":2346,"enrollment":697,"conditions":2367,"interventions":2368},[92],[2348],[2330,2350],{"trials":2370,"activeCount":102},[],{"trials":2372,"activeCount":102},[],{"intervention":2374,"totalTrials":116,"cells":2375},"aripiprazole",{"EARLY_PHASE1":2376,"PHASE1":2378,"PHASE2":2380,"PHASE3":2382,"PHASE4":2392,"NA":2394},{"trials":2377,"activeCount":102},[],{"trials":2379,"activeCount":102},[],{"trials":2381,"activeCount":102},[],{"trials":2383,"activeCount":102},[2384],{"nctId":2385,"briefTitle":2386,"status":419,"phases":2387,"primaryCompletion":2388,"completion":2388,"start":2389,"enrollment":33,"conditions":2390,"interventions":2391},"NCT01386086","Aripiprazole and Resistant Postpartum Depression",[92],"2013-11","2011-06",[119],[2374],{"trials":2393,"activeCount":102},[],{"trials":2395,"activeCount":102},[],{"intervention":2397,"totalTrials":116,"cells":2398},"Micro-particle Curcumin",{"EARLY_PHASE1":2399,"PHASE1":2401,"PHASE2":2403,"PHASE3":2405,"PHASE4":2418,"NA":2420},{"trials":2400,"activeCount":102},[],{"trials":2402,"activeCount":102},[],{"trials":2404,"activeCount":102},[],{"trials":2406,"activeCount":102},[2407],{"nctId":2408,"briefTitle":2409,"status":419,"phases":2410,"primaryCompletion":2411,"completion":2412,"start":2413,"enrollment":2414,"conditions":2415,"interventions":2417},"NCT02369549","Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease",[92],"2019-11","2020-05-15","2015-09",518,[2416],"Chronic Kidney Disease",[2397],{"trials":2419,"activeCount":102},[],{"trials":2421,"activeCount":102},[],{"intervention":2423,"totalTrials":116,"cells":2424},"clopidogrel",{"EARLY_PHASE1":2425,"PHASE1":2427,"PHASE2":2429,"PHASE3":2431,"PHASE4":2443,"NA":2445},{"trials":2426,"activeCount":102},[],{"trials":2428,"activeCount":102},[],{"trials":2430,"activeCount":102},[],{"trials":2432,"activeCount":102},[2433],{"nctId":2434,"briefTitle":2435,"status":419,"phases":2436,"primaryCompletion":2437,"completion":445,"start":2438,"enrollment":1129,"conditions":2439,"interventions":2441},"NCT01805596","Effect of Ticagrelor on Endothelial Function",[92],"2016-02","2013-04",[29,2440],"Endothelial Function",[2423,2442],"Ticagrelor",{"trials":2444,"activeCount":102},[],{"trials":2446,"activeCount":102},[],{"intervention":2442,"totalTrials":116,"cells":2448},{"EARLY_PHASE1":2449,"PHASE1":2451,"PHASE2":2453,"PHASE3":2455,"PHASE4":2461,"NA":2463},{"trials":2450,"activeCount":102},[],{"trials":2452,"activeCount":102},[],{"trials":2454,"activeCount":102},[],{"trials":2456,"activeCount":102},[2457],{"nctId":2434,"briefTitle":2435,"status":419,"phases":2458,"primaryCompletion":2437,"completion":445,"start":2438,"enrollment":1129,"conditions":2459,"interventions":2460},[92],[29,2440],[2423,2442],{"trials":2462,"activeCount":102},[],{"trials":2464,"activeCount":102},[],{"intervention":2466,"totalTrials":116,"cells":2467},"Gastrografin",{"EARLY_PHASE1":2468,"PHASE1":2470,"PHASE2":2472,"PHASE3":2474,"PHASE4":2484,"NA":2486},{"trials":2469,"activeCount":102},[],{"trials":2471,"activeCount":102},[],{"trials":2473,"activeCount":102},[],{"trials":2475,"activeCount":102},[2476],{"nctId":2477,"briefTitle":2478,"status":112,"phases":2479,"primaryCompletion":2480,"completion":2480,"start":1366,"enrollment":98,"conditions":2481,"interventions":2483},"NCT03573921","Gastrografin for Treating Small Bowel Obstruction in Children",[91,92],"2022-12-19",[2482],"Small Bowel Obstruction",[2466],{"trials":2485,"activeCount":102},[],{"trials":2487,"activeCount":102},[],{"intervention":1335,"totalTrials":116,"cells":2489},{"EARLY_PHASE1":2490,"PHASE1":2492,"PHASE2":2494,"PHASE3":2496,"PHASE4":2502,"NA":2504},{"trials":2491,"activeCount":102},[],{"trials":2493,"activeCount":102},[],{"trials":2495,"activeCount":102},[],{"trials":2497,"activeCount":102},[2498],{"nctId":1320,"briefTitle":1321,"status":216,"phases":2499,"primaryCompletion":1323,"completion":1324,"start":1325,"enrollment":1326,"conditions":2500,"interventions":2501},[91,92],[1328,1329,1330,1331,1332,1333],[1309,1335],{"trials":2503,"activeCount":102},[],{"trials":2505,"activeCount":102},[],{"intervention":2507,"totalTrials":116,"cells":2508},"Fampridine SR",{"EARLY_PHASE1":2509,"PHASE1":2511,"PHASE2":2513,"PHASE3":2515,"PHASE4":2526,"NA":2528},{"trials":2510,"activeCount":102},[],{"trials":2512,"activeCount":102},[],{"trials":2514,"activeCount":102},[],{"trials":2516,"activeCount":102},[2517],{"nctId":2518,"briefTitle":2519,"status":419,"phases":2520,"primaryCompletion":2521,"completion":2522,"start":1268,"enrollment":586,"conditions":2523,"interventions":2525},"NCT01667497","Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?",[91,92],"2015-07","2015-08",[2524],"Cognitive Fatigue",[2507],{"trials":2527,"activeCount":102},[],{"trials":2529,"activeCount":102},[],{"intervention":2531,"totalTrials":116,"cells":2532},"Ciprofloxacin",{"EARLY_PHASE1":2533,"PHASE1":2535,"PHASE2":2537,"PHASE3":2539,"PHASE4":2549,"NA":2551},{"trials":2534,"activeCount":102},[],{"trials":2536,"activeCount":102},[],{"trials":2538,"activeCount":102},[],{"trials":2540,"activeCount":102},[2541],{"nctId":2542,"briefTitle":2543,"status":112,"phases":2544,"primaryCompletion":1710,"completion":1710,"start":2388,"enrollment":2545,"conditions":2546,"interventions":2548},"NCT01873690","Efficacy of Antimicrobial Prophylaxis for Shock Wave Lithotripsy (SWL) on Reducing Urinary Tract Infection (UTI)",[92],360,[2547],"Urolithiasis",[2531],{"trials":2550,"activeCount":102},[],{"trials":2552,"activeCount":102},[],{"intervention":2554,"totalTrials":116,"cells":2555},"Intranasal ketamine",{"EARLY_PHASE1":2556,"PHASE1":2558,"PHASE2":2560,"PHASE3":2562,"PHASE4":2574,"NA":2576},{"trials":2557,"activeCount":102},[],{"trials":2559,"activeCount":102},[],{"trials":2561,"activeCount":102},[],{"trials":2563,"activeCount":102},[2564],{"nctId":2565,"briefTitle":2566,"status":825,"phases":2567,"primaryCompletion":2568,"completion":2569,"start":2570,"enrollment":102,"conditions":2571,"interventions":2573},"NCT05783492","INK Feasibility Study",[92],"2024-03-31","2024-04-30","2024-01-01",[2572],"Procedural Sedation",[2554],{"trials":2575,"activeCount":102},[],{"trials":2577,"activeCount":102},[],{"intervention":2579,"totalTrials":116,"cells":2580},"curcumin",{"EARLY_PHASE1":2581,"PHASE1":2583,"PHASE2":2585,"PHASE3":2587,"PHASE4":2599,"NA":2601},{"trials":2582,"activeCount":102},[],{"trials":2584,"activeCount":102},[],{"trials":2586,"activeCount":102},[],{"trials":2588,"activeCount":102},[2589],{"nctId":2590,"briefTitle":2591,"status":419,"phases":2592,"primaryCompletion":2593,"completion":1201,"start":1576,"enrollment":2594,"conditions":2595,"interventions":2598},"NCT01225094","Curcumin to Prevent Complications After Elective Abdominal Aortic Aneurysm (AAA) Repair",[91,92],"2014-11",606,[2596,2597],"Acute Kidney Injury","Abdominal Aortic Aneurysm",[2579],{"trials":2600,"activeCount":102},[],{"trials":2602,"activeCount":102},[],{"intervention":1373,"totalTrials":116,"cells":2604},{"EARLY_PHASE1":2605,"PHASE1":2607,"PHASE2":2609,"PHASE3":2611,"PHASE4":2617,"NA":2619},{"trials":2606,"activeCount":102},[],{"trials":2608,"activeCount":102},[],{"trials":2610,"activeCount":102},[],{"trials":2612,"activeCount":102},[2613],{"nctId":1362,"briefTitle":1363,"status":216,"phases":2614,"primaryCompletion":1365,"completion":609,"start":1366,"enrollment":1367,"conditions":2615,"interventions":2616},[92],[1369,1370,1371],[1373,1351],{"trials":2618,"activeCount":102},[],{"trials":2620,"activeCount":102},[],{"intervention":2622,"totalTrials":116,"cells":2623},"Standard Preparation",{"EARLY_PHASE1":2624,"PHASE1":2626,"PHASE2":2628,"PHASE3":2630,"PHASE4":2641,"NA":2643},{"trials":2625,"activeCount":102},[],{"trials":2627,"activeCount":102},[],{"trials":2629,"activeCount":102},[],{"trials":2631,"activeCount":102},[2632],{"nctId":2633,"briefTitle":2634,"status":419,"phases":2635,"primaryCompletion":2636,"completion":2636,"start":827,"enrollment":2637,"conditions":2638,"interventions":2640},"NCT01762020","Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation",[92],"2017-02",56,[531,2639],"Dermatitis",[2622],{"trials":2642,"activeCount":102},[],{"trials":2644,"activeCount":102},[],{"intervention":832,"totalTrials":116,"cells":2646},{"EARLY_PHASE1":2647,"PHASE1":2649,"PHASE2":2651,"PHASE3":2653,"PHASE4":2659,"NA":2661},{"trials":2648,"activeCount":102},[],{"trials":2650,"activeCount":102},[],{"trials":2652,"activeCount":102},[],{"trials":2654,"activeCount":102},[2655],{"nctId":823,"briefTitle":824,"status":825,"phases":2656,"primaryCompletion":827,"completion":828,"start":829,"enrollment":102,"conditions":2657,"interventions":2658},[92],[37],[812,832,833,834],{"trials":2660,"activeCount":102},[],{"trials":2662,"activeCount":102},[],{"intervention":2664,"totalTrials":116,"cells":2665},"corticosteroids",{"EARLY_PHASE1":2666,"PHASE1":2668,"PHASE2":2670,"PHASE3":2672,"PHASE4":2682,"NA":2684},{"trials":2667,"activeCount":102},[],{"trials":2669,"activeCount":102},[],{"trials":2671,"activeCount":102},[],{"trials":2673,"activeCount":102},[2674],{"nctId":2675,"briefTitle":2676,"status":419,"phases":2677,"primaryCompletion":2302,"completion":2302,"start":2344,"enrollment":2678,"conditions":2679,"interventions":2681},"NCT01524250","Optic Neuritis Recovery After Oral or IV Corticosteroids",[91,92],51,[2680],"Optic Neuritis",[2664,2664],{"trials":2683,"activeCount":102},[],{"trials":2685,"activeCount":102},[],{"intervention":2687,"totalTrials":116,"cells":2688},"Ropivacaine 0.5%",{"EARLY_PHASE1":2689,"PHASE1":2691,"PHASE2":2693,"PHASE3":2695,"PHASE4":2704,"NA":2706},{"trials":2690,"activeCount":102},[],{"trials":2692,"activeCount":102},[],{"trials":2694,"activeCount":102},[],{"trials":2696,"activeCount":102},[2697],{"nctId":2698,"briefTitle":2699,"status":419,"phases":2700,"primaryCompletion":1227,"completion":1227,"start":1152,"enrollment":2701,"conditions":2702,"interventions":2703},"NCT02541552","Effect of Volume of Local Anesthetic for Adductor Canal Block on Quadriceps Muscle Function: A Dose Finding Study",[92],26,[450],[2687],{"trials":2705,"activeCount":102},[],{"trials":2707,"activeCount":102},[],{"intervention":2709,"totalTrials":116,"cells":2710},"Ketamine and saline",{"EARLY_PHASE1":2711,"PHASE1":2713,"PHASE2":2715,"PHASE3":2717,"PHASE4":2728,"NA":2730},{"trials":2712,"activeCount":102},[],{"trials":2714,"activeCount":102},[],{"trials":2716,"activeCount":102},[],{"trials":2718,"activeCount":102},[2719],{"nctId":2720,"briefTitle":2721,"status":419,"phases":2722,"primaryCompletion":2723,"completion":2724,"start":2230,"enrollment":18,"conditions":2725,"interventions":2727},"NCT02402868","Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children",[92],"2018-01","2018-02",[2726],"Bone Fractures",[2709],{"trials":2729,"activeCount":102},[],{"trials":2731,"activeCount":102},[],{"intervention":2733,"totalTrials":116,"cells":2734},"Collatamp G sponge",{"EARLY_PHASE1":2735,"PHASE1":2737,"PHASE2":2739,"PHASE3":2741,"PHASE4":2751,"NA":2753},{"trials":2736,"activeCount":102},[],{"trials":2738,"activeCount":102},[],{"trials":2740,"activeCount":102},[],{"trials":2742,"activeCount":102},[2743],{"nctId":2744,"briefTitle":2745,"status":112,"phases":2746,"primaryCompletion":1398,"completion":2747,"start":827,"enrollment":18,"conditions":2748,"interventions":2750},"NCT01667874","Use of Collatamp G Antibiotic Impregnated Sponges in the Treatment of Peri-prosthetic Total Joint Infections",[92],"2016-09-01",[2749],"Infection",[2733],{"trials":2752,"activeCount":102},[],{"trials":2754,"activeCount":102},[],{"intervention":2756,"totalTrials":116,"cells":2757},"Intraarticular platelet rich plasma cervical facet",{"EARLY_PHASE1":2758,"PHASE1":2760,"PHASE2":2762,"PHASE3":2764,"PHASE4":2777,"NA":2779},{"trials":2759,"activeCount":102},[],{"trials":2761,"activeCount":102},[],{"trials":2763,"activeCount":102},[],{"trials":2765,"activeCount":102},[2766],{"nctId":2767,"briefTitle":2768,"status":419,"phases":2769,"primaryCompletion":2770,"completion":2771,"start":2772,"enrollment":423,"conditions":2773,"interventions":2775},"NCT04392999","Intra-articular Corticosteroid Injections to Platelet Rich Plasma (PRP) for Cervical Facetogenic Pain",[91,92],"2023-03-26","2024-08-15","2021-02-01",[2774],"Cervical Pain",[2756,2776],"Corticosteroid",{"trials":2778,"activeCount":102},[],{"trials":2780,"activeCount":102},[],{"intervention":2776,"totalTrials":116,"cells":2782},{"EARLY_PHASE1":2783,"PHASE1":2785,"PHASE2":2787,"PHASE3":2789,"PHASE4":2795,"NA":2797},{"trials":2784,"activeCount":102},[],{"trials":2786,"activeCount":102},[],{"trials":2788,"activeCount":102},[],{"trials":2790,"activeCount":102},[2791],{"nctId":2767,"briefTitle":2768,"status":419,"phases":2792,"primaryCompletion":2770,"completion":2771,"start":2772,"enrollment":423,"conditions":2793,"interventions":2794},[91,92],[2774],[2756,2776],{"trials":2796,"activeCount":102},[],{"trials":2798,"activeCount":102},[],{"intervention":2800,"totalTrials":116,"cells":2801},"TC-H x Paclitaxel",{"EARLY_PHASE1":2802,"PHASE1":2804,"PHASE2":2806,"PHASE3":2808,"PHASE4":2819,"NA":2821},{"trials":2803,"activeCount":102},[],{"trials":2805,"activeCount":102},[],{"trials":2807,"activeCount":102},[],{"trials":2809,"activeCount":102},[2810],{"nctId":2811,"briefTitle":2812,"status":419,"phases":2813,"primaryCompletion":2814,"completion":2814,"start":2815,"enrollment":2678,"conditions":2816,"interventions":2818},"NCT03705429","A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer",[92],"2022-05-11","2019-05-01",[2817],"Breast Neoplasms",[2800],{"trials":2820,"activeCount":102},[],{"trials":2822,"activeCount":102},[],{"intervention":2824,"totalTrials":116,"cells":2825},"IN ketamine",{"EARLY_PHASE1":2826,"PHASE1":2828,"PHASE2":2830,"PHASE3":2832,"PHASE4":2848,"NA":2850},{"trials":2827,"activeCount":102},[],{"trials":2829,"activeCount":102},[],{"trials":2831,"activeCount":102},[],{"trials":2833,"activeCount":102},[2834],{"nctId":2835,"briefTitle":2836,"status":216,"phases":2837,"primaryCompletion":2838,"completion":2839,"start":2840,"enrollment":2841,"conditions":2842,"interventions":2844},"NCT02828566","Intranasal Ketamine for Procedural Sedation",[92],"2019-01","2019-02","2017-10",470,[2726,2843],"Dislocations",[2824,2845,2846,2847],"IV ketamine","IN saline 0.9%","IV saline 0.9%",{"trials":2849,"activeCount":102},[],{"trials":2851,"activeCount":102},[],{"intervention":2845,"totalTrials":116,"cells":2853},{"EARLY_PHASE1":2854,"PHASE1":2856,"PHASE2":2858,"PHASE3":2860,"PHASE4":2866,"NA":2868},{"trials":2855,"activeCount":102},[],{"trials":2857,"activeCount":102},[],{"trials":2859,"activeCount":102},[],{"trials":2861,"activeCount":102},[2862],{"nctId":2835,"briefTitle":2836,"status":216,"phases":2863,"primaryCompletion":2838,"completion":2839,"start":2840,"enrollment":2841,"conditions":2864,"interventions":2865},[92],[2726,2843],[2824,2845,2846,2847],{"trials":2867,"activeCount":102},[],{"trials":2869,"activeCount":102},[],{"intervention":2846,"totalTrials":116,"cells":2871},{"EARLY_PHASE1":2872,"PHASE1":2874,"PHASE2":2876,"PHASE3":2878,"PHASE4":2884,"NA":2886},{"trials":2873,"activeCount":102},[],{"trials":2875,"activeCount":102},[],{"trials":2877,"activeCount":102},[],{"trials":2879,"activeCount":102},[2880],{"nctId":2835,"briefTitle":2836,"status":216,"phases":2881,"primaryCompletion":2838,"completion":2839,"start":2840,"enrollment":2841,"conditions":2882,"interventions":2883},[92],[2726,2843],[2824,2845,2846,2847],{"trials":2885,"activeCount":102},[],{"trials":2887,"activeCount":102},[],{"intervention":2847,"totalTrials":116,"cells":2889},{"EARLY_PHASE1":2890,"PHASE1":2892,"PHASE2":2894,"PHASE3":2896,"PHASE4":2902,"NA":2904},{"trials":2891,"activeCount":102},[],{"trials":2893,"activeCount":102},[],{"trials":2895,"activeCount":102},[],{"trials":2897,"activeCount":102},[2898],{"nctId":2835,"briefTitle":2836,"status":216,"phases":2899,"primaryCompletion":2838,"completion":2839,"start":2840,"enrollment":2841,"conditions":2900,"interventions":2901},[92],[2726,2843],[2824,2845,2846,2847],{"trials":2903,"activeCount":102},[],{"trials":2905,"activeCount":102},[],{"intervention":2907,"totalTrials":116,"cells":2908},"Mirabegron",{"EARLY_PHASE1":2909,"PHASE1":2911,"PHASE2":2913,"PHASE3":2915,"PHASE4":2926,"NA":2928},{"trials":2910,"activeCount":102},[],{"trials":2912,"activeCount":102},[],{"trials":2914,"activeCount":102},[],{"trials":2916,"activeCount":102},[2917],{"nctId":2918,"briefTitle":2919,"status":112,"phases":2920,"primaryCompletion":2723,"completion":2724,"start":2921,"enrollment":2922,"conditions":2923,"interventions":2925},"NCT02044510","Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients",[91,92],"2014-07",32,[2924],"Urinary Bladder, Neurogenic",[2907],{"trials":2927,"activeCount":102},[],{"trials":2929,"activeCount":102},[],{"intervention":2931,"totalTrials":116,"cells":2932},"Vancomycin",{"EARLY_PHASE1":2933,"PHASE1":2935,"PHASE2":2937,"PHASE3":2939,"PHASE4":2950,"NA":2952},{"trials":2934,"activeCount":102},[],{"trials":2936,"activeCount":102},[],{"trials":2938,"activeCount":102},[],{"trials":2940,"activeCount":102},[2941],{"nctId":2942,"briefTitle":2943,"status":216,"phases":2944,"primaryCompletion":2045,"completion":2045,"start":1201,"enrollment":697,"conditions":2945,"interventions":2947},"NCT02466698","Intestinal Lavage for the Treatment of Severe C. Difficile Infections",[91,92],[2946],"Clostridium Difficile",[2931,2948,2949],"PEG","Metronidazole",{"trials":2951,"activeCount":102},[],{"trials":2953,"activeCount":102},[],{"intervention":2948,"totalTrials":116,"cells":2955},{"EARLY_PHASE1":2956,"PHASE1":2958,"PHASE2":2960,"PHASE3":2962,"PHASE4":2968,"NA":2970},{"trials":2957,"activeCount":102},[],{"trials":2959,"activeCount":102},[],{"trials":2961,"activeCount":102},[],{"trials":2963,"activeCount":102},[2964],{"nctId":2942,"briefTitle":2943,"status":216,"phases":2965,"primaryCompletion":2045,"completion":2045,"start":1201,"enrollment":697,"conditions":2966,"interventions":2967},[91,92],[2946],[2931,2948,2949],{"trials":2969,"activeCount":102},[],{"trials":2971,"activeCount":102},[],{"intervention":2949,"totalTrials":116,"cells":2973},{"EARLY_PHASE1":2974,"PHASE1":2976,"PHASE2":2978,"PHASE3":2980,"PHASE4":2986,"NA":2988},{"trials":2975,"activeCount":102},[],{"trials":2977,"activeCount":102},[],{"trials":2979,"activeCount":102},[],{"trials":2981,"activeCount":102},[2982],{"nctId":2942,"briefTitle":2943,"status":216,"phases":2983,"primaryCompletion":2045,"completion":2045,"start":1201,"enrollment":697,"conditions":2984,"interventions":2985},[91,92],[2946],[2931,2948,2949],{"trials":2987,"activeCount":102},[],{"trials":2989,"activeCount":102},[],{"intervention":2991,"totalTrials":116,"cells":2992},"Adderall XR 5mg",{"EARLY_PHASE1":2993,"PHASE1":2995,"PHASE2":2997,"PHASE3":2999,"PHASE4":3013,"NA":3015},{"trials":2994,"activeCount":102},[],{"trials":2996,"activeCount":102},[],{"trials":2998,"activeCount":102},[],{"trials":3000,"activeCount":102},[3001],{"nctId":3002,"briefTitle":3003,"status":419,"phases":3004,"primaryCompletion":3005,"completion":3006,"start":1268,"enrollment":1176,"conditions":3007,"interventions":3011},"NCT01667484","Adderall XR and Processing Speed in Multiple Sclerosis (MS)",[91,92],"2013-02","2015-02",[3008,3009,3010],"Impaired Processing Speed","Cognitive Impairment","Multiple Sclerosis",[2991,3012],"Adderall XR 10 mg",{"trials":3014,"activeCount":102},[],{"trials":3016,"activeCount":102},[],{"intervention":3012,"totalTrials":116,"cells":3018},{"EARLY_PHASE1":3019,"PHASE1":3021,"PHASE2":3023,"PHASE3":3025,"PHASE4":3031,"NA":3033},{"trials":3020,"activeCount":102},[],{"trials":3022,"activeCount":102},[],{"trials":3024,"activeCount":102},[],{"trials":3026,"activeCount":102},[3027],{"nctId":3002,"briefTitle":3003,"status":419,"phases":3028,"primaryCompletion":3005,"completion":3006,"start":1268,"enrollment":1176,"conditions":3029,"interventions":3030},[91,92],[3008,3009,3010],[2991,3012],{"trials":3032,"activeCount":102},[],{"trials":3034,"activeCount":102},[],{"intervention":3036,"totalTrials":116,"cells":3037},"Hydroxychloroquine",{"EARLY_PHASE1":3038,"PHASE1":3040,"PHASE2":3042,"PHASE3":3044,"PHASE4":3055,"NA":3057},{"trials":3039,"activeCount":102},[],{"trials":3041,"activeCount":102},[],{"trials":3043,"activeCount":102},[],{"trials":3045,"activeCount":102},[3046],{"nctId":3047,"briefTitle":3048,"status":825,"phases":3049,"primaryCompletion":3050,"completion":3050,"start":3051,"enrollment":102,"conditions":3052,"interventions":3054},"NCT04397328","COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada",[92],"2021-04-30","2020-05-30",[3053],"COVID-19",[3036],{"trials":3056,"activeCount":102},[],{"trials":3058,"activeCount":102},[],{"intervention":3060,"totalTrials":116,"cells":3061},"Indocyanine green",{"EARLY_PHASE1":3062,"PHASE1":3064,"PHASE2":3066,"PHASE3":3068,"PHASE4":3081,"NA":3083},{"trials":3063,"activeCount":102},[],{"trials":3065,"activeCount":102},[],{"trials":3067,"activeCount":102},[],{"trials":3069,"activeCount":102},[3070],{"nctId":3071,"briefTitle":3072,"status":216,"phases":3073,"primaryCompletion":3074,"completion":3075,"start":3076,"enrollment":27,"conditions":3077,"interventions":3080},"NCT04904081","Feasibility of Use of Indocyanine Green in Pediatric Colorectal Surgery",[92],"2024-06","2024-07","2021-06-16",[3078,3079],"Hirschsprung Disease","Anorectal Malformations",[3060],{"trials":3082,"activeCount":102},[],{"trials":3084,"activeCount":102},[],{"intervention":3086,"totalTrials":116,"cells":3087},"St. John's Wort",{"EARLY_PHASE1":3088,"PHASE1":3090,"PHASE2":3092,"PHASE3":3094,"PHASE4":3105,"NA":3107},{"trials":3089,"activeCount":102},[],{"trials":3091,"activeCount":102},[],{"trials":3093,"activeCount":102},[],{"trials":3095,"activeCount":102},[3096],{"nctId":3097,"briefTitle":3098,"status":419,"phases":3099,"primaryCompletion":2132,"completion":2132,"start":3100,"enrollment":697,"conditions":3101,"interventions":3103},"NCT00351117","St. John's Wort in the Treatment of Raynaud's Phenomenon",[92],"2007-03",[3102],"Raynaud's Disease",[3086,3104],"Lactose",{"trials":3106,"activeCount":102},[],{"trials":3108,"activeCount":102},[],{"intervention":3104,"totalTrials":116,"cells":3110},{"EARLY_PHASE1":3111,"PHASE1":3113,"PHASE2":3115,"PHASE3":3117,"PHASE4":3123,"NA":3125},{"trials":3112,"activeCount":102},[],{"trials":3114,"activeCount":102},[],{"trials":3116,"activeCount":102},[],{"trials":3118,"activeCount":102},[3119],{"nctId":3097,"briefTitle":3098,"status":419,"phases":3120,"primaryCompletion":2132,"completion":2132,"start":3100,"enrollment":697,"conditions":3121,"interventions":3122},[92],[3102],[3086,3104],{"trials":3124,"activeCount":102},[],{"trials":3126,"activeCount":102},[],{"intervention":3128,"totalTrials":116,"cells":3129},"Acetaminophen, Analgesics, Non-Narcotic",{"EARLY_PHASE1":3130,"PHASE1":3132,"PHASE2":3134,"PHASE3":3136,"PHASE4":3151,"NA":3153},{"trials":3131,"activeCount":102},[],{"trials":3133,"activeCount":102},[],{"trials":3135,"activeCount":102},[],{"trials":3137,"activeCount":102},[3138],{"nctId":3139,"briefTitle":3140,"status":419,"phases":3141,"primaryCompletion":3142,"completion":3143,"start":3144,"enrollment":3145,"conditions":3146,"interventions":3149},"NCT02582307","Buscopan Versus Acetaminophen for Acute Abdominal Pain in Children",[92],"2018-12-03","2019-02-22","2017-03-20",236,[3147,3148],"Abdomen, Acute","Children",[3128,3150],"Hyoscine butylbromide, Analgesics, Non-Narcotic",{"trials":3152,"activeCount":102},[],{"trials":3154,"activeCount":102},[],{"intervention":3150,"totalTrials":116,"cells":3156},{"EARLY_PHASE1":3157,"PHASE1":3159,"PHASE2":3161,"PHASE3":3163,"PHASE4":3169,"NA":3171},{"trials":3158,"activeCount":102},[],{"trials":3160,"activeCount":102},[],{"trials":3162,"activeCount":102},[],{"trials":3164,"activeCount":102},[3165],{"nctId":3139,"briefTitle":3140,"status":419,"phases":3166,"primaryCompletion":3142,"completion":3143,"start":3144,"enrollment":3145,"conditions":3167,"interventions":3168},[92],[3147,3148],[3128,3150],{"trials":3170,"activeCount":102},[],{"trials":3172,"activeCount":102},[],{"intervention":3174,"totalTrials":116,"cells":3175},"Topical vancomycin paste",{"EARLY_PHASE1":3176,"PHASE1":3178,"PHASE2":3180,"PHASE3":3182,"PHASE4":3198,"NA":3200},{"trials":3177,"activeCount":102},[],{"trials":3179,"activeCount":102},[],{"trials":3181,"activeCount":102},[],{"trials":3183,"activeCount":102},[3184],{"nctId":3185,"briefTitle":3186,"status":216,"phases":3187,"primaryCompletion":3188,"completion":3189,"start":3190,"enrollment":3191,"conditions":3192,"interventions":3197},"NCT04238923","Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis",[91,92],"2021-05-01","2021-07-01","2020-05-01",356,[3193,3194,3195,3196],"Vascular Diseases","Peripheral Vascular Disease","Surgical Site Infection","Bypass Complication",[3174],{"trials":3199,"activeCount":102},[],{"trials":3201,"activeCount":102},[],{"intervention":3203,"totalTrials":116,"cells":3204},"N-acetylcysteine",{"EARLY_PHASE1":3205,"PHASE1":3207,"PHASE2":3209,"PHASE3":3211,"PHASE4":3220,"NA":3222},{"trials":3206,"activeCount":102},[],{"trials":3208,"activeCount":102},[],{"trials":3210,"activeCount":102},[],{"trials":3212,"activeCount":102},[3213],{"nctId":3214,"briefTitle":3215,"status":419,"phases":3216,"primaryCompletion":3217,"completion":3217,"start":2019,"enrollment":586,"conditions":3218,"interventions":3219},"NCT00506506","Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease",[92],"2008-10",[2416],[3203],{"trials":3221,"activeCount":102},[],{"trials":3223,"activeCount":102},[],{"intervention":1134,"totalTrials":116,"cells":3225},{"EARLY_PHASE1":3226,"PHASE1":3228,"PHASE2":3230,"PHASE3":3232,"PHASE4":3238,"NA":3240},{"trials":3227,"activeCount":102},[],{"trials":3229,"activeCount":102},[],{"trials":3231,"activeCount":102},[],{"trials":3233,"activeCount":102},[3234],{"nctId":1124,"briefTitle":1125,"status":419,"phases":3235,"primaryCompletion":1127,"completion":1127,"start":1128,"enrollment":1129,"conditions":3236,"interventions":3237},[92],[1131,223,1132],[1134,1112,1135],{"trials":3239,"activeCount":102},[],{"trials":3241,"activeCount":102},[],{"intervention":3243,"totalTrials":116,"cells":3244},"4L PegLyte + 15 mg bisacodyl",{"EARLY_PHASE1":3245,"PHASE1":3247,"PHASE2":3249,"PHASE3":3251,"PHASE4":3265,"NA":3267},{"trials":3246,"activeCount":102},[],{"trials":3248,"activeCount":102},[],{"trials":3250,"activeCount":102},[],{"trials":3252,"activeCount":102},[3253],{"nctId":3254,"briefTitle":3255,"status":419,"phases":3256,"primaryCompletion":3257,"completion":3257,"start":3258,"enrollment":3259,"conditions":3260,"interventions":3263},"NCT02976805","Multi-centre Failed Bowel Prep RCT",[92],"2020-02-19","2017-02-13",196,[3261,3262],"Colonoscopy","Bowel Preparation",[3243,3264],"6L PegLyte + 15 mg bisacodyl",{"trials":3266,"activeCount":102},[],{"trials":3268,"activeCount":102},[],{"intervention":3264,"totalTrials":116,"cells":3270},{"EARLY_PHASE1":3271,"PHASE1":3273,"PHASE2":3275,"PHASE3":3277,"PHASE4":3283,"NA":3285},{"trials":3272,"activeCount":102},[],{"trials":3274,"activeCount":102},[],{"trials":3276,"activeCount":102},[],{"trials":3278,"activeCount":102},[3279],{"nctId":3254,"briefTitle":3255,"status":419,"phases":3280,"primaryCompletion":3257,"completion":3257,"start":3258,"enrollment":3259,"conditions":3281,"interventions":3282},[92],[3261,3262],[3243,3264],{"trials":3284,"activeCount":102},[],{"trials":3286,"activeCount":102},[],{"intervention":3288,"totalTrials":98,"cells":3289},"Saline Nasal Mist",{"EARLY_PHASE1":3290,"PHASE1":3292,"PHASE2":3304,"PHASE3":3316,"PHASE4":3318,"NA":3320},{"trials":3291,"activeCount":102},[],{"trials":3293,"activeCount":102},[3294],{"nctId":3295,"briefTitle":3296,"status":419,"phases":3297,"primaryCompletion":3298,"start":2389,"enrollment":3299,"conditions":3300,"interventions":3302},"NCT01386333","Safety Study of Intranasal Oxytocin in Frontotemporal Dementia",[90],"2013-10",23,[3301],"Frontotemporal Dementia",[3303,3288],"oxytocin",{"trials":3305,"activeCount":102},[3306],{"nctId":3307,"briefTitle":3308,"status":419,"phases":3309,"primaryCompletion":3310,"completion":3310,"start":3311,"enrollment":3312,"conditions":3313,"interventions":3314},"NCT01937013","Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia",[91],"2017-12-21","2013-09-12",52,[3301],[3315,3288],"Intranasal oxytocin",{"trials":3317,"activeCount":102},[],{"trials":3319,"activeCount":102},[],{"trials":3321,"activeCount":102},[],{"intervention":3323,"totalTrials":116,"cells":3324},"Fecal Microbial Transplants",{"EARLY_PHASE1":3325,"PHASE1":3327,"PHASE2":3329,"PHASE3":3341,"PHASE4":3343,"NA":3345},{"trials":3326,"activeCount":102},[],{"trials":3328,"activeCount":102},[],{"trials":3330,"activeCount":102},[3331],{"nctId":3332,"briefTitle":3333,"status":216,"phases":3334,"primaryCompletion":3335,"completion":3336,"start":3337,"enrollment":3338,"conditions":3339,"interventions":3340},"NCT04150549","FMT for MS Patients",[91],"2025-05","2025-08","2023-06",34,[3010],[3323,3323],{"trials":3342,"activeCount":102},[],{"trials":3344,"activeCount":102},[],{"trials":3346,"activeCount":102},[],{"intervention":3348,"totalTrials":116,"cells":3349},"Ipratropium bromide",{"EARLY_PHASE1":3350,"PHASE1":3352,"PHASE2":3354,"PHASE3":3365,"PHASE4":3367,"NA":3369},{"trials":3351,"activeCount":102},[],{"trials":3353,"activeCount":102},[],{"trials":3355,"activeCount":102},[3356],{"nctId":3357,"briefTitle":3358,"status":216,"phases":3359,"primaryCompletion":3360,"completion":609,"start":3361,"enrollment":1106,"conditions":3362,"interventions":3364},"NCT03747536","Ipratropium Bromide Spray as Treatment for Sialorrhea in Children",[91],"2019-10-01","2019-01-01",[3363],"Sialorrhea",[3348],{"trials":3366,"activeCount":102},[],{"trials":3368,"activeCount":102},[],{"trials":3370,"activeCount":102},[],{"intervention":3372,"totalTrials":116,"cells":3373},"Concurrent platinum-based chemotherapy",{"EARLY_PHASE1":3374,"PHASE1":3376,"PHASE2":3378,"PHASE3":3388,"PHASE4":3390,"NA":3392},{"trials":3375,"activeCount":102},[],{"trials":3377,"activeCount":102},[],{"trials":3379,"activeCount":102},[3380],{"nctId":3381,"briefTitle":3382,"status":112,"phases":3383,"primaryCompletion":2047,"completion":2047,"start":1432,"enrollment":3384,"conditions":3385,"interventions":3387},"NCT02002052","Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial",[91],29,[3386],"Non-small Cell Lung Cancer",[3372],{"trials":3389,"activeCount":102},[],{"trials":3391,"activeCount":102},[],{"trials":3393,"activeCount":102},[],{"intervention":3395,"totalTrials":116,"cells":3396},"Intranasal Beclomethasone aerosol",{"EARLY_PHASE1":3397,"PHASE1":3399,"PHASE2":3401,"PHASE3":3414,"PHASE4":3416,"NA":3418},{"trials":3398,"activeCount":102},[],{"trials":3400,"activeCount":102},[],{"trials":3402,"activeCount":102},[3403],{"nctId":3404,"briefTitle":3405,"status":419,"phases":3406,"primaryCompletion":3407,"completion":3408,"start":3409,"enrollment":1106,"conditions":3410,"interventions":3412},"NCT00788463","A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps",[91],"2009-03-30","2011-11-30","2006-11-23",[3411],"Nasal Polyps",[3395,3413],"Intranasal Beclomethasone spray",{"trials":3415,"activeCount":102},[],{"trials":3417,"activeCount":102},[],{"trials":3419,"activeCount":102},[],{"intervention":3413,"totalTrials":116,"cells":3421},{"EARLY_PHASE1":3422,"PHASE1":3424,"PHASE2":3426,"PHASE3":3432,"PHASE4":3434,"NA":3436},{"trials":3423,"activeCount":102},[],{"trials":3425,"activeCount":102},[],{"trials":3427,"activeCount":102},[3428],{"nctId":3404,"briefTitle":3405,"status":419,"phases":3429,"primaryCompletion":3407,"completion":3408,"start":3409,"enrollment":1106,"conditions":3430,"interventions":3431},[91],[3411],[3395,3413],{"trials":3433,"activeCount":102},[],{"trials":3435,"activeCount":102},[],{"trials":3437,"activeCount":102},[],{"intervention":3439,"totalTrials":116,"cells":3440},"Beta blocker",{"EARLY_PHASE1":3441,"PHASE1":3443,"PHASE2":3445,"PHASE3":3457,"PHASE4":3459,"NA":3461},{"trials":3442,"activeCount":102},[],{"trials":3444,"activeCount":102},[],{"trials":3446,"activeCount":102},[3447],{"nctId":3448,"briefTitle":3449,"status":419,"phases":3450,"primaryCompletion":3451,"completion":3451,"start":3452,"enrollment":3453,"conditions":3454,"interventions":3456},"NCT03361280","Removal of Beta Blocker Drugs by Hemodialysis",[90,91],"2016-03-10","2015-02-27",8,[3455],"Chronic Kidney Diseases",[3439],{"trials":3458,"activeCount":102},[],{"trials":3460,"activeCount":102},[],{"trials":3462,"activeCount":102},[],{"intervention":3464,"totalTrials":116,"cells":3465},"Oxygen + Sevoflurane",{"EARLY_PHASE1":3466,"PHASE1":3468,"PHASE2":3470,"PHASE3":3481,"PHASE4":3483,"NA":3485},{"trials":3467,"activeCount":102},[],{"trials":3469,"activeCount":102},[],{"trials":3471,"activeCount":102},[3472],{"nctId":3473,"briefTitle":3474,"status":419,"phases":3475,"primaryCompletion":1909,"completion":1909,"start":3476,"enrollment":756,"conditions":3477,"interventions":3479},"NCT00971607","Sevoflurane In Acute Myocardial Infarction",[91],"2009-05",[3478],"Acute Myocardial Infarction",[3464,3480],"Oxygen",{"trials":3482,"activeCount":102},[],{"trials":3484,"activeCount":102},[],{"trials":3486,"activeCount":102},[],{"intervention":3480,"totalTrials":116,"cells":3488},{"EARLY_PHASE1":3489,"PHASE1":3491,"PHASE2":3493,"PHASE3":3499,"PHASE4":3501,"NA":3503},{"trials":3490,"activeCount":102},[],{"trials":3492,"activeCount":102},[],{"trials":3494,"activeCount":102},[3495],{"nctId":3473,"briefTitle":3474,"status":419,"phases":3496,"primaryCompletion":1909,"completion":1909,"start":3476,"enrollment":756,"conditions":3497,"interventions":3498},[91],[3478],[3464,3480],{"trials":3500,"activeCount":102},[],{"trials":3502,"activeCount":102},[],{"trials":3504,"activeCount":102},[],{"intervention":3506,"totalTrials":116,"cells":3507},"Ranibizumab",{"EARLY_PHASE1":3508,"PHASE1":3510,"PHASE2":3512,"PHASE3":3524,"PHASE4":3526,"NA":3528},{"trials":3509,"activeCount":102},[],{"trials":3511,"activeCount":102},[],{"trials":3513,"activeCount":102},[3514],{"nctId":3515,"briefTitle":3516,"status":419,"phases":3517,"primaryCompletion":3518,"completion":3519,"start":3520,"enrollment":2922,"conditions":3521,"interventions":3523},"NCT00841581","Lucentis to Treat Pigment Epithelial Detachment",[91],"2011-09","2011-12","2008-12",[3522],"Pigment Epithelial Detachment",[3506],{"trials":3525,"activeCount":102},[],{"trials":3527,"activeCount":102},[],{"trials":3529,"activeCount":102},[],{"intervention":3531,"totalTrials":116,"cells":3532},"Imatinib mesylate",{"EARLY_PHASE1":3533,"PHASE1":3535,"PHASE2":3537,"PHASE3":3547,"PHASE4":3549,"NA":3551},{"trials":3534,"activeCount":102},[],{"trials":3536,"activeCount":102},[],{"trials":3538,"activeCount":102},[3539],{"nctId":3540,"briefTitle":3541,"status":112,"phases":3542,"primaryCompletion":3520,"completion":3520,"start":3543,"enrollment":33,"conditions":3544,"interventions":3546},"NCT01545427","Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma",[91],"2008-04",[3545],"Scleroderma",[3531],{"trials":3548,"activeCount":102},[],{"trials":3550,"activeCount":102},[],{"trials":3552,"activeCount":102},[],{"intervention":3554,"totalTrials":116,"cells":3555},"Dextrose 50",{"EARLY_PHASE1":3556,"PHASE1":3558,"PHASE2":3560,"PHASE3":3571,"PHASE4":3573,"NA":3575},{"trials":3557,"activeCount":102},[],{"trials":3559,"activeCount":102},[],{"trials":3561,"activeCount":102},[3562],{"nctId":3563,"briefTitle":3564,"status":216,"phases":3565,"primaryCompletion":3566,"completion":3566,"start":3567,"enrollment":13,"conditions":3568,"interventions":3570},"NCT06293885","Pleurodesis Using Hypertonic Glucose",[91],"2025-04-30","2024-03-30",[3569],"Air Leak From Lung",[3554],{"trials":3572,"activeCount":102},[],{"trials":3574,"activeCount":102},[],{"trials":3576,"activeCount":102},[],{"intervention":3578,"totalTrials":116,"cells":3579},"Autologous",{"EARLY_PHASE1":3580,"PHASE1":3582,"PHASE2":3584,"PHASE3":3598,"PHASE4":3600,"NA":3602},{"trials":3581,"activeCount":102},[],{"trials":3583,"activeCount":102},[],{"trials":3585,"activeCount":102},[3586],{"nctId":3587,"briefTitle":3588,"status":419,"phases":3589,"primaryCompletion":3590,"completion":3591,"start":1342,"enrollment":3592,"conditions":3593,"interventions":3596},"NCT02496390","Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD",[90,91],"2018-04","2018-12",21,[3594,3595],"Diabetes Mellitus","Non-alcoholic Fatty Liver Disease",[3578,3597],"Allogeneic",{"trials":3599,"activeCount":102},[],{"trials":3601,"activeCount":102},[],{"trials":3603,"activeCount":102},[],{"intervention":3597,"totalTrials":116,"cells":3605},{"EARLY_PHASE1":3606,"PHASE1":3608,"PHASE2":3610,"PHASE3":3616,"PHASE4":3618,"NA":3620},{"trials":3607,"activeCount":102},[],{"trials":3609,"activeCount":102},[],{"trials":3611,"activeCount":102},[3612],{"nctId":3587,"briefTitle":3588,"status":419,"phases":3613,"primaryCompletion":3590,"completion":3591,"start":1342,"enrollment":3592,"conditions":3614,"interventions":3615},[90,91],[3594,3595],[3578,3597],{"trials":3617,"activeCount":102},[],{"trials":3619,"activeCount":102},[],{"trials":3621,"activeCount":102},[],{"intervention":3623,"totalTrials":116,"cells":3624},"L-thryoxine",{"EARLY_PHASE1":3625,"PHASE1":3627,"PHASE2":3629,"PHASE3":3641,"PHASE4":3643,"NA":3645},{"trials":3626,"activeCount":102},[],{"trials":3628,"activeCount":102},[],{"trials":3630,"activeCount":102},[3631],{"nctId":3632,"briefTitle":3633,"status":419,"phases":3634,"primaryCompletion":3476,"completion":3635,"start":3636,"enrollment":3338,"conditions":3637,"interventions":3639},"NCT00238030","Thyroxine Replacement in Organ Donors",[90,91],"2010-10","2004-12",[3638],"Brain Death",[3623,3640],"iv thryoxine",{"trials":3642,"activeCount":102},[],{"trials":3644,"activeCount":102},[],{"trials":3646,"activeCount":102},[],{"intervention":3640,"totalTrials":116,"cells":3648},{"EARLY_PHASE1":3649,"PHASE1":3651,"PHASE2":3653,"PHASE3":3659,"PHASE4":3661,"NA":3663},{"trials":3650,"activeCount":102},[],{"trials":3652,"activeCount":102},[],{"trials":3654,"activeCount":102},[3655],{"nctId":3632,"briefTitle":3633,"status":419,"phases":3656,"primaryCompletion":3476,"completion":3635,"start":3636,"enrollment":3338,"conditions":3657,"interventions":3658},[90,91],[3638],[3623,3640],{"trials":3660,"activeCount":102},[],{"trials":3662,"activeCount":102},[],{"trials":3664,"activeCount":102},[],{"intervention":3666,"totalTrials":116,"cells":3667},"Nandrolone",{"EARLY_PHASE1":3668,"PHASE1":3670,"PHASE2":3672,"PHASE3":3683,"PHASE4":3685,"NA":3687},{"trials":3669,"activeCount":102},[],{"trials":3671,"activeCount":102},[],{"trials":3673,"activeCount":102},[3674],{"nctId":3675,"briefTitle":3676,"status":112,"phases":3677,"primaryCompletion":2019,"completion":2019,"start":3678,"enrollment":697,"conditions":3679,"interventions":3682},"NCT00242463","Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients",[91],"2005-10",[3680,3681],"Malnutrition","Critical Illness",[3666],{"trials":3684,"activeCount":102},[],{"trials":3686,"activeCount":102},[],{"trials":3688,"activeCount":102},[],{"intervention":3690,"totalTrials":116,"cells":3691},"2% lidocaine gel",{"EARLY_PHASE1":3692,"PHASE1":3694,"PHASE2":3696,"PHASE3":3706,"PHASE4":3708,"NA":3710},{"trials":3693,"activeCount":102},[],{"trials":3695,"activeCount":102},[],{"trials":3697,"activeCount":102},[3698],{"nctId":3699,"briefTitle":3700,"status":419,"phases":3701,"primaryCompletion":1228,"completion":1228,"start":3519,"enrollment":3702,"conditions":3703,"interventions":3704},"NCT01690767","A Study to Assess the Ability of 2% Lidocaine Gel to Reduce the Discomfort of Urethral Catheterization",[91],133,[2233],[3690,3705],"Health Care Lubricating Jelly",{"trials":3707,"activeCount":102},[],{"trials":3709,"activeCount":102},[],{"trials":3711,"activeCount":102},[],{"intervention":3705,"totalTrials":116,"cells":3713},{"EARLY_PHASE1":3714,"PHASE1":3716,"PHASE2":3718,"PHASE3":3724,"PHASE4":3726,"NA":3728},{"trials":3715,"activeCount":102},[],{"trials":3717,"activeCount":102},[],{"trials":3719,"activeCount":102},[3720],{"nctId":3699,"briefTitle":3700,"status":419,"phases":3721,"primaryCompletion":1228,"completion":1228,"start":3519,"enrollment":3702,"conditions":3722,"interventions":3723},[91],[2233],[3690,3705],{"trials":3725,"activeCount":102},[],{"trials":3727,"activeCount":102},[],{"trials":3729,"activeCount":102},[],{"intervention":3731,"totalTrials":116,"cells":3732},"Silver Colloid",{"EARLY_PHASE1":3733,"PHASE1":3735,"PHASE2":3737,"PHASE3":3750,"PHASE4":3752,"NA":3754},{"trials":3734,"activeCount":102},[],{"trials":3736,"activeCount":102},[],{"trials":3738,"activeCount":102},[3739],{"nctId":3740,"briefTitle":3741,"status":419,"phases":3742,"primaryCompletion":3743,"completion":3744,"start":3745,"enrollment":3746,"conditions":3747,"interventions":3749},"NCT02403479","The Effectiveness of Topical Silver Colloid in Treating Patients With Recalcitrant Chronic Rhinosinusitis",[90,91],"2016-03-06","2017-04-08","2015-12-10",22,[3748],"Rhinosinusitis",[3731],{"trials":3751,"activeCount":102},[],{"trials":3753,"activeCount":102},[],{"trials":3755,"activeCount":102},[],{"intervention":3757,"totalTrials":116,"cells":3758},"Ambroxol",{"EARLY_PHASE1":3759,"PHASE1":3761,"PHASE2":3763,"PHASE3":3772,"PHASE4":3774,"NA":3776},{"trials":3760,"activeCount":102},[],{"trials":3762,"activeCount":102},[],{"trials":3764,"activeCount":102},[3765],{"nctId":3766,"briefTitle":3767,"status":216,"phases":3768,"primaryCompletion":754,"completion":754,"start":1227,"enrollment":423,"conditions":3769,"interventions":3771},"NCT02914366","Ambroxol as a Treatment for Parkinson's Disease Dementia",[91],[3770],"Parkinson's Disease Dementia",[3757],{"trials":3773,"activeCount":102},[],{"trials":3775,"activeCount":102},[],{"trials":3777,"activeCount":102},[],{"intervention":3779,"totalTrials":116,"cells":3780},"Fecal microbiota",{"EARLY_PHASE1":3781,"PHASE1":3783,"PHASE2":3785,"PHASE3":3799,"PHASE4":3801,"NA":3803},{"trials":3782,"activeCount":102},[],{"trials":3784,"activeCount":102},[],{"trials":3786,"activeCount":102},[3787],{"nctId":3788,"briefTitle":3789,"status":112,"phases":3790,"primaryCompletion":3791,"completion":3792,"start":3793,"enrollment":3794,"conditions":3795,"interventions":3798},"NCT03183869","Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients",[91],"2018-11-19","2019-01-25","2017-08-24",14,[3796,3797],"Autoimmune Diseases","Relapsing Multiple Sclerosis",[3779],{"trials":3800,"activeCount":102},[],{"trials":3802,"activeCount":102},[],{"trials":3804,"activeCount":102},[],{"intervention":3806,"totalTrials":116,"cells":3807},"bimodal solution",{"EARLY_PHASE1":3808,"PHASE1":3810,"PHASE2":3812,"PHASE3":3825,"PHASE4":3827,"NA":3829},{"trials":3809,"activeCount":102},[],{"trials":3811,"activeCount":102},[],{"trials":3813,"activeCount":102},[3814],{"nctId":3815,"briefTitle":3816,"status":419,"phases":3817,"primaryCompletion":3818,"completion":3818,"start":3819,"enrollment":3820,"conditions":3821,"interventions":3823},"NCT01242904","Use of a Bimodal Solution for Peritoneal Dialysis",[91],"2015-02-28","2010-09-30",36,[3822],"End Stage Renal Disease",[3806,3824],"icodextrin",{"trials":3826,"activeCount":102},[],{"trials":3828,"activeCount":102},[],{"trials":3830,"activeCount":102},[],{"intervention":3824,"totalTrials":116,"cells":3832},{"EARLY_PHASE1":3833,"PHASE1":3835,"PHASE2":3837,"PHASE3":3843,"PHASE4":3845,"NA":3847},{"trials":3834,"activeCount":102},[],{"trials":3836,"activeCount":102},[],{"trials":3838,"activeCount":102},[3839],{"nctId":3815,"briefTitle":3816,"status":419,"phases":3840,"primaryCompletion":3818,"completion":3818,"start":3819,"enrollment":3820,"conditions":3841,"interventions":3842},[91],[3822],[3806,3824],{"trials":3844,"activeCount":102},[],{"trials":3846,"activeCount":102},[],{"trials":3848,"activeCount":102},[],{"intervention":3850,"totalTrials":116,"cells":3851},"Metformin",{"EARLY_PHASE1":3852,"PHASE1":3854,"PHASE2":3856,"PHASE3":3866,"PHASE4":3868,"NA":3870},{"trials":3853,"activeCount":102},[],{"trials":3855,"activeCount":102},[],{"trials":3857,"activeCount":102},[3858],{"nctId":3859,"briefTitle":3860,"status":216,"phases":3861,"primaryCompletion":2723,"completion":2723,"start":1709,"enrollment":131,"conditions":3862,"interventions":3864},"NCT02360618","Metformin and Simvastatin Use in Bladder Cancer",[91],[3863],"Bladder Cancer",[3850,3865],"Simvastatin",{"trials":3867,"activeCount":102},[],{"trials":3869,"activeCount":102},[],{"trials":3871,"activeCount":102},[],{"intervention":3865,"totalTrials":116,"cells":3873},{"EARLY_PHASE1":3874,"PHASE1":3876,"PHASE2":3878,"PHASE3":3884,"PHASE4":3886,"NA":3888},{"trials":3875,"activeCount":102},[],{"trials":3877,"activeCount":102},[],{"trials":3879,"activeCount":102},[3880],{"nctId":3859,"briefTitle":3860,"status":216,"phases":3881,"primaryCompletion":2723,"completion":2723,"start":1709,"enrollment":131,"conditions":3882,"interventions":3883},[91],[3863],[3850,3865],{"trials":3885,"activeCount":102},[],{"trials":3887,"activeCount":102},[],{"trials":3889,"activeCount":102},[],{"intervention":3891,"totalTrials":116,"cells":3892},"Amino Acids w\u002FElectrolytes in Dextrose",{"EARLY_PHASE1":3893,"PHASE1":3895,"PHASE2":3897,"PHASE3":3906,"PHASE4":3908,"NA":3910},{"trials":3894,"activeCount":102},[],{"trials":3896,"activeCount":102},[],{"trials":3898,"activeCount":102},[3899],{"nctId":3900,"briefTitle":3901,"status":419,"phases":3902,"primaryCompletion":2724,"completion":2724,"start":1151,"enrollment":448,"conditions":3903,"interventions":3904},"NCT02632630","Nutrition Supplementation in Hospitalized Patients",[91],[3680],[3891,3905],"Crystalloid solutions",{"trials":3907,"activeCount":102},[],{"trials":3909,"activeCount":102},[],{"trials":3911,"activeCount":102},[],{"intervention":3905,"totalTrials":116,"cells":3913},{"EARLY_PHASE1":3914,"PHASE1":3916,"PHASE2":3918,"PHASE3":3924,"PHASE4":3926,"NA":3928},{"trials":3915,"activeCount":102},[],{"trials":3917,"activeCount":102},[],{"trials":3919,"activeCount":102},[3920],{"nctId":3900,"briefTitle":3901,"status":419,"phases":3921,"primaryCompletion":2724,"completion":2724,"start":1151,"enrollment":448,"conditions":3922,"interventions":3923},[91],[3680],[3891,3905],{"trials":3925,"activeCount":102},[],{"trials":3927,"activeCount":102},[],{"trials":3929,"activeCount":102},[],{"intervention":3931,"totalTrials":116,"cells":3932},"Luteinizing Hormone Releasing Hormone (LHRH) Agonist",{"EARLY_PHASE1":3933,"PHASE1":3935,"PHASE2":3937,"PHASE3":3946,"PHASE4":3948,"NA":3950},{"trials":3934,"activeCount":102},[],{"trials":3936,"activeCount":102},[],{"trials":3938,"activeCount":102},[3939],{"nctId":3940,"briefTitle":3941,"status":112,"phases":3942,"primaryCompletion":3943,"completion":3943,"start":3518,"enrollment":1712,"conditions":3944,"interventions":3945},"NCT01439542","FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer",[91],"2017-11",[17],[3931],{"trials":3947,"activeCount":102},[],{"trials":3949,"activeCount":102},[],{"trials":3951,"activeCount":102},[],{"intervention":3953,"totalTrials":116,"cells":3954},"Hydrogen Peroxide 30 % Topical Solution",{"EARLY_PHASE1":3955,"PHASE1":3957,"PHASE2":3959,"PHASE3":3971,"PHASE4":3973,"NA":3975},{"trials":3956,"activeCount":102},[],{"trials":3958,"activeCount":102},[],{"trials":3960,"activeCount":102},[3961],{"nctId":3962,"briefTitle":3963,"status":216,"phases":3964,"primaryCompletion":3965,"completion":3966,"start":1666,"enrollment":2678,"conditions":3967,"interventions":3970},"NCT04929535","Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment",[91],"2023-08","2023-12",[3968,3969],"Basal Cell Carcinoma","Squamous Cell Carcinoma of Skin Differentiated",[3953],{"trials":3972,"activeCount":102},[],{"trials":3974,"activeCount":102},[],{"trials":3976,"activeCount":102},[],{"intervention":3978,"totalTrials":116,"cells":3979},"Syntocinon",{"EARLY_PHASE1":3980,"PHASE1":3982,"PHASE2":3984,"PHASE3":3996,"PHASE4":3998,"NA":4000},{"trials":3981,"activeCount":102},[],{"trials":3983,"activeCount":102},[],{"trials":3985,"activeCount":102},[3986],{"nctId":3987,"briefTitle":3988,"status":216,"phases":3989,"primaryCompletion":3990,"completion":3991,"start":3992,"enrollment":3993,"conditions":3994,"interventions":3995},"NCT03260920","Intranasal Oxytocin for Frontotemporal Dementia",[91],"2023-06-30","2024-12-31","2018-01-31",112,[3301],[3978],{"trials":3997,"activeCount":102},[],{"trials":3999,"activeCount":102},[],{"trials":4001,"activeCount":102},[],{"intervention":4003,"totalTrials":116,"cells":4004},"Mesna",{"EARLY_PHASE1":4005,"PHASE1":4007,"PHASE2":4009,"PHASE3":4017,"PHASE4":4019,"NA":4021},{"trials":4006,"activeCount":102},[],{"trials":4008,"activeCount":102},[],{"trials":4010,"activeCount":102},[4011],{"nctId":4012,"briefTitle":4013,"status":419,"phases":4014,"completion":2133,"start":3100,"enrollment":33,"conditions":4015,"interventions":4016},"NCT00524199","Effects of Mesna on Homocysteine in Kidney Failure",[91],[3822],[4003],{"trials":4018,"activeCount":102},[],{"trials":4020,"activeCount":102},[],{"trials":4022,"activeCount":102},[],{"intervention":4024,"totalTrials":116,"cells":4025},"Panax Ginseng",{"EARLY_PHASE1":4026,"PHASE1":4028,"PHASE2":4030,"PHASE3":4043,"PHASE4":4045,"NA":4047},{"trials":4027,"activeCount":102},[],{"trials":4029,"activeCount":102},[],{"trials":4031,"activeCount":102},[4032],{"nctId":4033,"briefTitle":4034,"status":419,"phases":4035,"primaryCompletion":1189,"completion":2019,"start":4036,"enrollment":586,"conditions":4037,"interventions":4042},"NCT00401089","Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia",[90,91],"2002-12",[4038,4039,4040,4041,1935],"Schizophrenia","Schizoaffective Disorder","Tardive Dyskinesia","Insulin Resistance",[4024],{"trials":4044,"activeCount":102},[],{"trials":4046,"activeCount":102},[],{"trials":4048,"activeCount":102},[],{"intervention":4050,"totalTrials":116,"cells":4051},"Sirolimus",{"EARLY_PHASE1":4052,"PHASE1":4054,"PHASE2":4056,"PHASE3":4066,"PHASE4":4068,"NA":4070},{"trials":4053,"activeCount":102},[],{"trials":4055,"activeCount":102},[],{"trials":4057,"activeCount":102},[4058],{"nctId":4059,"briefTitle":4060,"status":419,"phases":4061,"primaryCompletion":4062,"completion":4062,"start":3519,"enrollment":18,"conditions":4063,"interventions":4065},"NCT01595841","Sirolimus Use in Angioplasty for Vascular Access Extension",[91],"2022-03",[3822,4064],"Venous Stenosis",[4050],{"trials":4067,"activeCount":102},[],{"trials":4069,"activeCount":102},[],{"trials":4071,"activeCount":102},[],{"intervention":4073,"totalTrials":116,"cells":4074},"Avastin",{"EARLY_PHASE1":4075,"PHASE1":4077,"PHASE2":4079,"PHASE3":4091,"PHASE4":4093,"NA":4095},{"trials":4076,"activeCount":102},[],{"trials":4078,"activeCount":102},[],{"trials":4080,"activeCount":102},[4081],{"nctId":4082,"briefTitle":4083,"status":419,"phases":4084,"primaryCompletion":1933,"completion":1933,"start":4085,"enrollment":4086,"conditions":4087,"interventions":4089},"NCT00376701","Combination Therapy for Age-Related Macular Degeneration.",[91],"2006-09",103,[4088],"Age Related Macular Degeneration",[4073,4090,4090,4090],"Bevacizumab",{"trials":4092,"activeCount":102},[],{"trials":4094,"activeCount":102},[],{"trials":4096,"activeCount":102},[],{"intervention":4090,"totalTrials":116,"cells":4098},{"EARLY_PHASE1":4099,"PHASE1":4101,"PHASE2":4103,"PHASE3":4109,"PHASE4":4111,"NA":4113},{"trials":4100,"activeCount":102},[],{"trials":4102,"activeCount":102},[],{"trials":4104,"activeCount":102},[4105],{"nctId":4082,"briefTitle":4083,"status":419,"phases":4106,"primaryCompletion":1933,"completion":1933,"start":4085,"enrollment":4086,"conditions":4107,"interventions":4108},[91],[4088],[4073,4090,4090,4090],{"trials":4110,"activeCount":102},[],{"trials":4112,"activeCount":102},[],{"trials":4114,"activeCount":102},[],{"intervention":1180,"totalTrials":116,"cells":4116},{"EARLY_PHASE1":4117,"PHASE1":4119,"PHASE2":4121,"PHASE3":4127,"PHASE4":4129,"NA":4131},{"trials":4118,"activeCount":102},[],{"trials":4120,"activeCount":102},[],{"trials":4122,"activeCount":102},[4123],{"nctId":1171,"briefTitle":1172,"status":419,"phases":4124,"primaryCompletion":1174,"completion":1174,"start":1175,"enrollment":1176,"conditions":4125,"interventions":4126},[91],[1178],[1162,1180],{"trials":4128,"activeCount":102},[],{"trials":4130,"activeCount":102},[],{"trials":4132,"activeCount":102},[],{"intervention":4134,"totalTrials":116,"cells":4135},"recombinant human annexin A5",{"EARLY_PHASE1":4136,"PHASE1":4138,"PHASE2":4140,"PHASE3":4154,"PHASE4":4156,"NA":4158},{"trials":4137,"activeCount":102},[],{"trials":4139,"activeCount":102},[],{"trials":4141,"activeCount":102},[4142],{"nctId":4143,"briefTitle":4144,"status":419,"phases":4145,"primaryCompletion":4146,"completion":4147,"start":4148,"enrollment":4149,"conditions":4150,"interventions":4153},"NCT04748757","Annexin A5 in Patients With Severe COVID-19 Disease",[91],"2022-04-03","2022-12-01","2021-04-20",18,[4151,4152],"Coronavirus Infection","Sepsis",[4134],{"trials":4155,"activeCount":102},[],{"trials":4157,"activeCount":102},[],{"trials":4159,"activeCount":102},[],{"intervention":4161,"totalTrials":116,"cells":4162},"Opioids",{"EARLY_PHASE1":4163,"PHASE1":4165,"PHASE2":4167,"PHASE3":4181,"PHASE4":4183,"NA":4185},{"trials":4164,"activeCount":102},[],{"trials":4166,"activeCount":102},[],{"trials":4168,"activeCount":102},[4169],{"nctId":4170,"briefTitle":4171,"status":419,"phases":4172,"primaryCompletion":4173,"completion":4173,"start":4174,"enrollment":4175,"conditions":4176,"interventions":4179},"NCT04221165","Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer",[91],"2023-09-15","2020-08-04",49,[4177,4178],"Head and Neck Cancer","Radiation-Induced Mucositis",[4161,4180],"PAiN - multimodal analgesia",{"trials":4182,"activeCount":102},[],{"trials":4184,"activeCount":102},[],{"trials":4186,"activeCount":102},[],{"intervention":4180,"totalTrials":116,"cells":4188},{"EARLY_PHASE1":4189,"PHASE1":4191,"PHASE2":4193,"PHASE3":4199,"PHASE4":4201,"NA":4203},{"trials":4190,"activeCount":102},[],{"trials":4192,"activeCount":102},[],{"trials":4194,"activeCount":102},[4195],{"nctId":4170,"briefTitle":4171,"status":419,"phases":4196,"primaryCompletion":4173,"completion":4173,"start":4174,"enrollment":4175,"conditions":4197,"interventions":4198},[91],[4177,4178],[4161,4180],{"trials":4200,"activeCount":102},[],{"trials":4202,"activeCount":102},[],{"trials":4204,"activeCount":102},[],{"intervention":4206,"totalTrials":116,"cells":4207},"Probiotic",{"EARLY_PHASE1":4208,"PHASE1":4210,"PHASE2":4212,"PHASE3":4222,"PHASE4":4224,"NA":4226},{"trials":4209,"activeCount":102},[],{"trials":4211,"activeCount":102},[],{"trials":4213,"activeCount":102},[4214],{"nctId":4215,"briefTitle":4216,"status":216,"phases":4217,"primaryCompletion":4218,"completion":3966,"start":4219,"enrollment":3820,"conditions":4220,"interventions":4221},"NCT02044965","Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder",[90,91],"2022-12","2015-01",[2233],[4206],{"trials":4223,"activeCount":102},[],{"trials":4225,"activeCount":102},[],{"trials":4227,"activeCount":102},[],{"intervention":1403,"totalTrials":116,"cells":4229},{"EARLY_PHASE1":4230,"PHASE1":4232,"PHASE2":4234,"PHASE3":4240,"PHASE4":4242,"NA":4244},{"trials":4231,"activeCount":102},[],{"trials":4233,"activeCount":102},[],{"trials":4235,"activeCount":102},[4236],{"nctId":1395,"briefTitle":1396,"status":419,"phases":4237,"primaryCompletion":1398,"completion":1398,"start":1268,"enrollment":1399,"conditions":4238,"interventions":4239},[91],[1401],[1403,1233],{"trials":4241,"activeCount":102},[],{"trials":4243,"activeCount":102},[],{"trials":4245,"activeCount":102},[],{"intervention":4247,"totalTrials":116,"cells":4248},"Vitamin C",{"EARLY_PHASE1":4249,"PHASE1":4251,"PHASE2":4253,"PHASE3":4263,"PHASE4":4265,"NA":4267},{"trials":4250,"activeCount":102},[],{"trials":4252,"activeCount":102},[],{"trials":4254,"activeCount":102},[4255],{"nctId":4256,"briefTitle":4257,"status":216,"phases":4258,"primaryCompletion":828,"completion":4259,"start":1932,"enrollment":697,"conditions":4260,"interventions":4262},"NCT01590303","Outcome Following Vitamin C Administration in Sepsis",[91],"2013-09",[4261],"Severe Sepsis",[4247],{"trials":4264,"activeCount":102},[],{"trials":4266,"activeCount":102},[],{"trials":4268,"activeCount":102},[],{"intervention":4270,"totalTrials":116,"cells":4271},"Bovine Lipid Extract Surfactant",{"EARLY_PHASE1":4272,"PHASE1":4274,"PHASE2":4276,"PHASE3":4287,"PHASE4":4289,"NA":4291},{"trials":4273,"activeCount":102},[],{"trials":4275,"activeCount":102},[],{"trials":4277,"activeCount":102},[4278],{"nctId":4279,"briefTitle":4280,"status":419,"phases":4281,"primaryCompletion":1665,"completion":4282,"start":4283,"enrollment":697,"conditions":4284,"interventions":4286},"NCT04375735","London's Exogenous Surfactant Study for COVID19",[90,91],"2021-10-06","2020-11-23",[4285,3053],"ARDS, Human",[4270],{"trials":4288,"activeCount":102},[],{"trials":4290,"activeCount":102},[],{"trials":4292,"activeCount":102},[],{"intervention":4294,"totalTrials":116,"cells":4295},"Androgen Suppression",{"EARLY_PHASE1":4296,"PHASE1":4298,"PHASE2":4300,"PHASE3":4310,"PHASE4":4312,"NA":4314},{"trials":4297,"activeCount":102},[],{"trials":4299,"activeCount":102},[],{"trials":4301,"activeCount":102},[4302],{"nctId":4303,"briefTitle":4304,"status":419,"phases":4305,"primaryCompletion":4306,"completion":4307,"start":1228,"enrollment":586,"conditions":4308,"interventions":4309},"NCT02229734","Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2",[91],"2017-08","2021-06-01",[17],[4294],{"trials":4311,"activeCount":102},[],{"trials":4313,"activeCount":102},[],{"trials":4315,"activeCount":102},[],{"intervention":4317,"totalTrials":116,"cells":4318},"Seacalphyx (sodium thiosulfate pentahydrate injection BP) 25%",{"EARLY_PHASE1":4319,"PHASE1":4321,"PHASE2":4332,"PHASE3":4334,"PHASE4":4336,"NA":4338},{"trials":4320,"activeCount":102},[],{"trials":4322,"activeCount":102},[4323],{"nctId":4324,"briefTitle":4325,"status":419,"phases":4326,"primaryCompletion":4327,"completion":4327,"start":4328,"enrollment":4149,"conditions":4329,"interventions":4331},"NCT04292184","Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation",[90],"2022-11-01","2021-03-21",[4330],"End Stage Renal Disease (ESRD)",[4317],{"trials":4333,"activeCount":102},[],{"trials":4335,"activeCount":102},[],{"trials":4337,"activeCount":102},[],{"trials":4339,"activeCount":102},[],{"intervention":4341,"totalTrials":116,"cells":4342},"metformin hydrochloride",{"EARLY_PHASE1":4343,"PHASE1":4345,"PHASE2":4362,"PHASE3":4364,"PHASE4":4366,"NA":4368},{"trials":4344,"activeCount":102},[],{"trials":4346,"activeCount":102},[4347],{"nctId":4348,"briefTitle":4349,"status":419,"phases":4350,"primaryCompletion":4351,"completion":4352,"start":4353,"enrollment":4354,"conditions":4355,"interventions":4360},"NCT00659568","Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma",[90],"2010-02","2010-08","2008-03",28,[531,4356,4357,4358,2259,4359],"Endometrial Cancer","Kidney Cancer","Lung Cancer","Unspecified Adult Solid Tumor, Protocol Specific",[4341,4361],"temsirolimus",{"trials":4363,"activeCount":102},[],{"trials":4365,"activeCount":102},[],{"trials":4367,"activeCount":102},[],{"trials":4369,"activeCount":102},[],{"intervention":4361,"totalTrials":116,"cells":4371},{"EARLY_PHASE1":4372,"PHASE1":4374,"PHASE2":4380,"PHASE3":4382,"PHASE4":4384,"NA":4386},{"trials":4373,"activeCount":102},[],{"trials":4375,"activeCount":102},[4376],{"nctId":4348,"briefTitle":4349,"status":419,"phases":4377,"primaryCompletion":4351,"completion":4352,"start":4353,"enrollment":4354,"conditions":4378,"interventions":4379},[90],[531,4356,4357,4358,2259,4359],[4341,4361],{"trials":4381,"activeCount":102},[],{"trials":4383,"activeCount":102},[],{"trials":4385,"activeCount":102},[],{"trials":4387,"activeCount":102},[],{"intervention":4389,"totalTrials":116,"cells":4390},"50 mL of 50% Glucose",{"EARLY_PHASE1":4391,"PHASE1":4393,"PHASE2":4406,"PHASE3":4408,"PHASE4":4410,"NA":4412},{"trials":4392,"activeCount":102},[],{"trials":4394,"activeCount":102},[4395],{"nctId":4396,"briefTitle":4397,"status":419,"phases":4398,"primaryCompletion":2772,"completion":2772,"start":4399,"enrollment":27,"conditions":4400,"interventions":4402},"NCT03905408","Pleurodesis Using Hypertonic Glucose to Treat Post-operative Air Leaks",[90],"2019-09-17",[4401],"Postoperative Air Leak",[4389,4403,4404,4405],"100 mL of 50% Glucose","150 mL of 50% Glucose","200 mL of 50% Glucose",{"trials":4407,"activeCount":102},[],{"trials":4409,"activeCount":102},[],{"trials":4411,"activeCount":102},[],{"trials":4413,"activeCount":102},[],{"intervention":4403,"totalTrials":116,"cells":4415},{"EARLY_PHASE1":4416,"PHASE1":4418,"PHASE2":4424,"PHASE3":4426,"PHASE4":4428,"NA":4430},{"trials":4417,"activeCount":102},[],{"trials":4419,"activeCount":102},[4420],{"nctId":4396,"briefTitle":4397,"status":419,"phases":4421,"primaryCompletion":2772,"completion":2772,"start":4399,"enrollment":27,"conditions":4422,"interventions":4423},[90],[4401],[4389,4403,4404,4405],{"trials":4425,"activeCount":102},[],{"trials":4427,"activeCount":102},[],{"trials":4429,"activeCount":102},[],{"trials":4431,"activeCount":102},[],{"intervention":4404,"totalTrials":116,"cells":4433},{"EARLY_PHASE1":4434,"PHASE1":4436,"PHASE2":4442,"PHASE3":4444,"PHASE4":4446,"NA":4448},{"trials":4435,"activeCount":102},[],{"trials":4437,"activeCount":102},[4438],{"nctId":4396,"briefTitle":4397,"status":419,"phases":4439,"primaryCompletion":2772,"completion":2772,"start":4399,"enrollment":27,"conditions":4440,"interventions":4441},[90],[4401],[4389,4403,4404,4405],{"trials":4443,"activeCount":102},[],{"trials":4445,"activeCount":102},[],{"trials":4447,"activeCount":102},[],{"trials":4449,"activeCount":102},[],{"intervention":4405,"totalTrials":116,"cells":4451},{"EARLY_PHASE1":4452,"PHASE1":4454,"PHASE2":4460,"PHASE3":4462,"PHASE4":4464,"NA":4466},{"trials":4453,"activeCount":102},[],{"trials":4455,"activeCount":102},[4456],{"nctId":4396,"briefTitle":4397,"status":419,"phases":4457,"primaryCompletion":2772,"completion":2772,"start":4399,"enrollment":27,"conditions":4458,"interventions":4459},[90],[4401],[4389,4403,4404,4405],{"trials":4461,"activeCount":102},[],{"trials":4463,"activeCount":102},[],{"trials":4465,"activeCount":102},[],{"trials":4467,"activeCount":102},[],{"intervention":4469,"totalTrials":116,"cells":4470},"Ethanol and Paclitaxel",{"EARLY_PHASE1":4471,"PHASE1":4473,"PHASE2":4485,"PHASE3":4487,"PHASE4":4489,"NA":4491},{"trials":4472,"activeCount":102},[],{"trials":4474,"activeCount":102},[4475],{"nctId":4476,"briefTitle":4477,"status":112,"phases":4478,"primaryCompletion":1431,"completion":1431,"start":1268,"enrollment":116,"conditions":4479,"interventions":4484},"NCT01525706","Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm",[90],[4480,4481,4482,4483],"Mucinous Cystic Tumor With Moderate Dysplasia","Mucinous Cystadenoma of Pancreas","Mucinous Cystadenocarcinoma of Pancreas","Benign Neoplasm of Pancreas",[4469],{"trials":4486,"activeCount":102},[],{"trials":4488,"activeCount":102},[],{"trials":4490,"activeCount":102},[],{"trials":4492,"activeCount":102},[],{"intervention":4494,"totalTrials":116,"cells":4495},"Premarin",{"EARLY_PHASE1":4496,"PHASE1":4498,"PHASE2":4509,"PHASE3":4511,"PHASE4":4513,"NA":4515},{"trials":4497,"activeCount":102},[],{"trials":4499,"activeCount":102},[4500],{"nctId":4501,"briefTitle":4502,"status":419,"phases":4503,"primaryCompletion":1189,"completion":4504,"start":1174,"enrollment":697,"conditions":4505,"interventions":4508},"NCT00318318","Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array",[90],"2007-02",[4506,4507],"Healthy","Estrogen Replacement Therapy",[4494],{"trials":4510,"activeCount":102},[],{"trials":4512,"activeCount":102},[],{"trials":4514,"activeCount":102},[],{"trials":4516,"activeCount":102},[],{"intervention":3303,"totalTrials":116,"cells":4518},{"EARLY_PHASE1":4519,"PHASE1":4521,"PHASE2":4527,"PHASE3":4529,"PHASE4":4531,"NA":4533},{"trials":4520,"activeCount":102},[],{"trials":4522,"activeCount":102},[4523],{"nctId":3295,"briefTitle":3296,"status":419,"phases":4524,"primaryCompletion":3298,"start":2389,"enrollment":3299,"conditions":4525,"interventions":4526},[90],[3301],[3303,3288],{"trials":4528,"activeCount":102},[],{"trials":4530,"activeCount":102},[],{"trials":4532,"activeCount":102},[],{"trials":4534,"activeCount":102},[],{"intervention":4536,"totalTrials":116,"cells":4537},"Icodextrin\u002FDextrose",{"EARLY_PHASE1":4538,"PHASE1":4540,"PHASE2":4551,"PHASE3":4553,"PHASE4":4555,"NA":4557},{"trials":4539,"activeCount":102},[],{"trials":4541,"activeCount":102},[4542],{"nctId":4543,"briefTitle":4544,"status":419,"phases":4545,"primaryCompletion":4546,"completion":4546,"start":4547,"enrollment":33,"conditions":4548,"interventions":4550},"NCT05185999","Icodextrin Study to Test Short-Term Safety, Tolerability and Preliminary Efficacy of Sodium-Free Solution in PD Patients",[90],"2023-10-20","2022-10-17",[4549],"Chronic Kidney Failure",[4536],{"trials":4552,"activeCount":102},[],{"trials":4554,"activeCount":102},[],{"trials":4556,"activeCount":102},[],{"trials":4558,"activeCount":102},[],{"intervention":4560,"totalTrials":116,"cells":4561},"Proparacaine drops 0.05%",{"EARLY_PHASE1":4562,"PHASE1":4564,"PHASE2":4575,"PHASE3":4577,"PHASE4":4579,"NA":4581},{"trials":4563,"activeCount":102},[],{"trials":4565,"activeCount":102},[4566],{"nctId":4567,"briefTitle":4568,"status":419,"phases":4569,"primaryCompletion":4085,"completion":4085,"start":3678,"enrollment":4570,"conditions":4571,"interventions":4573},"NCT00620997","Proparacaine vs Placebo for Corneal Injuries",[90],43,[4572],"Corneal Abrasions",[4560,4574],"saline drops",{"trials":4576,"activeCount":102},[],{"trials":4578,"activeCount":102},[],{"trials":4580,"activeCount":102},[],{"trials":4582,"activeCount":102},[],{"intervention":4574,"totalTrials":116,"cells":4584},{"EARLY_PHASE1":4585,"PHASE1":4587,"PHASE2":4593,"PHASE3":4595,"PHASE4":4597,"NA":4599},{"trials":4586,"activeCount":102},[],{"trials":4588,"activeCount":102},[4589],{"nctId":4567,"briefTitle":4568,"status":419,"phases":4590,"primaryCompletion":4085,"completion":4085,"start":3678,"enrollment":4570,"conditions":4591,"interventions":4592},[90],[4572],[4560,4574],{"trials":4594,"activeCount":102},[],{"trials":4596,"activeCount":102},[],{"trials":4598,"activeCount":102},[],{"trials":4600,"activeCount":102},[],{"intervention":4602,"totalTrials":116,"cells":4603},"Felodipine",{"EARLY_PHASE1":4604,"PHASE1":4606,"PHASE2":4616,"PHASE3":4618,"PHASE4":4620,"NA":4622},{"trials":4605,"activeCount":102},[],{"trials":4607,"activeCount":102},[4608],{"nctId":4609,"briefTitle":4610,"status":419,"phases":4611,"primaryCompletion":1711,"completion":1288,"start":4612,"enrollment":24,"conditions":4613,"interventions":4615},"NCT02232269","Coffee Interaction With the Antihypertensive Drug Felodipine",[90],"2012-02",[4614],"Food-Drug Interactions",[4602],{"trials":4617,"activeCount":102},[],{"trials":4619,"activeCount":102},[],{"trials":4621,"activeCount":102},[],{"trials":4623,"activeCount":102},[],{"intervention":4625,"totalTrials":116,"cells":4626},"Propranolol",{"EARLY_PHASE1":4627,"PHASE1":4638,"PHASE2":4640,"PHASE3":4642,"PHASE4":4644,"NA":4646},{"trials":4628,"activeCount":102},[4629],{"nctId":4630,"briefTitle":4631,"status":216,"phases":4632,"primaryCompletion":4633,"completion":67,"start":4634,"enrollment":756,"conditions":4635,"interventions":4637},"NCT06262061","Propranolol for the Treatment of Traumatic Brain Injury",[89],"2025-04","2024-03",[4636],"TBI (Traumatic Brain Injury)",[4625],{"trials":4639,"activeCount":102},[],{"trials":4641,"activeCount":102},[],{"trials":4643,"activeCount":102},[],{"trials":4645,"activeCount":102},[],{"trials":4647,"activeCount":102},[],{"intervention":4649,"totalTrials":116,"cells":4650},"Acetylsalicylic Acid",{"EARLY_PHASE1":4651,"PHASE1":4662,"PHASE2":4664,"PHASE3":4666,"PHASE4":4668,"NA":4670},{"trials":4652,"activeCount":102},[4653],{"nctId":4654,"briefTitle":4655,"status":216,"phases":4656,"primaryCompletion":3335,"completion":67,"start":3074,"enrollment":13,"conditions":4657,"interventions":4661},"NCT06383650","Use of 81 vs 325mg of ASA in Treatment of BCVI",[89],[4658,4659,4660],"Carotid Artery Injuries","Traumatic Injury","Vertebral Artery Injury",[4649],{"trials":4663,"activeCount":102},[],{"trials":4665,"activeCount":102},[],{"trials":4667,"activeCount":102},[],{"trials":4669,"activeCount":102},[],{"trials":4671,"activeCount":102},[],{"intervention":4673,"totalTrials":116,"cells":4674},"Yohimbine",{"EARLY_PHASE1":4675,"PHASE1":4688,"PHASE2":4690,"PHASE3":4692,"PHASE4":4694,"NA":4696},{"trials":4676,"activeCount":102},[4677],{"nctId":4678,"briefTitle":4679,"status":112,"phases":4680,"primaryCompletion":4681,"completion":4681,"start":1240,"enrollment":33,"conditions":4682,"interventions":4686},"NCT02963181","Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension",[89],"2019-05-28",[4683,4684,4685],"Hypotension, Orthostatic","Hypertension","Autonomic Nervous System Diseases",[4673,4687],"Melatonin",{"trials":4689,"activeCount":102},[],{"trials":4691,"activeCount":102},[],{"trials":4693,"activeCount":102},[],{"trials":4695,"activeCount":102},[],{"trials":4697,"activeCount":102},[],{"intervention":4687,"totalTrials":116,"cells":4699},{"EARLY_PHASE1":4700,"PHASE1":4706,"PHASE2":4708,"PHASE3":4710,"PHASE4":4712,"NA":4714},{"trials":4701,"activeCount":102},[4702],{"nctId":4678,"briefTitle":4679,"status":112,"phases":4703,"primaryCompletion":4681,"completion":4681,"start":1240,"enrollment":33,"conditions":4704,"interventions":4705},[89],[4683,4684,4685],[4673,4687],{"trials":4707,"activeCount":102},[],{"trials":4709,"activeCount":102},[],{"trials":4711,"activeCount":102},[],{"trials":4713,"activeCount":102},[],{"trials":4715,"activeCount":102},[],{"intervention":4717,"totalTrials":408,"cells":4718},"Lidocaine",{"EARLY_PHASE1":4719,"PHASE1":4721,"PHASE2":4723,"PHASE3":4725,"PHASE4":4727,"NA":4741},{"trials":4720,"activeCount":102},[],{"trials":4722,"activeCount":102},[],{"trials":4724,"activeCount":102},[],{"trials":4726,"activeCount":102},[],{"trials":4728,"activeCount":102},[4729],{"nctId":4730,"briefTitle":4731,"status":216,"phases":4732,"primaryCompletion":4733,"completion":4733,"start":4734,"enrollment":1229,"conditions":4735,"interventions":4739},"NCT02862769","Intra-operative Lidocaine Infusion in Preventing CPSP Post VATs",[93],"2019-12","2017-01-01",[4736,4737,4738],"Chronic Pain","Acute Pain","Neuralgia",[4717,4740],"Saline",{"trials":4742,"activeCount":102},[4743,4755,4763],{"nctId":4744,"briefTitle":4745,"status":419,"phases":4746,"primaryCompletion":4747,"completion":4747,"start":4748,"enrollment":4749,"conditions":4750,"interventions":4752},"NCT01224847","Intravitreal Injection Anesthesia - Comparison of Different Topical Agents",[94],"2009-11","2009-10",92,[4751],"Age-Related Macular Degeneration (AMD)",[4753,4754,4717],"Tetracaine","Cocaine",{"nctId":4756,"briefTitle":4757,"status":419,"phases":4758,"primaryCompletion":1710,"completion":1710,"start":3518,"enrollment":3338,"conditions":4759,"interventions":4761},"NCT01669967","The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin",[94],[4760],"Neuropathic Pain",[4717,4762],"Diphenhydramine",{"nctId":4764,"briefTitle":4765,"status":419,"phases":4766,"primaryCompletion":4767,"completion":4768,"start":4769,"enrollment":4770,"conditions":4771,"interventions":4773},"NCT03391427","Ketamine, Lidocaine and Combination for Postoperative Analgesia in Open Liver Resection",[94],"2015-11-04","2017-12-30","2011-03-01",124,[4772],"Hepatectomy",[4717,4774,4775,4740],"Ketamine","Lidocaine+ketamine",{"intervention":226,"totalTrials":1113,"cells":4777},{"EARLY_PHASE1":4778,"PHASE1":4780,"PHASE2":4782,"PHASE3":4784,"PHASE4":4790,"NA":4792},{"trials":4779,"activeCount":102},[],{"trials":4781,"activeCount":102},[],{"trials":4783,"activeCount":102},[],{"trials":4785,"activeCount":102},[4786],{"nctId":214,"briefTitle":215,"status":216,"phases":4787,"primaryCompletion":218,"start":219,"enrollment":220,"conditions":4788,"interventions":4789},[92],[222,223,224],[226,203,227,228,87,229],{"trials":4791,"activeCount":102},[],{"trials":4793,"activeCount":102},[4794,4801],{"nctId":4795,"briefTitle":4796,"status":419,"phases":4797,"primaryCompletion":218,"completion":218,"start":1710,"enrollment":1176,"conditions":4798,"interventions":4800},"NCT02657291","Costoclavicular vs Paracoracoid Approach to Infraclavicular Brachial Plexus Block: a Feasibility Study",[94],[4799],"Upper Limb Injury",[226],{"nctId":4802,"briefTitle":4803,"status":216,"phases":4804,"primaryCompletion":4805,"completion":3591,"start":4806,"enrollment":1229,"conditions":4807,"interventions":4809},"NCT03073928","Comparison of Paracoracoid Subscapularis Plane Block to Interscalene Block for Arthroscopic Shoulder Surgery",[94],"2018-03","2017-06-15",[4808],"Rotator Cuff Injury",[226],{"intervention":4740,"totalTrials":1113,"cells":4811},{"EARLY_PHASE1":4812,"PHASE1":4814,"PHASE2":4816,"PHASE3":4818,"PHASE4":4824,"NA":4830},{"trials":4813,"activeCount":102},[],{"trials":4815,"activeCount":102},[],{"trials":4817,"activeCount":102},[],{"trials":4819,"activeCount":102},[4820],{"nctId":214,"briefTitle":215,"status":216,"phases":4821,"primaryCompletion":218,"start":219,"enrollment":220,"conditions":4822,"interventions":4823},[92],[222,223,224],[226,203,227,228,87,229],{"trials":4825,"activeCount":102},[4826],{"nctId":4730,"briefTitle":4731,"status":216,"phases":4827,"primaryCompletion":4733,"completion":4733,"start":4734,"enrollment":1229,"conditions":4828,"interventions":4829},[93],[4736,4737,4738],[4717,4740],{"trials":4831,"activeCount":102},[4832],{"nctId":4764,"briefTitle":4765,"status":419,"phases":4833,"primaryCompletion":4767,"completion":4768,"start":4769,"enrollment":4770,"conditions":4834,"interventions":4835},[94],[4772],[4717,4774,4775,4740],{"intervention":3315,"totalTrials":98,"cells":4837},{"EARLY_PHASE1":4838,"PHASE1":4840,"PHASE2":4842,"PHASE3":4848,"PHASE4":4850,"NA":4852},{"trials":4839,"activeCount":102},[],{"trials":4841,"activeCount":102},[],{"trials":4843,"activeCount":102},[4844],{"nctId":3307,"briefTitle":3308,"status":419,"phases":4845,"primaryCompletion":3310,"completion":3310,"start":3311,"enrollment":3312,"conditions":4846,"interventions":4847},[91],[3301],[3315,3288],{"trials":4849,"activeCount":102},[],{"trials":4851,"activeCount":102},[],{"trials":4853,"activeCount":102},[4854],{"nctId":4855,"briefTitle":4856,"status":419,"phases":4857,"primaryCompletion":4858,"completion":4858,"start":4859,"enrollment":2022,"conditions":4860,"interventions":4862},"NCT01002300","Oxytocin and Social Cognition in Frontotemporal Dementia",[94],"2010-11","2009-09",[3301,4861],"Pick's Disease",[4863],"intranasal oxytocin",{"intervention":4774,"totalTrials":98,"cells":4865},{"EARLY_PHASE1":4866,"PHASE1":4868,"PHASE2":4870,"PHASE3":4872,"PHASE4":4874,"NA":4876},{"trials":4867,"activeCount":102},[],{"trials":4869,"activeCount":102},[],{"trials":4871,"activeCount":102},[],{"trials":4873,"activeCount":102},[],{"trials":4875,"activeCount":102},[],{"trials":4877,"activeCount":102},[4878,4885],{"nctId":4879,"briefTitle":4880,"status":419,"phases":4881,"primaryCompletion":1710,"completion":1710,"start":4882,"enrollment":27,"conditions":4883,"interventions":4884},"NCT02016664","Plasma Concentration of Ketamine and Norketamine .",[94],"2014-04",[4736],[4774],{"nctId":4764,"briefTitle":4765,"status":419,"phases":4886,"primaryCompletion":4767,"completion":4768,"start":4769,"enrollment":4770,"conditions":4887,"interventions":4888},[94],[4772],[4717,4774,4775,4740],{"intervention":4890,"totalTrials":116,"cells":4891},"Tranexamic Acid",{"EARLY_PHASE1":4892,"PHASE1":4894,"PHASE2":4896,"PHASE3":4898,"PHASE4":4900,"NA":4902},{"trials":4893,"activeCount":102},[],{"trials":4895,"activeCount":102},[],{"trials":4897,"activeCount":102},[],{"trials":4899,"activeCount":102},[],{"trials":4901,"activeCount":102},[],{"trials":4903,"activeCount":102},[4904],{"nctId":4905,"briefTitle":4906,"status":419,"phases":4907,"primaryCompletion":2437,"completion":2437,"start":4908,"enrollment":4909,"conditions":4910,"interventions":4911},"NCT02056444","Efficacy of Intravenous Versus Topical Tranexamic Acid in Primary Total Hip Arthroplasty",[94],"2014-02",149,[222],[4890],{"intervention":4913,"totalTrials":116,"cells":4914},"Cisatracurium",{"EARLY_PHASE1":4915,"PHASE1":4917,"PHASE2":4919,"PHASE3":4921,"PHASE4":4923,"NA":4925},{"trials":4916,"activeCount":102},[],{"trials":4918,"activeCount":102},[],{"trials":4920,"activeCount":102},[],{"trials":4922,"activeCount":102},[],{"trials":4924,"activeCount":102},[],{"trials":4926,"activeCount":102},[4927],{"nctId":4928,"briefTitle":4929,"status":216,"phases":4930,"primaryCompletion":1228,"completion":3006,"start":447,"enrollment":4931,"conditions":4932,"interventions":4934},"NCT02033733","When Cooling a Patient After Cardiac Arrest, Does Use of a Neuromuscular Blocking Agent Make Your Job Easier?",[],400,[4933],"Postcardiac Arrest Therapeutic Hypothermia",[4913,4935],"Cisatracurium prn bolus",{"intervention":4935,"totalTrials":116,"cells":4937},{"EARLY_PHASE1":4938,"PHASE1":4940,"PHASE2":4942,"PHASE3":4944,"PHASE4":4946,"NA":4948},{"trials":4939,"activeCount":102},[],{"trials":4941,"activeCount":102},[],{"trials":4943,"activeCount":102},[],{"trials":4945,"activeCount":102},[],{"trials":4947,"activeCount":102},[],{"trials":4949,"activeCount":102},[4950],{"nctId":4928,"briefTitle":4929,"status":216,"phases":4951,"primaryCompletion":1228,"completion":3006,"start":447,"enrollment":4931,"conditions":4952,"interventions":4953},[],[4933],[4913,4935],{"intervention":4955,"totalTrials":116,"cells":4956},"Individual-specific statin causing myopathy",{"EARLY_PHASE1":4957,"PHASE1":4959,"PHASE2":4961,"PHASE3":4963,"PHASE4":4965,"NA":4967},{"trials":4958,"activeCount":102},[],{"trials":4960,"activeCount":102},[],{"trials":4962,"activeCount":102},[],{"trials":4964,"activeCount":102},[],{"trials":4966,"activeCount":102},[],{"trials":4968,"activeCount":102},[4969],{"nctId":4970,"briefTitle":4971,"status":419,"phases":4972,"primaryCompletion":4973,"completion":4973,"start":4974,"enrollment":33,"conditions":4975,"interventions":4977},"NCT01259791","Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design",[94],"2013-08","2010-09",[4976],"Statin Myopathy",[4955],{"intervention":4979,"totalTrials":116,"cells":4980},"Protamine Sulfate",{"EARLY_PHASE1":4981,"PHASE1":4983,"PHASE2":4985,"PHASE3":4987,"PHASE4":4989,"NA":4991},{"trials":4982,"activeCount":102},[],{"trials":4984,"activeCount":102},[],{"trials":4986,"activeCount":102},[],{"trials":4988,"activeCount":102},[],{"trials":4990,"activeCount":102},[],{"trials":4992,"activeCount":102},[4993],{"nctId":4994,"briefTitle":4995,"status":216,"phases":4996,"primaryCompletion":4997,"completion":4998,"start":4999,"enrollment":448,"conditions":5000,"interventions":5002},"NCT03787641","Systematic Evaluation of Protamine Doze in Cardiac Surgery",[94],"2019-12-31","2020-02-28","2018-09-20",[5001],"Cardiac Surgery With Cardiopulmonary Bypass",[4979],{"intervention":5004,"totalTrials":116,"cells":5005},"Pramipexole",{"EARLY_PHASE1":5006,"PHASE1":5008,"PHASE2":5010,"PHASE3":5012,"PHASE4":5014,"NA":5016},{"trials":5007,"activeCount":102},[],{"trials":5009,"activeCount":102},[],{"trials":5011,"activeCount":102},[],{"trials":5013,"activeCount":102},[],{"trials":5015,"activeCount":102},[],{"trials":5017,"activeCount":102},[5018],{"nctId":5019,"briefTitle":5020,"status":419,"phases":5021,"primaryCompletion":5022,"completion":3991,"start":5023,"enrollment":5024,"conditions":5025,"interventions":5028},"NCT07382960","Pramipexole and the Risk of Serious Adverse Events",[],"2024-12-01","2008-01-01",1100,[5026,5027],"Older Adults (65 Years and Older)","Chronic Kidney Disease (CKD)",[5004],{"intervention":5030,"totalTrials":116,"cells":5031},"Venlafaxine or duloxetine",{"EARLY_PHASE1":5032,"PHASE1":5034,"PHASE2":5036,"PHASE3":5038,"PHASE4":5040,"NA":5042},{"trials":5033,"activeCount":102},[],{"trials":5035,"activeCount":102},[],{"trials":5037,"activeCount":102},[],{"trials":5039,"activeCount":102},[],{"trials":5041,"activeCount":102},[],{"trials":5043,"activeCount":102},[5044],{"nctId":5045,"briefTitle":5046,"status":419,"phases":5047,"primaryCompletion":193,"completion":86,"start":5048,"enrollment":5049,"conditions":5050,"interventions":5051},"NCT07531173","Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events",[],"2008-09-01",8688,[2416],[5030],{"intervention":5053,"totalTrials":116,"cells":5054},"Ranibizumab Ophthalmic",{"EARLY_PHASE1":5055,"PHASE1":5057,"PHASE2":5059,"PHASE3":5061,"PHASE4":5063,"NA":5065},{"trials":5056,"activeCount":102},[],{"trials":5058,"activeCount":102},[],{"trials":5060,"activeCount":102},[],{"trials":5062,"activeCount":102},[],{"trials":5064,"activeCount":102},[],{"trials":5066,"activeCount":102},[5067],{"nctId":5068,"briefTitle":5069,"status":419,"phases":5070,"primaryCompletion":4306,"completion":4306,"start":1735,"enrollment":2678,"conditions":5071,"interventions":5073},"NCT02979665","Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema",[],[5072],"Diabetic Macular Edema",[5053],{"intervention":4753,"totalTrials":116,"cells":5075},{"EARLY_PHASE1":5076,"PHASE1":5078,"PHASE2":5080,"PHASE3":5082,"PHASE4":5084,"NA":5086},{"trials":5077,"activeCount":102},[],{"trials":5079,"activeCount":102},[],{"trials":5081,"activeCount":102},[],{"trials":5083,"activeCount":102},[],{"trials":5085,"activeCount":102},[],{"trials":5087,"activeCount":102},[5088],{"nctId":4744,"briefTitle":4745,"status":419,"phases":5089,"primaryCompletion":4747,"completion":4747,"start":4748,"enrollment":4749,"conditions":5090,"interventions":5091},[94],[4751],[4753,4754,4717],{"intervention":4754,"totalTrials":116,"cells":5093},{"EARLY_PHASE1":5094,"PHASE1":5096,"PHASE2":5098,"PHASE3":5100,"PHASE4":5102,"NA":5104},{"trials":5095,"activeCount":102},[],{"trials":5097,"activeCount":102},[],{"trials":5099,"activeCount":102},[],{"trials":5101,"activeCount":102},[],{"trials":5103,"activeCount":102},[],{"trials":5105,"activeCount":102},[5106],{"nctId":4744,"briefTitle":4745,"status":419,"phases":5107,"primaryCompletion":4747,"completion":4747,"start":4748,"enrollment":4749,"conditions":5108,"interventions":5109},[94],[4751],[4753,4754,4717],{"intervention":5111,"totalTrials":116,"cells":5112},"Intrathecal Morphine",{"EARLY_PHASE1":5113,"PHASE1":5115,"PHASE2":5117,"PHASE3":5119,"PHASE4":5121,"NA":5123},{"trials":5114,"activeCount":102},[],{"trials":5116,"activeCount":102},[],{"trials":5118,"activeCount":102},[],{"trials":5120,"activeCount":102},[],{"trials":5122,"activeCount":102},[],{"trials":5124,"activeCount":102},[5125],{"nctId":5126,"briefTitle":5127,"status":112,"phases":5128,"primaryCompletion":5129,"completion":5129,"start":5130,"enrollment":3453,"conditions":5131,"interventions":5132},"NCT02339766","Quadratus Lumborum Block for Post-Cesarean Analgesia",[94],"2017-02-05","2015-10-01",[450],[5111,5133],"Intrathecal Saline",{"intervention":5133,"totalTrials":116,"cells":5135},{"EARLY_PHASE1":5136,"PHASE1":5138,"PHASE2":5140,"PHASE3":5142,"PHASE4":5144,"NA":5146},{"trials":5137,"activeCount":102},[],{"trials":5139,"activeCount":102},[],{"trials":5141,"activeCount":102},[],{"trials":5143,"activeCount":102},[],{"trials":5145,"activeCount":102},[],{"trials":5147,"activeCount":102},[5148],{"nctId":5126,"briefTitle":5127,"status":112,"phases":5149,"primaryCompletion":5129,"completion":5129,"start":5130,"enrollment":3453,"conditions":5150,"interventions":5151},[94],[450],[5111,5133],{"intervention":5153,"totalTrials":116,"cells":5154},"Premarin vaginal cream",{"EARLY_PHASE1":5155,"PHASE1":5157,"PHASE2":5159,"PHASE3":5161,"PHASE4":5163,"NA":5165},{"trials":5156,"activeCount":102},[],{"trials":5158,"activeCount":102},[],{"trials":5160,"activeCount":102},[],{"trials":5162,"activeCount":102},[],{"trials":5164,"activeCount":102},[],{"trials":5166,"activeCount":102},[5167],{"nctId":5168,"briefTitle":5169,"status":419,"phases":5170,"primaryCompletion":446,"completion":446,"start":5171,"enrollment":5172,"conditions":5173,"interventions":5176},"NCT01843166","Vaginal Estrogen With Pessary Treatment",[94],"2012-07",150,[5174,2233,5175],"Vaginal Infection","Quality of Life",[5153],{"intervention":5178,"totalTrials":116,"cells":5179},"sitagliptin",{"EARLY_PHASE1":5180,"PHASE1":5182,"PHASE2":5184,"PHASE3":5186,"PHASE4":5188,"NA":5190},{"trials":5181,"activeCount":102},[],{"trials":5183,"activeCount":102},[],{"trials":5185,"activeCount":102},[],{"trials":5187,"activeCount":102},[],{"trials":5189,"activeCount":102},[],{"trials":5191,"activeCount":102},[5192],{"nctId":5193,"briefTitle":5194,"status":112,"phases":5195,"primaryCompletion":1152,"completion":1152,"start":5196,"enrollment":27,"conditions":5197,"interventions":5199},"NCT01260246","Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes",[94],"2010-12",[1936,5198],"Nonalcoholic Steatohepatitis",[5178],{"intervention":5201,"totalTrials":116,"cells":5202},"Administration of Hypertonic Solution 7.5% vs Mannitol 20%",{"EARLY_PHASE1":5203,"PHASE1":5205,"PHASE2":5207,"PHASE3":5209,"PHASE4":5211,"NA":5213},{"trials":5204,"activeCount":102},[],{"trials":5206,"activeCount":102},[],{"trials":5208,"activeCount":102},[],{"trials":5210,"activeCount":102},[],{"trials":5212,"activeCount":102},[],{"trials":5214,"activeCount":102},[5215],{"nctId":5216,"briefTitle":5217,"status":419,"phases":5218,"completion":5219,"start":5220,"enrollment":5221,"conditions":5222,"interventions":5228},"NCT00199511","Hypertonic Saline 75% vs Mannitol 20%",[94],"2007-04","2005-01",162,[5223,5224,5225,5226,5227],"Brain Tumor","Tumor, Brain","Brain Neoplasm","Neoplasm, Supratentorial","Tumor, Supratentorial",[5201],{"intervention":5230,"totalTrials":116,"cells":5231},"Ametop",{"EARLY_PHASE1":5232,"PHASE1":5234,"PHASE2":5236,"PHASE3":5238,"PHASE4":5240,"NA":5242},{"trials":5233,"activeCount":102},[],{"trials":5235,"activeCount":102},[],{"trials":5237,"activeCount":102},[],{"trials":5239,"activeCount":102},[],{"trials":5241,"activeCount":102},[],{"trials":5243,"activeCount":102},[5244],{"nctId":5245,"briefTitle":5246,"status":825,"phases":5247,"completion":1189,"start":5248,"enrollment":102,"conditions":5249,"interventions":5250},"NCT00353002","A Comparison of Amethocaine Cream vs. Liposomal Lidocaine Cream for Venipuncture in Children.",[94],"2006-07",[1848],[5230,5251],"Maxilene",{"intervention":5251,"totalTrials":116,"cells":5253},{"EARLY_PHASE1":5254,"PHASE1":5256,"PHASE2":5258,"PHASE3":5260,"PHASE4":5262,"NA":5264},{"trials":5255,"activeCount":102},[],{"trials":5257,"activeCount":102},[],{"trials":5259,"activeCount":102},[],{"trials":5261,"activeCount":102},[],{"trials":5263,"activeCount":102},[],{"trials":5265,"activeCount":102},[5266],{"nctId":5245,"briefTitle":5246,"status":825,"phases":5267,"completion":1189,"start":5248,"enrollment":102,"conditions":5268,"interventions":5269},[94],[1848],[5230,5251],{"intervention":5271,"totalTrials":116,"cells":5272},"Fenofibrate",{"EARLY_PHASE1":5273,"PHASE1":5275,"PHASE2":5277,"PHASE3":5279,"PHASE4":5281,"NA":5283},{"trials":5274,"activeCount":102},[],{"trials":5276,"activeCount":102},[],{"trials":5278,"activeCount":102},[],{"trials":5280,"activeCount":102},[],{"trials":5282,"activeCount":102},[],{"trials":5284,"activeCount":102},[5285],{"nctId":5286,"briefTitle":5287,"status":112,"phases":5288,"primaryCompletion":3006,"completion":3006,"start":3520,"enrollment":408,"conditions":5289,"interventions":5291},"NCT00884819","Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome",[94],[5290],"Polycystic Ovary Syndrome",[5271],{"intervention":5293,"totalTrials":116,"cells":5294},"Hypertonic 50% dextrose pleurodesis",{"EARLY_PHASE1":5295,"PHASE1":5297,"PHASE2":5299,"PHASE3":5301,"PHASE4":5303,"NA":5305},{"trials":5296,"activeCount":102},[],{"trials":5298,"activeCount":102},[],{"trials":5300,"activeCount":102},[],{"trials":5302,"activeCount":102},[],{"trials":5304,"activeCount":102},[],{"trials":5306,"activeCount":102},[5307],{"nctId":5308,"briefTitle":5309,"status":419,"phases":5310,"primaryCompletion":2437,"completion":2437,"start":1152,"enrollment":33,"conditions":5311,"interventions":5313},"NCT02376218","Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial.",[94],[5312],"Pulmonary Surgical Procedures",[5293],{"intervention":5315,"totalTrials":116,"cells":5316},"Dose of ropivacaine",{"EARLY_PHASE1":5317,"PHASE1":5319,"PHASE2":5321,"PHASE3":5323,"PHASE4":5325,"NA":5327},{"trials":5318,"activeCount":102},[],{"trials":5320,"activeCount":102},[],{"trials":5322,"activeCount":102},[],{"trials":5324,"activeCount":102},[],{"trials":5326,"activeCount":102},[],{"trials":5328,"activeCount":102},[5329],{"nctId":5330,"briefTitle":5331,"status":216,"phases":5332,"primaryCompletion":5333,"completion":5333,"start":2838,"enrollment":423,"conditions":5334,"interventions":5336},"NCT03824717","MEV 90 of 0.5% Ropivacaine In Infraclavicular Blocks",[94],"2020-06",[5335],"Infraclavicular Brachial Plexus Block",[5315],{"intervention":5338,"totalTrials":116,"cells":5339},"6% Hydroxyethyl Starch 130\u002F0.4",{"EARLY_PHASE1":5340,"PHASE1":5342,"PHASE2":5344,"PHASE3":5346,"PHASE4":5348,"NA":5350},{"trials":5341,"activeCount":102},[],{"trials":5343,"activeCount":102},[],{"trials":5345,"activeCount":102},[],{"trials":5347,"activeCount":102},[],{"trials":5349,"activeCount":102},[],{"trials":5351,"activeCount":102},[5352],{"nctId":5353,"briefTitle":5354,"status":112,"phases":5355,"primaryCompletion":1777,"completion":1711,"start":5356,"enrollment":5357,"conditions":5358,"interventions":5360},"NCT00964015","Starch or Saline After Cardiac Surgery",[94],"2009-08",69,[5359],"Coronary Artery Bypass Surgery",[5338,5361],"0.9% Normal Saline",{"intervention":5361,"totalTrials":116,"cells":5363},{"EARLY_PHASE1":5364,"PHASE1":5366,"PHASE2":5368,"PHASE3":5370,"PHASE4":5372,"NA":5374},{"trials":5365,"activeCount":102},[],{"trials":5367,"activeCount":102},[],{"trials":5369,"activeCount":102},[],{"trials":5371,"activeCount":102},[],{"trials":5373,"activeCount":102},[],{"trials":5375,"activeCount":102},[5376],{"nctId":5353,"briefTitle":5354,"status":112,"phases":5377,"primaryCompletion":1777,"completion":1711,"start":5356,"enrollment":5357,"conditions":5378,"interventions":5379},[94],[5359],[5338,5361],{"intervention":4762,"totalTrials":116,"cells":5381},{"EARLY_PHASE1":5382,"PHASE1":5384,"PHASE2":5386,"PHASE3":5388,"PHASE4":5390,"NA":5392},{"trials":5383,"activeCount":102},[],{"trials":5385,"activeCount":102},[],{"trials":5387,"activeCount":102},[],{"trials":5389,"activeCount":102},[],{"trials":5391,"activeCount":102},[],{"trials":5393,"activeCount":102},[5394],{"nctId":4756,"briefTitle":4757,"status":419,"phases":5395,"primaryCompletion":1710,"completion":1710,"start":3518,"enrollment":3338,"conditions":5396,"interventions":5397},[94],[4760],[4717,4762],{"intervention":5399,"totalTrials":116,"cells":5400},"Comparison of Effects of Phenylephrine and Norepinephrine",{"EARLY_PHASE1":5401,"PHASE1":5403,"PHASE2":5405,"PHASE3":5407,"PHASE4":5409,"NA":5411},{"trials":5402,"activeCount":102},[],{"trials":5404,"activeCount":102},[],{"trials":5406,"activeCount":102},[],{"trials":5408,"activeCount":102},[],{"trials":5410,"activeCount":102},[],{"trials":5412,"activeCount":102},[5413],{"nctId":5414,"briefTitle":5415,"status":216,"phases":5416,"completion":5417,"start":5417,"enrollment":5418,"conditions":5419,"interventions":5423},"NCT00294606","Comparison of the Effects of Phenylephrine and Norepinephrine on Cardiac Function During Carotid Artery Surgery",[94],"2006-02",86,[5420,5421,5422],"Vasopressor Agents","Endarterectomy, Carotid","Echocardiography, Transesophageal",[5399],{"intervention":5425,"totalTrials":116,"cells":5426},"BYL719",{"EARLY_PHASE1":5427,"PHASE1":5429,"PHASE2":5431,"PHASE3":5433,"PHASE4":5435,"NA":5437},{"trials":5428,"activeCount":102},[],{"trials":5430,"activeCount":102},[],{"trials":5432,"activeCount":102},[],{"trials":5434,"activeCount":102},[],{"trials":5436,"activeCount":102},[],{"trials":5438,"activeCount":102},[5439],{"nctId":5440,"briefTitle":5441,"status":419,"phases":5442,"primaryCompletion":5443,"completion":5444,"start":5445,"enrollment":504,"conditions":5446,"interventions":5448},"NCT03138070","A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719",[94],"2021-09-13","2025-11-26","2017-10-20",[5447],"Head and Neck Squamous Cell Cancer",[5425],{"intervention":5450,"totalTrials":116,"cells":5451},"Clavulin",{"EARLY_PHASE1":5452,"PHASE1":5454,"PHASE2":5456,"PHASE3":5458,"PHASE4":5460,"NA":5462},{"trials":5453,"activeCount":102},[],{"trials":5455,"activeCount":102},[],{"trials":5457,"activeCount":102},[],{"trials":5459,"activeCount":102},[],{"trials":5461,"activeCount":102},[],{"trials":5463,"activeCount":102},[5464],{"nctId":5465,"briefTitle":5466,"status":825,"phases":5467,"primaryCompletion":5468,"completion":5469,"start":5470,"enrollment":102,"conditions":5471,"interventions":5473},"NCT01715610","Assessing the Necessity of Prescribing Antibiotics (Clavulin or Clindamycin Versus Placebo) Post-peritonsillar Abscess Drainage",[94],"2015-11-30","2015-12-02","2012-05-24",[5472],"Peritonsillar Abscess",[5450,5474,5475],"Randomization to Placebo","Clindamycin",{"intervention":5474,"totalTrials":116,"cells":5477},{"EARLY_PHASE1":5478,"PHASE1":5480,"PHASE2":5482,"PHASE3":5484,"PHASE4":5486,"NA":5488},{"trials":5479,"activeCount":102},[],{"trials":5481,"activeCount":102},[],{"trials":5483,"activeCount":102},[],{"trials":5485,"activeCount":102},[],{"trials":5487,"activeCount":102},[],{"trials":5489,"activeCount":102},[5490],{"nctId":5465,"briefTitle":5466,"status":825,"phases":5491,"primaryCompletion":5468,"completion":5469,"start":5470,"enrollment":102,"conditions":5492,"interventions":5493},[94],[5472],[5450,5474,5475],{"intervention":5475,"totalTrials":116,"cells":5495},{"EARLY_PHASE1":5496,"PHASE1":5498,"PHASE2":5500,"PHASE3":5502,"PHASE4":5504,"NA":5506},{"trials":5497,"activeCount":102},[],{"trials":5499,"activeCount":102},[],{"trials":5501,"activeCount":102},[],{"trials":5503,"activeCount":102},[],{"trials":5505,"activeCount":102},[],{"trials":5507,"activeCount":102},[5508],{"nctId":5465,"briefTitle":5466,"status":825,"phases":5509,"primaryCompletion":5468,"completion":5469,"start":5470,"enrollment":102,"conditions":5510,"interventions":5511},[94],[5472],[5450,5474,5475],{"intervention":5513,"totalTrials":116,"cells":5514},"Sertraline 50 mg",{"EARLY_PHASE1":5515,"PHASE1":5517,"PHASE2":5519,"PHASE3":5521,"PHASE4":5523,"NA":5525},{"trials":5516,"activeCount":102},[],{"trials":5518,"activeCount":102},[],{"trials":5520,"activeCount":102},[],{"trials":5522,"activeCount":102},[],{"trials":5524,"activeCount":102},[],{"trials":5526,"activeCount":102},[5527],{"nctId":5528,"briefTitle":5529,"status":419,"phases":5530,"primaryCompletion":503,"completion":501,"start":1531,"enrollment":5531,"conditions":5532,"interventions":5535},"NCT07387120","Sertraline and the Risk of Serious Adverse Events",[],6893,[5027,5533,5534],"Elderly","Outpatient",[5513,5536],"Sertraline 25 mg",{"intervention":5536,"totalTrials":116,"cells":5538},{"EARLY_PHASE1":5539,"PHASE1":5541,"PHASE2":5543,"PHASE3":5545,"PHASE4":5547,"NA":5549},{"trials":5540,"activeCount":102},[],{"trials":5542,"activeCount":102},[],{"trials":5544,"activeCount":102},[],{"trials":5546,"activeCount":102},[],{"trials":5548,"activeCount":102},[],{"trials":5550,"activeCount":102},[5551],{"nctId":5528,"briefTitle":5529,"status":419,"phases":5552,"primaryCompletion":503,"completion":501,"start":1531,"enrollment":5531,"conditions":5553,"interventions":5554},[],[5027,5533,5534],[5513,5536],{"intervention":5556,"totalTrials":116,"cells":5557},"Escitalopram",{"EARLY_PHASE1":5558,"PHASE1":5560,"PHASE2":5562,"PHASE3":5564,"PHASE4":5566,"NA":5568},{"trials":5559,"activeCount":102},[],{"trials":5561,"activeCount":102},[],{"trials":5563,"activeCount":102},[],{"trials":5565,"activeCount":102},[],{"trials":5567,"activeCount":102},[],{"trials":5569,"activeCount":102},[5570],{"nctId":5571,"briefTitle":5572,"status":419,"phases":5573,"primaryCompletion":944,"completion":5574,"start":5023,"enrollment":5575,"conditions":5576,"interventions":5577},"NCT07274241","Escitalopram and the Risk of Serious Adverse Events",[],"2025-11-15",12145,[5027,5533,5534],[5556],{"intervention":5579,"totalTrials":116,"cells":5580},"Nortriptyline Hydrochloride",{"EARLY_PHASE1":5581,"PHASE1":5583,"PHASE2":5585,"PHASE3":5587,"PHASE4":5589,"NA":5591},{"trials":5582,"activeCount":102},[],{"trials":5584,"activeCount":102},[],{"trials":5586,"activeCount":102},[],{"trials":5588,"activeCount":102},[],{"trials":5590,"activeCount":102},[],{"trials":5592,"activeCount":102},[5593],{"nctId":5594,"briefTitle":5595,"status":419,"phases":5596,"primaryCompletion":193,"completion":86,"start":5023,"enrollment":5597,"conditions":5598,"interventions":5599},"NCT07527481","Nortriptyline and the Risk of Serious Adverse Events",[],5000,[2416],[5579],{"intervention":5601,"totalTrials":116,"cells":5602},"Macugen",{"EARLY_PHASE1":5603,"PHASE1":5605,"PHASE2":5607,"PHASE3":5609,"PHASE4":5611,"NA":5613},{"trials":5604,"activeCount":102},[],{"trials":5606,"activeCount":102},[],{"trials":5608,"activeCount":102},[],{"trials":5610,"activeCount":102},[],{"trials":5612,"activeCount":102},[],{"trials":5614,"activeCount":102},[5615],{"nctId":5616,"briefTitle":5617,"status":419,"phases":5618,"primaryCompletion":5619,"completion":5619,"start":5620,"enrollment":4354,"conditions":5621,"interventions":5623},"NCT00446381","Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)",[94],"2008-09","2006-10",[5622,5072],"Proliferative Diabetic Retinopathy",[5601,5601],{"intervention":5625,"totalTrials":116,"cells":5626},"6% hydroxyethyl starch",{"EARLY_PHASE1":5627,"PHASE1":5629,"PHASE2":5631,"PHASE3":5633,"PHASE4":5635,"NA":5637},{"trials":5628,"activeCount":102},[],{"trials":5630,"activeCount":102},[],{"trials":5632,"activeCount":102},[],{"trials":5634,"activeCount":102},[],{"trials":5636,"activeCount":102},[],{"trials":5638,"activeCount":102},[5639],{"nctId":5640,"briefTitle":5641,"status":419,"phases":5642,"primaryCompletion":5643,"completion":3590,"start":2302,"enrollment":5644,"conditions":5645,"interventions":5647},"NCT02329158","Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery",[],"2016-04",2000,[5646],"Cardiac Surgical Procedures",[5625],{"intervention":5649,"totalTrials":116,"cells":5650},"Donepezil",{"EARLY_PHASE1":5651,"PHASE1":5653,"PHASE2":5655,"PHASE3":5657,"PHASE4":5659,"NA":5661},{"trials":5652,"activeCount":102},[],{"trials":5654,"activeCount":102},[],{"trials":5656,"activeCount":102},[],{"trials":5658,"activeCount":102},[],{"trials":5660,"activeCount":102},[],{"trials":5662,"activeCount":102},[5663],{"nctId":5664,"briefTitle":5665,"status":419,"phases":5666,"primaryCompletion":2838,"completion":2838,"start":4859,"enrollment":586,"conditions":5667,"interventions":5672},"NCT00934531","Donepezil and the Risk of Falls in Seniors With Cognitive Impairment",[94],[5668,5669,5670,5671],"Falls","Gait","Balance","Mild Cognitive Impairment (MCI)",[5649],{"intervention":5674,"totalTrials":116,"cells":5675},"Citalopram 10 MG",{"EARLY_PHASE1":5676,"PHASE1":5678,"PHASE2":5680,"PHASE3":5682,"PHASE4":5684,"NA":5686},{"trials":5677,"activeCount":102},[],{"trials":5679,"activeCount":102},[],{"trials":5681,"activeCount":102},[],{"trials":5683,"activeCount":102},[],{"trials":5685,"activeCount":102},[],{"trials":5687,"activeCount":102},[5688],{"nctId":5689,"briefTitle":5690,"status":419,"phases":5691,"primaryCompletion":944,"completion":501,"start":5023,"enrollment":5692,"conditions":5693,"interventions":5694},"NCT07399795","Citalopram and the Risk of Serious Adverse Events",[],7110,[5027,5533,5534],[5674,5695],"Citalopram 20 MG",{"intervention":5695,"totalTrials":116,"cells":5697},{"EARLY_PHASE1":5698,"PHASE1":5700,"PHASE2":5702,"PHASE3":5704,"PHASE4":5706,"NA":5708},{"trials":5699,"activeCount":102},[],{"trials":5701,"activeCount":102},[],{"trials":5703,"activeCount":102},[],{"trials":5705,"activeCount":102},[],{"trials":5707,"activeCount":102},[],{"trials":5709,"activeCount":102},[5710],{"nctId":5689,"briefTitle":5690,"status":419,"phases":5711,"primaryCompletion":944,"completion":501,"start":5023,"enrollment":5692,"conditions":5712,"interventions":5713},[],[5027,5533,5534],[5674,5695],{"intervention":4775,"totalTrials":116,"cells":5715},{"EARLY_PHASE1":5716,"PHASE1":5718,"PHASE2":5720,"PHASE3":5722,"PHASE4":5724,"NA":5726},{"trials":5717,"activeCount":102},[],{"trials":5719,"activeCount":102},[],{"trials":5721,"activeCount":102},[],{"trials":5723,"activeCount":102},[],{"trials":5725,"activeCount":102},[],{"trials":5727,"activeCount":102},[5728],{"nctId":4764,"briefTitle":4765,"status":419,"phases":5729,"primaryCompletion":4767,"completion":4768,"start":4769,"enrollment":4770,"conditions":5730,"interventions":5731},[94],[4772],[4717,4774,4775,4740],{"intervention":5733,"totalTrials":116,"cells":5734},"Phenylephrine",{"EARLY_PHASE1":5735,"PHASE1":5737,"PHASE2":5739,"PHASE3":5741,"PHASE4":5743,"NA":5745},{"trials":5736,"activeCount":102},[],{"trials":5738,"activeCount":102},[],{"trials":5740,"activeCount":102},[],{"trials":5742,"activeCount":102},[],{"trials":5744,"activeCount":102},[],{"trials":5746,"activeCount":102},[5747],{"nctId":5748,"briefTitle":5749,"status":419,"phases":5750,"primaryCompletion":5751,"completion":4733,"start":5643,"enrollment":1153,"conditions":5752,"interventions":5755},"NCT02635555","The Effects of Height and Weight Adjusted Dose of Local Anesthetic.",[94],"2019-06",[5753,5754],"Complications; Cesarean Section","Hypotension",[5733],{"intervention":5757,"totalTrials":116,"cells":5758},"Lorazepam",{"EARLY_PHASE1":5759,"PHASE1":5761,"PHASE2":5763,"PHASE3":5765,"PHASE4":5767,"NA":5769},{"trials":5760,"activeCount":102},[],{"trials":5762,"activeCount":102},[],{"trials":5764,"activeCount":102},[],{"trials":5766,"activeCount":102},[],{"trials":5768,"activeCount":102},[],{"trials":5770,"activeCount":102},[5771],{"nctId":5772,"briefTitle":5773,"status":419,"phases":5774,"primaryCompletion":5775,"completion":676,"start":5023,"enrollment":5776,"conditions":5777,"interventions":5778},"NCT07179978","Lorazepam and the Risk of Serious Adverse Events",[],"2024-09-01",12308,[5027],[5757],{"intervention":5780,"totalTrials":116,"cells":5781},"Trazodone HCl",{"EARLY_PHASE1":5782,"PHASE1":5784,"PHASE2":5786,"PHASE3":5788,"PHASE4":5790,"NA":5792},{"trials":5783,"activeCount":102},[],{"trials":5785,"activeCount":102},[],{"trials":5787,"activeCount":102},[],{"trials":5789,"activeCount":102},[],{"trials":5791,"activeCount":102},[],{"trials":5793,"activeCount":102},[5794],{"nctId":5795,"briefTitle":5796,"status":419,"phases":5797,"primaryCompletion":5798,"completion":5799,"start":5023,"enrollment":5800,"conditions":5801,"interventions":5802},"NCT07381101","Trazodone and the Risk of Serious Adverse Events",[],"2025-03-01","2025-03-31",31459,[5027,5026],[5780],{"intervention":452,"totalTrials":116,"cells":5804},{"EARLY_PHASE1":5805,"PHASE1":5807,"PHASE2":5809,"PHASE3":5811,"PHASE4":5813,"NA":5815},{"trials":5806,"activeCount":102},[],{"trials":5808,"activeCount":102},[],{"trials":5810,"activeCount":102},[],{"trials":5812,"activeCount":102},[],{"trials":5814,"activeCount":102},[],{"trials":5816,"activeCount":102},[5817],{"nctId":442,"briefTitle":443,"status":419,"phases":5818,"primaryCompletion":445,"completion":446,"start":447,"enrollment":448,"conditions":5819,"interventions":5820},[94],[450],[87,452],{"intervention":5822,"totalTrials":116,"cells":5823},"Domperidone",{"EARLY_PHASE1":5824,"PHASE1":5826,"PHASE2":5828,"PHASE3":5830,"PHASE4":5832,"NA":5834},{"trials":5825,"activeCount":102},[],{"trials":5827,"activeCount":102},[],{"trials":5829,"activeCount":102},[],{"trials":5831,"activeCount":102},[],{"trials":5833,"activeCount":102},[],{"trials":5835,"activeCount":102},[5836],{"nctId":5837,"briefTitle":5838,"status":419,"phases":5839,"primaryCompletion":1324,"completion":5840,"start":5023,"enrollment":5841,"conditions":5842,"interventions":5843},"NCT07098078","Domperidone and the Risk of Serious Adverse Events",[],"2024-10-30",15000,[5027],[5822],{"intervention":5845,"totalTrials":116,"cells":5846},"Cytochrome P450 2D6 (CYP2D6) genetic screening.",{"EARLY_PHASE1":5847,"PHASE1":5849,"PHASE2":5851,"PHASE3":5853,"PHASE4":5855,"NA":5857},{"trials":5848,"activeCount":102},[],{"trials":5850,"activeCount":102},[],{"trials":5852,"activeCount":102},[],{"trials":5854,"activeCount":102},[],{"trials":5856,"activeCount":102},[],{"trials":5858,"activeCount":102},[5859],{"nctId":5860,"briefTitle":5861,"status":419,"phases":5862,"primaryCompletion":5863,"completion":5863,"start":5864,"enrollment":5865,"conditions":5866,"interventions":5868},"NCT01050400","CYP2D6 Screening for Adverse Drug Reactions to Codeine in Breast Milk",[],"2012-12-31","2009-02-24",330,[5867],"Cytochrome P450 2D6 Ultra-rapid Metabolism",[5845],{"intervention":5870,"totalTrials":116,"cells":5871},"Tamsulosin",{"EARLY_PHASE1":5872,"PHASE1":5874,"PHASE2":5876,"PHASE3":5878,"PHASE4":5880,"NA":5882},{"trials":5873,"activeCount":102},[],{"trials":5875,"activeCount":102},[],{"trials":5877,"activeCount":102},[],{"trials":5879,"activeCount":102},[],{"trials":5881,"activeCount":102},[],{"trials":5883,"activeCount":102},[5884],{"nctId":5885,"briefTitle":5886,"status":419,"phases":5887,"primaryCompletion":5022,"completion":5798,"start":5023,"enrollment":5888,"conditions":5889,"interventions":5890},"NCT07274228","Tamsulosin and the Risk of Serious Adverse Events",[],14000,[5027],[5870],{"intervention":5892,"totalTrials":116,"cells":5893},"General Anesthesia",{"EARLY_PHASE1":5894,"PHASE1":5896,"PHASE2":5898,"PHASE3":5900,"PHASE4":5902,"NA":5904},{"trials":5895,"activeCount":102},[],{"trials":5897,"activeCount":102},[],{"trials":5899,"activeCount":102},[],{"trials":5901,"activeCount":102},[],{"trials":5903,"activeCount":102},[],{"trials":5905,"activeCount":102},[5906],{"nctId":5907,"briefTitle":5908,"status":216,"phases":5909,"primaryCompletion":1602,"completion":1602,"start":5910,"enrollment":697,"conditions":5911,"interventions":5914},"NCT03247998","GA vs. CS for Endovascular Stroke Therapy",[94],"2017-08-31",[26,5912,5913],"Endovascular Repair","Anesthesia",[5892,5915],"Conscious Sedation with Remifentanil",{"intervention":5915,"totalTrials":116,"cells":5917},{"EARLY_PHASE1":5918,"PHASE1":5920,"PHASE2":5922,"PHASE3":5924,"PHASE4":5926,"NA":5928},{"trials":5919,"activeCount":102},[],{"trials":5921,"activeCount":102},[],{"trials":5923,"activeCount":102},[],{"trials":5925,"activeCount":102},[],{"trials":5927,"activeCount":102},[],{"trials":5929,"activeCount":102},[5930],{"nctId":5907,"briefTitle":5908,"status":216,"phases":5931,"primaryCompletion":1602,"completion":1602,"start":5910,"enrollment":697,"conditions":5932,"interventions":5933},[94],[26,5912,5913],[5892,5915],{"intervention":5935,"totalTrials":116,"cells":5936},"5ARI",{"EARLY_PHASE1":5937,"PHASE1":5939,"PHASE2":5941,"PHASE3":5943,"PHASE4":5945,"NA":5947},{"trials":5938,"activeCount":102},[],{"trials":5940,"activeCount":102},[],{"trials":5942,"activeCount":102},[],{"trials":5944,"activeCount":102},[],{"trials":5946,"activeCount":102},[],{"trials":5948,"activeCount":102},[5949],{"nctId":5950,"briefTitle":5951,"status":419,"phases":5952,"primaryCompletion":1909,"completion":5953,"start":5954,"enrollment":5955,"conditions":5956,"interventions":5959},"NCT02876757","5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression",[],"2017-03","2003-01",186394,[5957,20,5958],"BPH","Suicide",[5935],{"intervention":5961,"totalTrials":116,"cells":5962},"Prednisolone and prednisone",{"EARLY_PHASE1":5963,"PHASE1":5965,"PHASE2":5967,"PHASE3":5969,"PHASE4":5971,"NA":5973},{"trials":5964,"activeCount":102},[],{"trials":5966,"activeCount":102},[],{"trials":5968,"activeCount":102},[],{"trials":5970,"activeCount":102},[],{"trials":5972,"activeCount":102},[],{"trials":5974,"activeCount":102},[5975],{"nctId":5976,"briefTitle":5977,"status":419,"phases":5978,"primaryCompletion":5979,"completion":5979,"start":5980,"enrollment":697,"conditions":5981,"interventions":5983},"NCT01260623","Pilot Study of How Children With Asthma Exacerbations Metabolize Prednisone",[],"2013-05-31","2009-09-09",[5982],"Asthma Exacerbation",[5961],{"intervention":5985,"totalTrials":116,"cells":5986},"100 mL of 0.9% normal saline",{"EARLY_PHASE1":5987,"PHASE1":5989,"PHASE2":5991,"PHASE3":5993,"PHASE4":5995,"NA":5997},{"trials":5988,"activeCount":102},[],{"trials":5990,"activeCount":102},[],{"trials":5992,"activeCount":102},[],{"trials":5994,"activeCount":102},[],{"trials":5996,"activeCount":102},[],{"trials":5998,"activeCount":102},[5999],{"nctId":6000,"briefTitle":6001,"status":216,"phases":6002,"primaryCompletion":2253,"completion":2254,"start":2255,"enrollment":6003,"conditions":6004,"interventions":6008},"NCT05908851","Perioperative Pain Management for Total Shoulder Arthroplasty: A Pilot Non-Inferiority Trial",[94],80,[6005,6006,6007],"Shoulder Arthritis","Anesthesia, Local","Local Infiltration",[5985],{"intervention":6010,"totalTrials":116,"cells":6011},"Ibuprofen Regular Dosing",{"EARLY_PHASE1":6012,"PHASE1":6014,"PHASE2":6016,"PHASE3":6018,"PHASE4":6020,"NA":6022},{"trials":6013,"activeCount":102},[],{"trials":6015,"activeCount":102},[],{"trials":6017,"activeCount":102},[],{"trials":6019,"activeCount":102},[],{"trials":6021,"activeCount":102},[],{"trials":6023,"activeCount":102},[6024],{"nctId":6025,"briefTitle":6026,"status":419,"phases":6027,"primaryCompletion":1342,"completion":1342,"start":4351,"enrollment":448,"conditions":6028,"interventions":6030},"NCT01092676","Regular vs Intermittent Dose Ibuprofen for the Treatment of Ankle Sprains in Children",[94],[1233,6029],"Ankle Injuries",[6010,6031],"PRN dosing Ibuprofen",{"intervention":6031,"totalTrials":116,"cells":6033},{"EARLY_PHASE1":6034,"PHASE1":6036,"PHASE2":6038,"PHASE3":6040,"PHASE4":6042,"NA":6044},{"trials":6035,"activeCount":102},[],{"trials":6037,"activeCount":102},[],{"trials":6039,"activeCount":102},[],{"trials":6041,"activeCount":102},[],{"trials":6043,"activeCount":102},[],{"trials":6045,"activeCount":102},[6046],{"nctId":6025,"briefTitle":6026,"status":419,"phases":6047,"primaryCompletion":1342,"completion":1342,"start":4351,"enrollment":448,"conditions":6048,"interventions":6049},[94],[1233,6029],[6010,6031],{"intervention":6051,"totalTrials":116,"cells":6052},"Indomethacin and Pantoprazole",{"EARLY_PHASE1":6053,"PHASE1":6055,"PHASE2":6057,"PHASE3":6059,"PHASE4":6061,"NA":6063},{"trials":6054,"activeCount":102},[],{"trials":6056,"activeCount":102},[],{"trials":6058,"activeCount":102},[],{"trials":6060,"activeCount":102},[],{"trials":6062,"activeCount":102},[],{"trials":6064,"activeCount":102},[6065],{"nctId":6066,"briefTitle":6067,"status":216,"phases":6068,"primaryCompletion":2411,"completion":2411,"start":1343,"enrollment":5172,"conditions":6069,"interventions":6071},"NCT01744314","Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma",[94],[6070],"Elbow Trauma Requiring Operative Management",[6051,6072],"microcrystalline cellulose powder",{"intervention":6072,"totalTrials":116,"cells":6074},{"EARLY_PHASE1":6075,"PHASE1":6077,"PHASE2":6079,"PHASE3":6081,"PHASE4":6083,"NA":6085},{"trials":6076,"activeCount":102},[],{"trials":6078,"activeCount":102},[],{"trials":6080,"activeCount":102},[],{"trials":6082,"activeCount":102},[],{"trials":6084,"activeCount":102},[],{"trials":6086,"activeCount":102},[6087],{"nctId":6066,"briefTitle":6067,"status":216,"phases":6088,"primaryCompletion":2411,"completion":2411,"start":1343,"enrollment":5172,"conditions":6089,"interventions":6090},[94],[6070],[6051,6072],{"intervention":6092,"totalTrials":116,"cells":6093},"Moxifloxacin 0.5%",{"EARLY_PHASE1":6094,"PHASE1":6096,"PHASE2":6098,"PHASE3":6100,"PHASE4":6102,"NA":6104},{"trials":6095,"activeCount":102},[],{"trials":6097,"activeCount":102},[],{"trials":6099,"activeCount":102},[],{"trials":6101,"activeCount":102},[],{"trials":6103,"activeCount":102},[],{"trials":6105,"activeCount":102},[6106],{"nctId":6107,"briefTitle":6108,"status":419,"phases":6109,"primaryCompletion":3519,"completion":3519,"start":4858,"enrollment":2637,"conditions":6110,"interventions":6112},"NCT01577342","Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora",[94],[6111],"Age-Related Macular Degeneration",[6092],{"intervention":6114,"totalTrials":116,"cells":6115},"Connectivity-based neurofeedback",{"EARLY_PHASE1":6116,"PHASE1":6118,"PHASE2":6120,"PHASE3":6122,"PHASE4":6124,"NA":6126},{"trials":6117,"activeCount":102},[],{"trials":6119,"activeCount":102},[],{"trials":6121,"activeCount":102},[],{"trials":6123,"activeCount":102},[],{"trials":6125,"activeCount":102},[],{"trials":6127,"activeCount":102},[6128],{"nctId":6129,"briefTitle":6130,"status":825,"phases":6131,"primaryCompletion":755,"completion":755,"start":6132,"enrollment":102,"conditions":6133,"interventions":6136},"NCT04875221","Network-based Neurofeedback in PTSD",[94],"2023-10-01",[6134,6135],"PTSD","Post-traumatic Stress Disorder",[6114]]